vancomycin has been researched along with daptomycin in 635 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 35 (5.51) | 18.7374 |
| 1990's | 34 (5.35) | 18.2507 |
| 2000's | 124 (19.53) | 29.6817 |
| 2010's | 359 (56.54) | 24.3611 |
| 2020's | 83 (13.07) | 2.80 |
| Authors | Studies |
|---|---|
| Fenoll, A; López de Felipe, F; Martínez-Suárez, JV; Rodríguez-Tudela, JL | 1 |
| Eliopoulos, GM; Moellering, RC; Thauvin-Eliopoulos, C | 1 |
| Hanberger, H | 1 |
| Nishino, T | 1 |
| Bailey, EM; Kaatz, GW; Lamp, KC; Rybak, MJ | 2 |
| Handwerger, S; Mildvan, D; Shonekan, D | 1 |
| Bayer, AS; Eliopoulos, GM; Grayson, ML; Ramos, MC | 1 |
| Chin, NX; Neu, HC; Niu, WW | 1 |
| Brumfitt, W; Hamilton-Miller, JM | 1 |
| Neu, HC; Niu, WW | 1 |
| Courvalin, P; Derlot, E | 1 |
| Hanberger, H; Isaksson, B; Maller, R; Nilsson, LE | 1 |
| Tawfik, AF | 1 |
| Bingen, E; Bourgeois, F; Doit, C; Lambert-Zechovsky, N; Mariani-Kurkdjian, P; Petitjean, O; Tod, M | 1 |
| Garau, J; Lite, J; Ortega, L | 1 |
| Bartoloni, A; Colao, MG; Dei, R; Giganti, E; Orsi, A; Parenti, F | 1 |
| Kuechle, DK; Landon, GC; Musher, DM; Noble, PC | 1 |
| Chambers, HF | 1 |
| Garrison, MW; Larson, TA; Rotschafer, JC; Toscano, JP; Vance-Bryan, K | 1 |
| Avent, K; Cobbs, G; Dill, R; Graves, A; Lyon, D; Smith, K | 1 |
| Bailey, EM; Kaatz, GW; Reddy, VN; Rybak, MJ; Seo, SM | 1 |
| Bingen, E; Doit, C; Lambert-Zechovsky, N; Leclercq, R; Mariani-Kurkdjian, P | 1 |
| Bille, J; Cantoni, L; Glauser, MP | 1 |
| Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR; Sinn, LM | 1 |
| Beauchamp, D; Bergeron, MG; Gourde, P; Pellerin, M; Pettigrew, M | 1 |
| Haworth, CS; Park, TS; Scheld, WM; Sobieski, MW | 1 |
| Fontana, R; Grossato, A; Ligozzi, M; Tonin, EA | 1 |
| Gristina, A; Myrvik, QN; Naylor, PT | 1 |
| Low, DE; McGeer, A; Poon, R | 1 |
| Cordin, X; Duez, JM; Kazmierczak, A; Péchinot, A; Siébor, E | 1 |
| Adams, K; Mader, JT | 1 |
| Eliopoulos, GM; Moellering, RC; Yao, JD | 1 |
| Lentino, JR; Strodthman, R | 1 |
| Buxton, TB; Luu, QN; Nelson, DR; Rissing, JP | 1 |
| Blenkharn, JI; Darrell, JH | 1 |
| Caillon, J; Drugeon, HB; Juvin, ME; Pirault, JL | 1 |
| de la Maza, L; Ferraro, MJ; Ruoff, KL | 1 |
| Clarke, B; Gilmore, MS; Kissinger, J; Mulder, R; Murray, PR; Sahm, DF; Solliday, J | 1 |
| Van der Auwera, P | 1 |
| Liu, C; Stratton, CW; Weeks, LS | 1 |
| Liu, C; Ratner, HB; Stratton, CW; Weeks, LS | 1 |
| Chang, TW; Dong, MY; Gorbach, SL | 1 |
| Beaudette, F; Benson, CA; Trenholm, G | 1 |
| Pohlod, DJ; Saravolatz, LD; Somerville, MM | 1 |
| Archer, GL; Coudron, PE; Johnston, JL | 1 |
| Greenwood, D; Palfreyman, J | 1 |
| Peters, G; Pulverer, G; Schumacher-Perdreau, F | 1 |
| Lindmark, A; Nord, CE; Persson, I | 2 |
| Bemis, AT; Norton, JA; Reynolds, J; Smith, JW; Treger, T; Wheat, LJ | 1 |
| Canawati, HN; Ginunas, VJ; Montgomerie, JZ; Sapico, FL | 1 |
| Esposito, AL; Kephart, PA | 1 |
| Carret, G; Fardel, G; Flandrois, JP | 1 |
| Cheng, N; Chow, AW | 1 |
| Carret, G; Flandrois, JP; Peyret, M; Pichat, C | 1 |
| Garrison, MW; Rodvold, KA; Rotschafer, JC | 1 |
| Knapp, CC; Washington, JA | 1 |
| Verbist, L | 1 |
| Gilligan, PH; Hodinka, RL; Jack-Wait, K; Walden, TP; Wannamaker, N | 1 |
| Jorgensen, JH; Maher, LA; Redding, JS | 1 |
| Braveny, I; Machka, K | 1 |
| Eliopoulos, GM; Karchmer, AW; Moellering, RC; Spitzer, PG | 1 |
| Low, DE; Poon, R | 1 |
| Landman, D; Mobarakai, N; Quale, JM | 1 |
| Broeders, PH; Goessens, WH; Kuyvenhoven, J; Michel, MF; Schmal-Bauer, WC; Thompson, J; Voorn, GP | 1 |
| Marone, P; Monzillo, V; Navarra, A; Perversi, L; Sartirana, E | 1 |
| Garcia, R; Raad, I | 1 |
| Grucz, RG; Hershberger, E; Moldovan, T; Rybak, MJ | 1 |
| Akins, RL; Rybak, MJ | 2 |
| Barry, AL; Brown, SD; Fuchs, PC | 2 |
| Boyce, JM; Jacobus, NV; Lonks, JR; McDermott, LA; Snydman, DR | 1 |
| King, A; Phillips, I | 1 |
| Saxén, H; Vaara, M | 1 |
| Citron, DM; Fernandez, HT; Goldstein, EJ; Merriam, CV; Tyrrell, KL; Warren, YA | 2 |
| Bisognano, C; Francois, P; Lew, DP; Li, D; Schrenzel, J; Vaudaux, P | 1 |
| Alder, J; Laganas, V; Silverman, JA | 1 |
| Cha, R; Rybak, MJ | 1 |
| Hermsen, ED; Hotchkiss, JR; Hovde, LB; Rotschafer, JC | 1 |
| Arbeit, RD; Campanaro, E; Eisenstein, BI; Maki, D; Tally, FP | 1 |
| Lundstrom, TS; Sobel, JD | 1 |
| Acosta, F; Cottagnoud, M; Cottagnoud, P; Flatz, L; Kühn, F; Müller, HP; Pfister, M; Stucki, A | 1 |
| LaPlante, KL; Rybak, MJ | 2 |
| Hall, EW; Hanssen, AD; Jacofsky, DJ; Osmon, DR; Patel, R; Rouse, MS; Steckelberg, JM | 1 |
| Lipsky, BA; Stoutenburgh, U | 1 |
| Lehn, N; Naber, KG; Wagenlehner, FM; Witte, W | 1 |
| Rybak, MJ; Tsuji, BT | 1 |
| Donskey, CJ; Pultz, NJ; Stiefel, U | 1 |
| Jacobson, M; Jacofsky, DJ; Patel, R; Piper, KE; Rouse, MS; Steckelberg, JM | 1 |
| Acosta, F; Cottagnoud, M; Cottagnoud, P; Gerber, P; Stucki, A | 1 |
| Cui, L; Hiramatsu, K; Neoh, HM; Tominaga, E | 1 |
| Allen, SE; Mercier, RC; Pai, MP | 1 |
| Alder, J; Eliopoulos, GM; Moellering, RC; Sakoulas, G; Thauvin-Eliopoulos, C | 1 |
| Bento, M; Lew, DP; Schaad, HJ; Vaudaux, P | 1 |
| Hageman, J; Jevitt, LA; McDonald, LC; Patel, JB; Tenover, FC | 1 |
| Antony, SJ | 1 |
| English, BK; Maryniw, EM; Meals, EA; Talati, AJ | 1 |
| Fritsche, TR; Jones, RN; Sader, HS | 1 |
| Jones, RN; Mariani, PG; Sader, HS | 1 |
| Jones, RN; Sader, HS | 2 |
| Abrutyn, E; Bernstein, JM; Boucher, HW; Brodt, HR; Cabell, CH; Chambers, HF; Cook, P; Corey, GR; Cosgrove, SE; DeMeyer, I; Fätkenheuer, G; Filler, SG; Forrest, GN; Fowler, VG; Gareca, M; Karchmer, AW; Levine, DP; Link, AS; Parsonnet, J; Price, CS; Rehm, SJ; Rupp, ME; Tally, FP; Tice, A; Vigliani, GA; Zervos, M | 1 |
| Brown, KR; Edmiston, CE; Goheen, MP; Johnson, CP; Lewis, BD; Seabrook, GR; Towne, JB | 1 |
| Fraser, TG; Hansen, C; Long, JK | 1 |
| Anasetti, C; Green, MR; Greene, JN; Rolfe, NE; Sandin, RL | 1 |
| Firsov, AA; Lubenko, IY; Portnoy, YA; Smirnova, MV; Vostrov, SN; Zinner, SH | 1 |
| Entenza, JM; Giddey, M; Moreillon, P; Vouillamoz, J | 1 |
| MacGowan, AP; Walsh, TR; Wootton, M | 1 |
| Siegman-Igra, Y; Talan, DA | 1 |
| Caballero-Granado, FJ; Canueto, J; Torres-Tortosa, M | 1 |
| Brauers, J; Kresken, M; Menke, A; Morrissey, I; Orland, A; Weiher, H | 1 |
| Firsov, AA; Lubenko, IY; Portnoy, YA; Smirnova, MV; Zinner, SH | 1 |
| Draghi, DC; Goldstein, BP; Hogan, P; Sahm, DF; Sheehan, DJ | 1 |
| Baltch, AL; Bopp, LH; Michelsen, PB; Ritz, WJ; Smith, RP | 1 |
| Houck, HJ; Rand, KH; Silverman, JA | 1 |
| LaPlante, KL; Mermel, LA | 1 |
| Eliopoulos, GM; Gold, HS; Moellering, RC; Pillai, SK; Sakoulas, G; Wennersten, C | 1 |
| Aguilar, L; Alou, L; Cafini, F; Giménez, MJ; González, N; Prieto, J; Sevillano, D; Torrico, M; Vallejo, P | 1 |
| Kaatz, GW; Rose, WE; Rybak, MJ; Sakoulas, G; Tsuji, BT | 1 |
| Bronze, MS; Greenfield, RA; Hoffman-Roberts, HL; Obritsch, MD | 1 |
| Manfredi, R | 1 |
| Bell, JM; Biedenbach, DJ; Fritsche, TR; Jones, RN; Sader, HS; Turnidge, JD | 1 |
| Chambers, HF; Hegde, SS | 1 |
| Carleton, HA; Chambers, HF; Graber, CJ; Haller, BL; Perdreau-Remington, F; Wong, MK | 1 |
| Mergenhagen, KA; Pasko, MT | 1 |
| Graninger, W; Hirschl, AM; Kratzer, C; Presterl, E; Rabitsch, W | 1 |
| Alder, JD; Mascio, CT; Silverman, JA | 1 |
| Jenkins, I | 1 |
| Carpenter, CF; Kaatz, GW; Leonard, SN; Rose, WE; Rybak, MJ; Sakoulas, G; Sheth, A; Zervos, MJ | 1 |
| Anstead, GM; Lewis, JS; Quinones-Nazario, G | 1 |
| Loffler, CA; Macdougall, C | 1 |
| Holmes, RL; Jorgensen, JH | 1 |
| Davis, SL; Delgado, G; Hall, LM; McKinnon, PS; Rose, W; Rybak, MJ; Wilson, RF | 1 |
| Hsueh, PR; Huang, YT; Liao, CH; Teng, LJ | 1 |
| Kollef, MH; Micek, ST; Skrupky, LP | 1 |
| Cosgrove, SE; Fowler, VG | 1 |
| Bennett, JW; Holmes, RL; Jorgensen, JH; Murray, CK; Patterson, JE | 1 |
| Guglielmo, BJ; Ngo, PD; Schwartz, BS | 1 |
| Montero, CI; Murray, PR; Stock, F | 1 |
| Hsiao, CH; Hsueh, PR; Huang, YT; Lee, CW; Liao, CH | 1 |
| Andes, DR; Craig, WA; LaPlante, KL; Leonard, SN; Rybak, MJ | 1 |
| Almela, M; Amat, E; Armero, Y; de la Mària, CG; del Río, A; Gatell, JM; Jiménez de Anta, MT; Marco, F; Mestres, CA; Miró, JM; Moreno, A; Soy, D | 1 |
| Aguilar, L; Barberán, J; Giménez, M; Prieto, J | 1 |
| Aguilar, L; Alou, L; Giménez, MJ; Sevillano, D; Torrico, M | 1 |
| Cheung, CM; Leonard, SN; Rybak, MJ | 1 |
| Brewer, J; Bulchandani, D; Fitzsimmons, C; Jost, P; Nachnani, J | 1 |
| Fowler, VG; Luperchio, SA; McCalla, C; Moise, PA; Robinson, DA; Sakoulas, G; Smyth, DS; Steenbergen, J | 1 |
| Chou, NK; Hsueh, PR; Kuo, CC; Tsai, CW; Wang, SS; Wu, V | 1 |
| Appelbaum, PC; Julian, K; Kosowska-Shick, K; Lemaire, S; Tulkens, PM; Van Bambeke, F | 1 |
| Abrutyn, E; Boucher, H; Campion, M; Corey, GR; Eisenstein, BI; Levine, D; Rehm, SJ; Vigliani, GA | 1 |
| Hsueh, PR; Huang, YT; Kuo, CC; Liao, CH; Wu, VC | 1 |
| Stein, RA | 1 |
| Camargo, IL; Cui, L; Hiramatsu, K; Neoh, HM | 1 |
| Evans, RP; Haggard, WO; McLaren, SG; Smeltzer, MS; Weiss, BD; Weiss, EC | 1 |
| Leonard, SN; Rybak, MJ | 1 |
| Decker, CF; Johnson, MD | 1 |
| Gonzalez-Ruiz, A; Richardson, J | 1 |
| Manzur, A; Pujol, M; Suárez, C; Tubau, F | 1 |
| Cunha, BA; Pherez, FM | 1 |
| Beltrand, E; Fayad, G; Legout, L; Leroy, O; Senneville, E | 1 |
| Sakoulas, G | 1 |
| Rolston, KV | 1 |
| Abrutyn, E; Boucher, HW; Chambers, HF; Corey, GR; Cosgrove, SE; Fowler, VG; Karchmer, AW; Levine, DP; Rupp, ME; Vigliani, GA | 1 |
| Bernardo, P; Biermann, EJ; Donfrid, B; Eisenstein, BI; Link, AS; Martone, WJ; Pertel, PE | 1 |
| Brown, SD; Katz, BD; Steenbergen, JN; Traczewski, MM | 1 |
| Alexandre, SS; Huang, V; McGowan, JE; Segal, RE; Sinner, SW; Tenover, FC; Weinstein, MP | 1 |
| Abu-Alfa, AK; Brewster, UC; Hall, I; Huen, SC; Mahnensmith, RL; Topal, J | 1 |
| Daily, SJ; Smeltzer, MS; Spencer, HJ; Weiss, BD; Weiss, EC | 1 |
| Arav-Boger, R; Carroll, KC; Jacobson, LM; Milstone, AM; Zenilman, J | 1 |
| Acosta, F; Cottagnoud, M; Cottagnoud, P; Egermann, U; Gerber, P; Ramin, A; Stanga, Z; Stucki, A | 1 |
| Graninger, W; Hajdu, S; Hirschl, AM; Lassnigg, A; Presterl, E | 1 |
| Jones, RN; Rhomberg, PR; Sader, HS | 1 |
| Kang, CI; Mook-Kanamori, BB; Patel, R; Rouse, MS; Steckelberg, JM; van de Beek, D | 1 |
| Graninger, W; Hajdu, S; Hirschl, AM; Holinka, J; Lassnigg, AM; Presterl, E | 1 |
| Kaiser, GM; Mathe, Z; Paul, A; Rath, PM; Saner, FH; Treckmann, J; Vernadakis, S | 1 |
| Back, MR; Bandyk, DF; Heller, L; Johnson, BL; Keeling, WB; Myers, AR; Shames, ML; Stone, PA; Widen, R | 1 |
| LaPlante, KL; Woodmansee, S | 1 |
| Al Laham, N; Tsuji, BT; von Eiff, C; Wu, M | 1 |
| LaPlante, KL; Sakoulas, G | 1 |
| Ambrose, PG; Bhavnani, SM; Hammel, JP; Prakhya, A | 1 |
| Fey, PD; Fish, DN; Jones, RN; Limaye, AP; Madinger, N; Pankey, G; Rahal, J; Rybak, MJ; Sader, HS; Snydman, DR; Steed, LL; Waites, K | 1 |
| Bruss, JB | 1 |
| Bilal, M; Cleveland, KO; Gelfand, MS | 1 |
| Boucher, HW; Campion, M; Corey, GR; Fowler, VG; Kanafani, ZA; Katz, DE; Kourany, WM; Levine, DP; Vigliani, GA | 1 |
| Jones, RN; Rossi, KL; Rybak, MJ; Sader, HS | 1 |
| Bowker, KE; MacGowan, AP; Noel, AR | 1 |
| Carson, RT; Friedman, M; Marton, JP; Menzin, J; Meyers, JL; Rothermel, CD | 1 |
| Eliopoulos, GM; Karchmer, AW; Moellering, RC; Pillai, SK; Venkataraman, L; Wennersten, C | 1 |
| Moise, PA; North, D; Sakoulas, G; Steenbergen, JN | 1 |
| Bonafede, M; Evans, A; Ferro, S; Harrington, S; Lodise, TP; Lubanski, P; Patel, N; Stellrecht, K | 1 |
| Nailor, MD; Sobel, JD | 1 |
| Basuino, L; Bauer, D; Chambers, HF; Diep, BA; Tattevin, P | 1 |
| Aguilar, L; Alou, L; Cafini, F; Cleeland, R; Giménez, MJ; González, N; Prieto, J; Sevillano, D; Torrico, M | 2 |
| Golden, M; Havill, N; Shaib, W | 1 |
| Ellermann-Eriksen, S; Kristensen, L; Rathe, M; Schumacher, H; Thomsen, MK | 1 |
| Bossaer, JB; Garrett-Mayer, E; Hall, PD | 1 |
| Becker, HK; Jones, RN; Moet, GJ; Sader, HS | 1 |
| Betriu, C; Culebras, E; Gómez, M; López-Fabal, F; Morales, G; Picazo, JJ; Rodríguez-Avial, I | 1 |
| Dambrot, C; Dogterom-Ballering, HC; Kruithof, S; Nibbering, PH; van der Plas, MJ; van Dissel, JT | 1 |
| Appleman, MD; Citron, DM | 1 |
| Leonard, SN; Rybak, MJ; Vidaillac, C | 1 |
| Janechek, MJ; Jones, RN; Mendes, RE; Moet, GJ | 1 |
| Johnson, L; Pawlak, J; Saravolatz, L | 1 |
| Almela, M; Armero, Y; Cervera, C; del Río, A; Falces, C; García-de-la-Mària, C; Gatell, JM; Jiménez de Anta, MT; Marco, F; Mestres, CA; Miró, JM; Moreno, A; Ninot, S; Soy, D | 1 |
| Hennenfent, J; Lambert, BL; McBride, MV; Rodvold, KA; Schiff, G; Schumock, GT; Trese, AM; Tverdek, F; Yang, Y | 1 |
| Bumgardner, JD; Courtney, HS; Haggard, WO; Smeltzer, MS; Smith, JK | 1 |
| Brinch, KS; Frimodt-Møller, N; Høiby, N; Kristensen, HH; Tulkens, PM; Van Bambeke, F | 1 |
| Crompton, JA; Forrest, GN; Lamp, KC; North, DS; Steenbergen, JN; Yoon, M | 1 |
| Burillo, A; Gil, Y; Gómez-Garcés, JL; López-Fabal, F | 1 |
| Bandettini, R; Castagnola, E; Caviglia, I; Lorenzi, I; Macrina, G; Tacchella, A | 1 |
| Cheung, CM; Leuthner, KD; Rybak, MJ; Vidaillac, C | 1 |
| Ali, A; James, C; Lawson, S; Mary, E; Modak, A; Patrick, S | 1 |
| Graninger, W; Hajdu, S; Hirschl, AM; Holinka, J; Presterl, E; Reichmann, S | 1 |
| Parra-Ruiz, J; Rose, WE; Rybak, MJ; Vidaillac, C | 1 |
| Barsić, B; Bukovski-Simonoski, S; Pangercić, A | 1 |
| Fey, PD; Olson, ME; Rupp, ME; Slater, SR | 1 |
| Daurel, C; Leclercq, R | 1 |
| Camargo, IL; Cui, L; Fukuda, M; Hiramatsu, K; Hishinuma, T; Isii, T; Neoh, HM; Ochiai, T; Shoji, M; Watanabe, Y | 1 |
| Amador, G; Asseray, N; Caillon, J; Jacqueline, C; Le Mabecque, V; Lefebvre, M; Miegeville, A; Potel, G | 1 |
| Beisser, PS; Croes, S; Deurenberg, RH; Neef, C; Stobberingh, EE; Terporten, PH | 1 |
| Conejo, Mdel C; García, I; Ojeda, A; Pascual, A; Rodríguez-Baño, J | 1 |
| Ariza, J; Cabellos, C; Cabo, J; Euba, G; Garrigós, C; Murillo, O; Tubau, F; Verdaguer, R | 1 |
| Aleo, A; Bonura, C; Calà, C; di Carlo, P; Mammina, C; Monastero, R; Palma, DM | 1 |
| Levy, F; Peterson, SM; Reynolds, SA; Sarubbi, FA; Shams, W; Walker, ES | 1 |
| Aslanzadeh, J; Keel, RA; Kuti, JL; Nicolau, DP; Sutherland, CA | 1 |
| Benadda, S; Chau, F; Dubée, V; Fantin, B; Lefort, A | 1 |
| Brown-Driver, V; Conrad, M; Finn, J; G C, K; Haselbeck, RJ; Rubio, A; Silverman, JA | 1 |
| Nau, GJ; Potoski, BA; Sheridan, KR; Shields, RK | 1 |
| Bookstaver, PB; Hashem, MG; Iqbal, R; James, CL; Le, J; Rudisill, CN; Sakoulas, G | 1 |
| Farrell, DJ; Love, WG; Rhys-Williams, W; Robbins, M | 1 |
| Derendorf, H; Estes, KS | 1 |
| Dryden, M; Eckmann, C | 1 |
| Gosbell, IB; Paterson, DL; van Hal, SJ | 1 |
| Bogard, KN; Erwin, MW; Fuller, PD; Olsen, KM; Peterson, NT; Plumb, TJ | 1 |
| Aguirre, CA; English, BK; Lazar, L; Meals, E; Rayburn, MS; Shapley, RK; Spentzas, T; Walker, BS | 1 |
| Diagre, D; Hussain, Z; John, MA; Milburn, S; Stuart, JI; Wilson, B | 1 |
| Cauda, R; Esposito, S; Garau, J; Gould, IM; Gudiol, F; Mazzei, T | 1 |
| Rybak, MJ; Steed, ME; Vidaillac, C | 2 |
| Fitzgibbons, LN; Forrest, GN; Mackay, K; Puls, DL | 1 |
| Danesi, R; Di Paolo, A; Ferrari, M; Lambelet, P; Menichetti, F; Polillo, M; Tascini, C | 1 |
| Balsam, AR; Boulware, DR; Boyle-Vavra, S; Daum, RS; Devries, A; Gourley, BL; Holmes, M; Jawahir, S; Jones, M; Kline, S; Peterson, SN; Ruf, R | 1 |
| Fantin, B; Grohs, P; Gutmann, L; Lefort, A; Mainardi, JL; Wolff, M | 1 |
| Gao, W; Howden, BP; Kelley, PG; Ward, PB | 1 |
| Amaya-Villar, R; de la Torre, MV; Garnacho-Montero, J; Gómez-Grande, ML; Jerez, V; Lorente-Ramos, L; Loza, A; Martínez, A; Ortiz, C; Pomares, J; Pozo, JC; Sierra, R | 1 |
| Armitige, LY; Dundas, NE; Kruzel, MC; Lewis, CT; Lewis, EM; Mohr, JF; Wanger, A; Welsh, KJ | 1 |
| Barberán, J | 1 |
| Cercenado, E | 1 |
| Brescini, L; Cirioni, O; Dawgul, M; Ghiselli, R; Giacometti, A; Guerrieri, M; Kamysz, W; Myszka, H; Orlando, F; Silvestri, C | 1 |
| Gould, IM | 1 |
| Chang, SC; Chen, YC; Kao, TM; Wang, JT; Weng, CM | 1 |
| Gray, JW; Patel, M | 1 |
| Fajardo Olivares, M; Hidalgo Orozco, R; Robles Marcos, M; Rodríguez Garrido, S; Rodríguez-Vidigal, FF; Vera Tomé, A | 1 |
| Bicking, K; Desai, S; King, EA; McCoy, D; Nyirenda, T | 1 |
| Biek, D; Costello, AJ; Critchley, IA; Diekema, DJ; Doern, GV; Dohrn, CL; Heilmann, KP; Kroeger, JS; Riahi, F; Richter, SS | 1 |
| Arya, A; Bertolami, S; Chen, L; Li, T; Mortin, LI; Van Praagh, AD; Zhang, S; Zhang, XX | 1 |
| Bayer, AS; Chen, L; Kreiswirth, BN; McKinnell, J; Mishra, NN; Nast, CC; Rubio, A; Yeaman, MR | 1 |
| Hartmann, B; Keller, F; Maus, S; Rothermund, L | 1 |
| Kaatz, GW; Rose, WE; Rybak, MJ; Steed, ME; Vidaillac, C; Winterfield, P | 1 |
| Farrell, DJ; Jones, RN; Sader, HS | 1 |
| Betrisey, B; Corvec, S; Furustrand Tafin, U; Majic, I; Trampuz, A; Zalila Belkhodja, C; Zimmerli, W | 1 |
| Crémieux, AC; Dinh, A; Massias, L; Muller-Serieys, C; Saleh-Mghir, A | 1 |
| Cleveland, KO; Gelfand, MS; Twilla, JD; Usery, JB | 1 |
| Cleveland, KO; Gelfand, MS; Holloway, K; King, ST; Koeth, L; Usery, JB | 1 |
| Chang, Y; Chen, DW; Chen, WC; Hsieh, PH; Lee, MS; Shih, HN; Ueng, SW | 1 |
| Açıkgöz, ZC; Celikbilek, N; Güner, HR; Gürelik, FC; Güvenman, S; Ozdem, B | 1 |
| Sancak, B | 1 |
| Cuervo, J; Gil-Parrado, S; Grau, S; Rebollo, P | 1 |
| Budin, G; Chung, HJ; Issadore, D; Lee, H; Liong, M; Min, C; Reiner, T; Weissleder, R | 1 |
| Chaves, RL; Fierlbeck, G; Loeffler, J; Quist, SR; Seaton, RA | 1 |
| Eskandarian, R; Jobson, S; Moise, PA | 1 |
| Baig, W; Lowe, E; Patel, PA; Sandoe, J | 1 |
| Kelesidis, T | 1 |
| Broyles, JE; Finch, CK; Gelfand, MS; Hudson, JQ; Twilla, JD; Usery, JB | 1 |
| Allen, DL; Bell, J; Bennett-Wood, V; Chua, K; Coombs, G; Davies, JK; Gao, W; Harrison, PF; Howden, BP; McEvoy, CR; Porter, JL; Robins-Browne, R; Seemann, T; Stinear, TP | 1 |
| Boucher, HW; Weston, A | 2 |
| Donabedian, S; Haque, NZ; Moore, CL; Osaki-Kiyan, P; Perri, MB; Zervos, MJ | 1 |
| Docobo-Pérez, F; Domínguez-Herrera, J; Lepe, JA; López-Rojas, R; Pachón, J; Pichardo, C; Ruiz-Valderas, R | 1 |
| Bayer, AS; Mishra, NN; Moise, PA; Nizet, V; Pogliano, J; Sakoulas, G; Tsuji, BT; Yang, SJ; Yeaman, MR | 1 |
| Lenoble, M | 1 |
| Cook, I; Edwards, B; Gould, IM; Lawes, T; Milne, K; Robb, A | 1 |
| Akid, R; Banerjee, RD; Dodds, S; Nichol, T; Smith, TJ; Stephenson, J; Stockley, I; Townsend, R | 1 |
| Bankowski, MJ; Bello, EF; Chaiwongkarjohn, S; Koyamatsu, T; Pramyothin, P; Seifried, SE; Suwantarat, N | 1 |
| Abbanat, D; Amsler, K; Barron, AM; Fernandez, J; Flamm, RK; Hastings, J; He, W; Lynch, AS; Melton, JL; Queenan, AM; Shang, W | 1 |
| Bertuccio, T; Cafiso, V; Campanile, F; Di Pietro, C; Purrello, M; Purrello, S; Spina, D; Stefani, S | 1 |
| Citron, DM; Goldstein, EJ; Tyrrell, KL; Warren, YA | 1 |
| Betriu, C; Canut, A; Gascón, AR; Isla, A | 1 |
| Bourcier, T; Jehl, F; Lefèvre, S; Marcellin, L; Prévost, G; Saleh, M; Subilia, A | 1 |
| Billi, F; Francis, KP; Miller, LS; Niska, JA; Pribaz, JR; Ramos, RI; Shahbazian, JH | 1 |
| Brown, JE; Christensen, KJ; Fominaya, C; Lamp, KC; McConnell, SA | 1 |
| López-Cortés, LE; Pascual, Á; Rodríguez-Baño, J | 1 |
| Berscheid, A; Bierbaum, G; Gottschalk, G; Jansen, A; Oedenkoven, M; Sass, P; Strittmatter, A; Szekat, C | 1 |
| Arias, CA; Hall, AD; Murray, BE; Rybak, MJ; Steed, ME | 1 |
| Álvarez-Lerma, F; Gimeno Costa, R; Gracia Arnillas, MP; Insausti Ordeñana, J; López Pueyo, MJ; Olaechea Astigarraga, P; Palomar Martínez, M; Seijas Betolaza, I | 1 |
| Iribarren, JA; Llinares, P | 1 |
| Becker, K; Denis, O; Garcia, LG; Kahl, BC; Lemaire, S; Proctor, RA; Tulkens, PM; Van Bambeke, F | 1 |
| Chang, CM; Chou, CH; Ko, WC; Lee, CC; Lee, HC; Lee, NY | 1 |
| Bonilla, H; Fakih, MG; Fugelli, A; Johnson, L; Olsen, WM; Pawlak, J; Saravolatz, LD | 1 |
| He, WJ; Tan, NH; Xu, HM; Xu, WY; Zeng, GZ; Zhao, SM | 1 |
| Arias, CA; Diaz, L; Munita, JM; Murray, BE; Panesso, D; Reyes, J; Tran, TT; Wanger, A | 1 |
| Graviss, EA; Marconescu, P; Musher, DM | 1 |
| Fallon, M; Moran, JJ; Rose, WE; Vanderloo, JP | 1 |
| Niki, Y | 1 |
| Finnegan, PM; Linneman, TW; McDonald, JR; Moenster, RP | 1 |
| Crispell, EK; Passalacqua, KD; Read, TD; Satola, SW | 1 |
| Edwards, B; Gould, IM; Lawes, T; Ludwig, F | 1 |
| de Magalhaes Silverman, M; Gingrich, RD; Wudhikarn, K | 1 |
| Avery, LM; Hasan, M; Rybak, MJ; Steed, ME; Woodruff, AE | 1 |
| Anastasiou, D; Byren, I; Campanaro, E; Evans, R; Kuropatkin, G; Rege, S; Yankelev, S | 1 |
| Humphries, RM; Kelesidis, T; Nizet, V; Rose, WE; Sakoulas, G; Schork, N; Tewhey, R | 1 |
| Arslan, U; Aydın, F; Bayramoğlu, G; Baysan, BO; Berktaş, M; Cesur, S; Cöplü, N; Demiröz, AP; Esen, B; Gencer, S; Gülay, Z; Hoşoğlu, S; Irmak, H; Karabiber, N; Kılıç, H; Simşek, H; Yalçın, AN | 1 |
| da Costa Darini, AL; da Silva, LP; Martinez, R; Pitondo-Silva, A | 1 |
| Daniel, RA; Domínguez-Cuevas, P; Mascher, T; Wolf, D | 1 |
| Blake, KL; O'Neill, AJ | 1 |
| Abdelghany, O; Ruggero, MA; Topal, JE | 1 |
| Pogliano, J; Rose, WE; Rybak, MJ; Sakoulas, G; Tewhey, R; Werth, BJ | 1 |
| Aumeran, C; Boisnoir, M; Forestier, C; Guyot, P; Lesens, O; Robin-Hennequin, C; Traore, O; Vidal, M | 1 |
| Aikawa, N; Kato, Y; Kusachi, S; Mikamo, H; Morita, A; Takesue, Y; Tanaka, Y; Tsumori, K; Watanabe, S; Yoshinari, T | 1 |
| Arhin, FF; Belley, A; Deng, H; Moeck, G; Rose, W; Sarmiento, I | 1 |
| Bheemreddy, S; Biedron, C; Chalana, IK; Collins, V; Hayakawa, K; Ho, K; Judge, T; Kamatam, S; Kaye, KS; Khammam, V; Lephart, PR; Marchaim, D; Martin, ET; Nanjireddy, P; Parveen, S; Pogue, JM; Reddy, SM; Rybak, MJ; Tiwari, N; Tumma, RS; Yousuf, A | 1 |
| Das, D; Garcia, LG; Lemaire, S; Mélard, A; Rozenberg, R; Tulkens, PM; Van Bambeke, F | 1 |
| Cheung, AL; Cho, JS; Donegan, NP; Guo, Y; Miller, LS; Ramos, RI | 1 |
| Bathina, P; Bheemreddy, S; Campbell, ML; Chugh, N; Hayakawa, K; Kaye, KS; Ku, K; Lephart, PR; Marchaim, D; Martin, ET; Moshos, J; Pogue, JM; Pulluru, H; Rybak, MJ; Sunkara, B; Wilson, MN | 1 |
| Bayer, AS; Sahl, HG; Schneider, T | 1 |
| Descourouez, JL; Jorgenson, MR; Rose, WE; Wergin, JE | 1 |
| Andes, DR; Craig, WA; Lee, DG; Murakami, Y | 1 |
| Grau, S; Majos, N; Rubio-Rodríguez, D; Rubio-Terrés, C | 1 |
| Chang, HJ; Cheng, CW; Hsu, PC; Huang, CT; Lee, MH; Siu, LK; Wu, TL; Yang, CC | 1 |
| Arda, B; Bardak-Ozcem, S; Isikgoz-Tasbakan, M; Pullukcu, H; Sipahi, H; Sipahi, OR; Turhan, T; Ulusoy, S; Yamazhan, T | 1 |
| Anik, S; Beasley, FC; Borkowski, AW; Dorrestein, PC; Gonzalez, DJ; Gusarov, I; Nizet, V; Nudler, E; van Sorge, NM; von Köckritz-Blickwede, M | 1 |
| Heidari, A; Jongsma, K; Joson, J | 1 |
| Flamm, RK; Jones, RN; Sader, HS | 2 |
| Aksoy, U; Bahar, AY; Comez, A; Coskun, E; Demir, T; Erbagci, I; Gurler, B; Okumus, S; Tatar, MG; Zer, Y | 1 |
| Davis, SL; Kaye, KS; Kullar, R; Lephart, P; Murray, KP; Rybak, MJ; Zhao, JJ | 1 |
| Almela, M; Armero, Y; Castañeda, X; Cervera, C; Del Río, A; Espinal, PA; Falces, C; García-de-la-Mària, C; Gatell, JM; Marco, F; Mestres, CA; Miró, JM; Moreno, A; Ninot, S; Pericas, JM; Soy, D; Vila, J; Vila-Farrés, X | 1 |
| DeRyke, CA; Goering, R; Hoover, V; Velazquez, A; Wallace, MR | 1 |
| Coyle, E; Kapadia, M; Prince, RA; Rolston, KV; Tarrand, J | 1 |
| Arias, CA; Diaz, L; Munita, JM; Murray, BE; Panesso, D; Reyes, J; Tran, TT | 1 |
| Couet, W; Gobin, P; Lauda, M; Le Moal, G; Marchand, S; Roblot, F | 1 |
| Benton, BM; Lunde, CS; Song, Y; Wilkinson, BJ | 1 |
| Bowler, IC; Collier, J; Colston, JM; Scarborough, M | 1 |
| Courtney, HS; Haggard, WO; Jennings, JA; Moshref, AR; Smith, JK | 1 |
| Chugh, TD; Gaind, R; Jain, S | 1 |
| Doig, K; Gao, W; Howden, BP; McEvoy, CR; Ngo, D; Porter, JL; Seemann, T; Stinear, TP; Tsuji, B | 1 |
| Bauer, KA; Lustberg, ME | 1 |
| Hasçelik, G; Mirza, HC; Sancak, B; Yagci, S | 1 |
| Alvarez-Rocha, L; Arias, J; Azanza, JR; Barberán, J; Candel, F; de Alarcón, CA; Fortún, J; García, JE; Gómez, J; Grau, S; Llinares, P; Marco, F; Maseda, E; Mensa, J; Montejo, M; Moreno, A; Parra, J; Pasquau, J; Picazo, J; Salavert, M; Soriano, A; Soy, D | 1 |
| Gardner, J; Toledo-Pereyra, LH; Zaffiri, L | 1 |
| Arias, CA; Kong, J; Miller, C; Saxer, G; Shamoo, Y; Tran, TT | 1 |
| Besece, D; Lamp, KC; McConnell, SA; Rolston, KV; White, P; Yoon, M | 1 |
| Amoroso, L; Bandettini, R; Banov, L; Barabino, P; Castagnola, E; Ciucci, A; Faraci, M; Loy, A; Moscatelli, A; Risso, F | 1 |
| Akdeniz, H; Bayram, R; Bucak, Ö; Bucak, YY; Erdurmuş, M; Küçükbayrak, A; Mengeloğlu, FZ; Özyalvaçlı, G; Taş, T | 1 |
| Humphries, RM; Pollett, S; Sakoulas, G | 1 |
| Bétrisey, B; Furustrand Tafin, U; Jeddari, S; Maiolo, EM; Oliva, A; Trampuz, A | 1 |
| Chen, GY; Kuo, CH; Lin, SW; Sun, HY; Tsai, IL | 1 |
| Babcock, HM; Khair, HN; Liang, SY; Marschall, J; McDonald, JR | 1 |
| Bhalodi, AA; Hagihara, M; Kuti, JL; Nicolau, DP | 1 |
| Hagioka, S; Hagiya, H; Otsuka, F | 1 |
| Cleveland, KO; Gelfand, MS | 1 |
| Balli, EP; Miyakis, S; Venetis, CA | 1 |
| Belliveau, PP; McDaneld, PM; Mohr, JF; Spooner, LM | 1 |
| Carey, JR; Chu, YW; Engebretson, DA | 1 |
| Akalin, H; Aksit, F; Dündar, DO; Gülay, Z; Gür, D; Hayran, M; Korten, V; Ogunc, D; Ozakin, C; Sancak, B; Söyletir, G; Topçu, AW; Usluer, G; Yagci, S; Yalcin, AN | 1 |
| Belausov, N; Ben-David, D; Keller, N; Maor, Y; Rahav, G; Smollan, G | 1 |
| Ibrahim, SA; Noreddin, AM; Salem, AH; Zhanel, GG | 1 |
| Heil, E; Joshi, M; Memoli, D; Shepardson, A | 1 |
| Drew, RJ; Paulus, S | 1 |
| Collins, CD; McComb, MN | 1 |
| Cars, O; Forsberg, P; Giske, CG; Hickman, RA; Lagerbäck, P; Tängdén, T | 1 |
| Gordon, SM; Mason, P; Neuner, E; Nutter, B; O'Rourke, C; Rehm, SJ; Shrestha, NK | 1 |
| Farrell, DJ; Flamm, RK; Jones, RN; Sader, HS | 1 |
| Almirante, B; Basas, J; Del Pozo, JL; Fernández-Hidalgo, N; Gavaldà, J; Martín, MT; Meije, Y; Pahissa, A; Shan, A | 1 |
| Abduljaleel, SA; Atshan, SS; Awang Hamat, R; Ghaznavi-Rad, E; Jeevajothi Nathan, J; Karunanidhi, A; Lung, LT; Mateg Ali, A; Nor Shamsudin, M; Pei Pei, C; Sekawi, Z | 1 |
| Muscedere, J | 1 |
| Campanile, F; Cavallo, R; Corcione, S; De Rosa, FG; Di Perri, G; Fossati, L; Motta, I; Ranieri, VM; Stefani, S | 1 |
| Johnson, LB; Martin, H; Pawlak, J; Saravolatz, LD; Saravolatz, SN | 1 |
| Golan, Y; Holcroft, C; Snydman, DR; Weston, A | 1 |
| Almela, M; Armero, Y; Castañeda, X; Cervera, C; de la Maria, CG; del Rio, A; Falces, C; Gatell, JM; Marco, F; Mestres, CA; Miro, JM; Moreno, A; Ninot, S; Pare, JC; Pericas, JM; Soy, D | 1 |
| Barber, KE; Ireland, CE; Rybak, MJ; Werth, BJ | 1 |
| Gautam, V; Kaur, H; Mewara, A; Ray, P | 1 |
| Carroll, KC; Dam, LM; Eisinger, SW; Neoh, KM; Riedel, S; Tekle, T | 1 |
| Angelova, SN; Chernen'kaia, TV; Ershova, MG; Gostev, VV; Khokhlova, OE; Kruglov, AN; Molchanova, IV; Naumenko, ZS; Poletaeva, ED; Popenko, LN; Sidorenko, SV; Voroshilova, TM; Zakharova, IuA | 1 |
| Barber, KE; Hall Snyder, A; Rybak, MJ; Sakoulas, G; Werth, BJ | 1 |
| Arias, CA; Carvajal, LP; Diaz, L; Miller, WR; Munita, JM; Murray, BE; Panesso, D; Reyes, J; Rincon, S; Rojas, NL; Shamoo, Y; Tran, TT; Weinstock, GM; Wollam, A | 1 |
| Arhin, FF; Moeck, G; Sarmiento, I | 1 |
| Archuleta, S; de Souza, NN; Gandhi, M; Kalimuddin, S; Low, JG; Lye, D; Phillips, R; Tan, TT | 1 |
| Arias, CA; Carvajal, LP; Díaz, L; Munita, JM; Panesso, D; Reyes, J; Rincón, S | 1 |
| Denetclaw, TH; Suehiro, I; Tolliver, GL; Wang, PK | 1 |
| Bizzini, A; Hartke, A; Rio-Marques, L | 1 |
| Fan, W; Kongnakorn, T; LaPensee, KT; Pelligra, CG; Revankar, N; Ward, AJ | 1 |
| Denis, O; Hallin, M; Mingeot-Leclercq, MP; Siala, W; Tulkens, PM; Van Bambeke, F | 1 |
| Dorrestein, PC; Kersten, RD; Liu, WT; Mohimani, H; Moore, BS; Pevzner, PA | 1 |
| Barber, KE; Rybak, MJ; Sakoulas, G | 1 |
| Charlton, CL; Hindler, JA; Humphries, RM; Turnidge, J | 1 |
| Hohenforst-Schmidt, W; Huang, H; Kioumis, I; Lampaki, S; Li, Q; Organtzis, J; Pataka, A; Petridis, D; Pezirkianidis, N; Pitsiou, G; Porpodis, K; Spyratos, D; Yarmus, L; Zarogoulidis, K; Zarogoulidis, P | 1 |
| Fukushima, S; Matsumoto, T; Mizuno, Y; Nakamura, I; Okamura, S; Sato, A; Tsukimori, A; Yamaguchi, T | 1 |
| Cleveland, KO; Finch, CK; Gelfand, MS; Self, TH; Usery, JB; Vo, NH | 1 |
| Arnold, C; Fowler, VG; Holland, TL | 1 |
| Fujimura, S; Nakano, Y; Watanabe, A | 1 |
| Coato, P; Cojutti, P; Pea, F; Rigoli, R; Sartor, A; Scarparo, C | 1 |
| Hsu, AJ; Tamma, PD | 1 |
| Ahmad, S; Allen, SL; Kabir, R; Patel, K | 1 |
| Barros, EM; Cavalcante, FS; Chamon, RC; da Costa, TM; Dantas, TS; Dos Santos, KR; Ferreira, Dde C; Maia, F | 1 |
| Gallagher, JC; Patel, R | 1 |
| Chang, SC; Chuang, YC; Lin, HY; Wang, JT | 1 |
| Hung, YM; Wang, JH; Wann, SR | 1 |
| Farrell, DJ; Flamm, RK; Jones, RN; Mendes, RE; Sader, HS | 1 |
| Alpfidan, I; Demir, LS; Goktas, S; Kurtoglu, MG; Omeroglu, E; Ozcimen, M; Ozcımen, S; Saglam, F; Sakarya, R; Sakarya, Y; Yener, HI | 1 |
| Baumgarten, G; Bode, C; Boehm, O; Diedrich, B; Hoeft, A; Jahnert, S; Meyer, R; Muenster, S; Steinhagen, F; Weisheit, C | 1 |
| Barber, KE; Raut, A; Rybak, MJ; Smith, JR | 2 |
| Almeida, AJ; Bétrisey, B; Bettencourt, A; Ferreira, IS; Gonçalves, LM; Trampuz, A | 1 |
| Ito, N; Masuya, A; Matsumoto, T; Miura, Y; Nakamura, I; Okamura, S; Shiina, T; Suzuki, S; Tsukimori, A; Yamaguchi, T | 1 |
| Basuino, L; Chambers, HF; Chan, LC; Dip, EC | 1 |
| Gomes, DM; LaPlante, KL; Ward, KE | 1 |
| Gür, D; Mirza, HC; Sancak, B | 1 |
| DePestel, DD; Lamp, KC; McKinnell, JA; Moise, PA; Reyes, K; Sakoulas, G; Yoon, MJ; Zervos, MJ | 1 |
| Barber, KE; Boles, BR; Ireland, CE; Rose, WE; Rybak, MJ; Smith, JR | 1 |
| Buyck, JM; Peyrusson, F; Tulkens, PM; Van Bambeke, F | 1 |
| Kaul, M; LaVoie, EJ; Lyu, YL; Mark, L; Parhi, AK; Pawlak, J; Pilch, DS; Saravolatz, LD; Saravolatz, S; Weinstein, MP; Zhang, Y | 1 |
| Behl, P; Chander, J; Gupta, V; Sahoo, T; Singla, N | 1 |
| Barber, KE; Hallesy, J; Raut, A; Rybak, MJ; Smith, JR | 1 |
| Amicizia, D; Cristina, ML; Orlando, P; Panatto, D; Perdelli, F; Spagnolo, AM | 1 |
| Culshaw, D; Lamp, KC; Lodise, TP; Yoon, MJ | 1 |
| Almeida, AJ; Bétrisey, B; Bettencourt, AF; Ferreira, IS; Gonçalves, LM; Kasper, S; Kikhney, J; Moter, A; Trampuz, A | 1 |
| Miksza, KF; Morales, HM; Pecoit-Filho, R; Rocha, JL; Sakumoto, MH; Tuon, FF | 1 |
| Baos, E; Candel, FJ; Nieto, M; Picazo, JJ | 1 |
| Baillon-Plot, N; Charbonneau, C; Corman, S; Eckmann, C; Haider, S; Lawson, W; Li, J; Macahilig, C; Nathwani, D; Solem, C; Stephens, J | 1 |
| AbuRahma, AF; Campbell, JR; Emmett, M; Hass, SM; Modak, A; Mousa, AY; Nanjundappa, A; Srivastiva, M; Stone, PA | 1 |
| Chan, MC; Chang, CN; Lo, WT; Wang, CC; Yu, CM | 1 |
| Bæk, KT; Cameron, DR; Frees, D; Mellergaard, M; Mogenssen, RG; Peleg, AY; Petersen, A; Skov, S; Thomsen, LE; Thøgersen, L | 1 |
| Anastassiou, ED; Doudoulakakis, A; Drougka, E; Giormezis, N; Kolonitsiou, F; Konsolakis, C; Koutsia, C; Lebessi, E; Marangos, M; Papadimitriou-Olivgeris, M; Petinaki, E; Sarrou, S; Spiliopoulou, I; Vourli, S; Zerva, L | 1 |
| LaPlante, KL; Luther, MK | 1 |
| Andes, D; Lepak, A; Marchillo, K; VanHecker, J | 1 |
| Misra, R; Prasad, KN; Rahman, M; Rai, RP; Singh, A; Singh, SK; Srivastava, JK; Tripathi, A | 1 |
| Fermann, G; Hart, K; Korfhagen, J; Lindsell, CJ; Meunier, JM; Shaw, GJ; Wayne, B | 1 |
| Coronado-Álvarez, NM; Hernández-Quero, J; Parra, D; Parra-Ruiz, J; Peña-Monje, A | 1 |
| Esterbrooks, DJ; Haddad, TM; Sundaragiri, PR; Vallabhajosyula, S | 1 |
| Arhin, FF; Biedenbach, DJ; Lynch, TF; Moeck, G; Sahm, DF | 1 |
| Bedolla, J; Brenneman, SK; Corey, GR; Friedman, B; Garcia-Diaz, J; Hoehns, JD; Jauregui-Peredo, L; Kauf, TL; Lodise, T; McKinnon, P; Mercier, RC; Ng, D; Riska, PF; Sims, M | 1 |
| Budimir, A | 1 |
| Adamson, R; Bauer, K; Bensman, J; Chaudhry, SB; Culshaw, DL; Eskandarian, R; Goff, DA; Lamp, KC; Leuthner, K; Lodise, T; McKinnell, JA; Moise, PA; Reyes, K; Smith, WJ; Virata, MD; Wong-Beringer, A; Zervos, MJ | 1 |
| Akamatsu, N; Hasegawa, H; Kawakami, K; Kimura, Y; Kosai, K; Matsuda, J; Matsuo, H; Morinaga, Y; Uno, N; Yamaryo, T; Yanagihara, K | 1 |
| Bartolomeu, AR; Brito, CI; Camargo, CH; Cunha, ML; Oliveira, A; Pereira, VC; Pinheiro, L | 1 |
| Nesher, L; Prince, RA; Rolston, KV; Shelburne, SA; Wang, W | 1 |
| Brazeau, DA; Brown, T; Bulman, ZP; Gill, SR; Lenhard, JR; Meaney, CJ; Norgard, NB; Rybak, MJ; Tsuji, BT | 1 |
| Bhardwaj, P; Palmer, KL; Ziegler, E | 1 |
| Cafiso, V; Campanile, F; Capone, A; Mariani, B; Parisi, G; Petrosillo, N; Stefani, S | 1 |
| Kuo, FC; Lee, MS; Peng, KT; Wang, JW; Yen, SH | 1 |
| Raut, A; Rybak, MJ; Smith, JR; Yim, J | 1 |
| Boudjemaa, R; Boutoille, D; Breteche, A; Caillon, J; Fontaine-Aupart, MP; Jacqueline, C; Le Mabecque, V; Michelet, C; Potel, G; Revest, M; Steenkeste, K; Tattevin, P | 1 |
| Brunetto, PS; Fromm, KM; Khanna, N; Kuehl, R; Rajacic, Z; Terracciano, L; Varisco, M; Vosbeck, J; Woischnig, AK | 1 |
| Chen, HJ; Hsueh, PR; Hung, WC; Lin, YT; Teng, LJ; Tsai, JC; Yamamoto, T | 1 |
| Chatfield, M; Cheng, AC; Davis, JS; Fowler, VG; Howden, BP; Lipman, J; Lye, D; Nelson, J; O'Sullivan, M; Paterson, DL; Robinson, JO; Tong, SY; Van Hal, S; Yahav, D | 1 |
| Dagnæs-Hansen, F; Fuursted, K; Jørgensen, NP; Meyer, RL; Petersen, E; Skovdal, SM | 1 |
| Allen, M; Browne, C; Chapman, R; Gould, IM; Marsh, K; Muszbek, N; Seaton, RA | 1 |
| Gnanasambandam, S; Kanjani, A; Nambi, PS; Prabhudesai, S; Ramachandran, B | 1 |
| Concia, E; Falcone, M; Giusti, M; Mazzone, A; Santini, C; Stefani, S; Violi, F | 1 |
| Aguado, JM; Ardanuy, C; Chaves, F; de Cueto, M; Fernández-Ruiz, M; Fortún, J; Lalueza, A; López-Medrano, F; Loza, E; Morales, I; Morales-Cartagena, A; Orellana, MÁ; Pujol, M; Resino-Foz, E; Rico, A; Romero, MP; San-Juan, R; Viedma, E | 1 |
| Deresinski, S; Holubar, M; Meng, L | 1 |
| Dimitriou, G; Gkentzi, D; Kolyva, S; Marangos, M; Spiliopoulou, I | 1 |
| Ertugrul, BM; Gunay, N; Ozturk, B; Sakarya, S | 1 |
| Abdelhady, W; Bayer, AS; Tang, C'; Xiong, YQ | 1 |
| Casapao, AM; Claeys, KC; Compton, MT; Davis, SL; Hallesy, JA; Kaye, KS; Lagnf, AM; Levine, DP; Nagel, JL; Nguyen, CT; Rybak, MJ; Zasowski, EJ | 1 |
| DeFrates, SR; Hladnik, LM; Nedved, AN; Stockerl-Goldstein, KE | 1 |
| Candel, FJ; Chiarella, F; García, AB; López, L; Viñuela-Prieto, JM | 1 |
| Desai, S; Nair, S; Poonacha, N; Sharma, U; Vipra, A | 1 |
| Jorgensen, JH; King, CJ; McCullor, KA; McShan, WM; Nguyen, SV; Rahman, M | 1 |
| Eggimann, P; Paiva, JA | 1 |
| Hsieh, YC; Huang, YC; Lin, YC | 1 |
| Bangdiwala, A; Chong, PP; Gilligan, PH; Ivanova, A; Miller, WC; Shea, TC; van Duin, D; Weber, DJ | 1 |
| Aitken, SL; Arias, CA; DiPippo, AJ; Munita, JM; Shelburne, SA; Tarrand, JJ; Tran, TT; Tverdek, FP | 1 |
| Garau, J; Giamarellos, E; Mazzei, T; Pea, F; Purrello, SM; Soriano, A; Stefani, S | 1 |
| Casapao, AM; Claeys, KC; Davis, SL; Klinker, KP; Lagnf, AM; Rybak, MJ; Sabagha, N; Trinh, TD; Zasowski, EJ | 1 |
| Abgueguen, P; Aubin, GG; Boutoille, D; Caillon, J; Corvec, S; Deschanvres, C; Lepelletier, D; Moal, F; Navas, D | 1 |
| Arber, M; Barata, T; Eales, J; Fleetwood, K; Glanville, J; Gould, IM; Kauf, TL; McCool, R | 1 |
| Hattori, N; Hirano, K; Iwanaga, N; Izumikawa, K; Kajihara, T; Kohno, N; Kohno, S; Miyazaki, T; Miyazaki, Y; Mukae, H; Nakamura, S; Oshima, K; Yanagihara, K | 1 |
| Arshad, S; Hartman, P; Huang, V; Moreno, D; Perri, MB; Zervos, MJ | 1 |
| Aubry, JM; Belmessieri, D; Duclos, MC; Duguet, N; Dumitrescu, O; Gozlan, C; Lemaire, M; Lina, G; Molinier, V; Redl, A | 1 |
| Anastasiou, D; Arnold, SR; Arrieta, A; Bokesch, P; Bradley, J; Congeni, B; Daum, RS; Glasser, C; Kojaoghlanian, T; Patino, H; Wolf, DJ; Yoon, M | 1 |
| Arias, CA; Carvajal, LP; Chambers, HF; Diaz, L; Garavito, JD; Miller, WR; Munita, JM; Nigo, M; Panesso, D; Rios, R; Tran, TT; Wanger, A; Weinstock, G | 1 |
| Azuara, G; Buján, J; De la Torre, B; Duocastella-Codina, L; Fernández-Gutiérrez, M; García-García, J; González-Gómez, A; Ibarra, B; Molina-Crisol, M; Parra, J; Parra-Ruíz, FJ; San Román, J; Vázquez-Lasa, B | 1 |
| Britt, NS; Patel, N; Potter, EM; Steed, ME | 1 |
| Boka, K; Cortes, J; Lee, Y; Sagar, AS; Sandhu, U | 1 |
| Kim, YJ; Kim, YK; Kwon, HI; Lee, HS; Lee, JC; Lee, WK; Na, SH; Nicholas, A; Selasi, GN; Shin, JH; Song, KE | 1 |
| Aguado, J; Andaluz-Ojeda, D; Blasco-Navalpotro, MA; Del Valle-Ortiz, M; Díaz-Lamas, A; Nuvials-Casals, X; Ortiz-Piquer, M; Ramirez, P; Reig-Valero, R; Roche-Campo, F; Rodriguez-Aguirregabiria, M; Ruiz-Ramos, J; Tamayo-Lomas, L; Vidal-Cortés, P | 1 |
| Ajmal, S; Beam, E; Saleh, OA | 1 |
| Desai, S; Hiremath, D; Mohan, T; Nair, S; Poonacha, N; Sharma, U; Tuppad, D; Vipra, A | 1 |
| Becker, K; Bisdas, T; Herten, M; Idelevich, EA; Osada, N; Scherzinger, AS; Sielker, S; Torsello, GB | 1 |
| Agostinho, A; Bartolone, P; Betz, M; Guanziroli, N; Öztürk, M; Pires, D; Pittet, D; Tscholl, P; Uçkay, I | 1 |
| Bal, AM; David, MZ; Garau, J; Gottlieb, T; Gould, IM; Mazzei, T; Scaglione, F; Tattevin, P | 1 |
| Arhin, FF; Belley, A; Moeck, G; Seguin, DL | 1 |
| Arai, S; Ikeda, M; Koya, J; Kurokawa, M; Matsuda, K; Moriya, K; Nakamura, F; Okugawa, S; Toyama, K | 1 |
| Bojer, MS; Ingmer, H; Krogsgård Nielsen, C; Meyer, RL; Nøhr-Meldgaard, K; Peschel, A; Slavetinsky, C; Vestergaard, M | 1 |
| Dolapçı, İ; Gençtürk, Z; Öcal, DN; Tekeli, A | 1 |
| Klare, I; Layer, F; Strommenger, B; Weber, RE; Werner, G | 1 |
| Banerjee, M; Chanderraj, R; Rao, K | 1 |
| Arhin, FF; Belley, A; Moeck, G | 1 |
| Almirante, B; Basas, J; Del Pozo, JL; Gavaldà, J; Gomis, X; Martín-Gómez, MT; Palau, M; Ratia, C; Torrents, E | 1 |
| Chang, YJ; Kuo, FC; Lee, CH; Lee, MS; Lin, PC | 1 |
| Chan, D; Chang, E; Saedi-Kwon, H; Schwartz, J; Turner, RB; Wilson, DE; Won, R | 1 |
| Amado, M; Beevers, APG; Betley, JR; Blaskovich, MAT; Bradford, TA; Butler, MS; Cheng, M; Cooper, MA; Daud, NH; Deecke, JE; Edwards, DJ; Elliott, AG; Gong, Y; Hansford, KA; Huang, JX; Karoli, T; Kavanagh, AM; Lee, JC; Lindahl, F; Muldoon, C; Paterson, DL; Pelingon, R; Phetsang, W; Premraj, R; Ramaologa, S; Ramu, S; Roberts, JA; Sidjabat, HE; Silva, AB; Smith, RAG; Ziora, Z; Zuegg, J | 1 |
| Altman, DR; Beckford, C; Chacko, KI; Ciferri, B; Hamula, CL; Kasarskis, A; Pak, TR; Sebra, R; Sullivan, MJ; van Bakel, H | 1 |
| Peyrusson, F; Tulkens, PM; Van Bambeke, F | 1 |
| Bhavan, K; Ortwine, JK | 1 |
| Barros, AJ; Lewis, JD; Sifri, CD | 2 |
| Gould, IM; Khan, A; Wilson, B | 1 |
| Baell, JB; Carter, GP; Harjani, JR; Howden, BP; Li, L; Nong, Y; Pitcher, NP; Riley, TV; Stinear, TP; Williamson, DA | 1 |
| Breusch, SJ; Dall, GF; Gallagher, MP; Gwynne, PJ; MacKenzie, SP; Simpson, AHRW; Tsang, SJ | 1 |
| Castellanos-Ortega, Á; Concha, P; Frasquet, J; Gordon, M; Ramirez, P; Ruiz, J; Salavert-Lletí, M; Villarreal, E | 1 |
| Helon, P; Juda, M; Malm, A | 1 |
| Prince, RA; Raad, II; Reitzel, R; Rolston, KVI; Shelburne, SA; Vargas-Cruz, N | 1 |
| Avaca-Crusca, JS; Camargo, ILBDC; Dabul, ANG; Okado, JB; Oliveira, AL | 1 |
| Archuleta, S; Chan, YFZ; Kalimuddin, S; Low, JGH; Lye, DC; Ong, SP; Phillips, R; Tan, TT | 1 |
| Cho, JE; Hwang, JH; Jang, HC; Jung, SI; Kim, DM; Kim, ES; Kim, HB; Kim, M; Kwak, YG; Lee, CS; Lee, JH; Lee, KS; Nam, EY; Park, KH; Park, SY; Park, Y; Song, KH; Yang, SJ; Yoon, N | 1 |
| Branch-Elliman, W; LaSalvia, MT; Schrank, GM; Wright, SB | 1 |
| Duncan, LR; Flamm, RK; Mendes, RE; Pfaller, MA; Sader, HS | 1 |
| Foster, TJ | 1 |
| Channabasappa, S; Chikkamadaiah, R; Durgaiah, M; Kumar, S; Ramesh, K; Sreekanthan, A; Sriram, B | 1 |
| Kalil, AC; Kanjilal, S; Klompas, M | 1 |
| Descourouez, JL; Fernandez, LA; Jorgenson, MR; Leverson, GE; Rose, WE; Smith, JA | 1 |
| Hagiwara, D; Kamada, M; Kamimura, H; Miyazaki, M; Moriwaki, N; Nakano, T; Sato, K; Shiotsuka, S; Takata, T; Togawa, A; Toh, H; Tokushige, C | 1 |
| Chamorro-Pareja, N; Gonzalez-Estrada, A; Patel, A; Youngberg, G | 1 |
| Aiba, Y; Cui, L; Fujisaki, S; Kanesaka, I; Katsuse, AK; Kobayashi, I; Mikawa, T; Takahashi, H; Watanabe, S | 1 |
| Barros, EM; Gilmore, MS; Lebreton, F; Martin, MJ; Sampaio, JLM; Selleck, EM | 1 |
| Arda, B; Avci, M; Cag, Y; Demirdal, T; Dizbay, M; Erdem, HA; Kahraman, H; Kandemir, O; Karasahin, O; Kaya, S; Kurtaran, B; Kutlu, M; Oruc, E; Oztoprak, N; Pullukcu, H; Sipahi, H; Sipahi, OR; Tasbakan, M; Tunccan, OG; Ulug, M; Ulusoy, S; Yamazhan, T; Yetkin, F | 1 |
| Barousch, W; Burgmann, H; Karer, M; Kussmann, M; Lagler, H; Makristathis, A; Moser, D; Nehr, M; Obermueller, M; Poeppl, W; Ramharter, M; Schmidt, K; Thalhammer, F; Winkler, S | 1 |
| Abbott, IJ; Baines, SL; Cameron, DR; Dexter, C; Howden, BP; Jiang, JH; Kostoulias, X; Monk, IR; Nethercott, C; Peleg, AY; Spelman, DW | 1 |
| Aguilar, L; Artero, A; Barberan, J; Calleja, JL; Epelde, F; Giménez, MJ; Granizo, JJ; Guerra, JM; Martínez-Gil, I; Mensa, J; Rodriguez, JC; Ruiz-Morales, J | 1 |
| Baines, SL; Ballard, SA; Buising, K; Chan, HT; Douglas, AP; Howden, BP; Madigan, V; Marshall, C; Ritchie, D; Slavin, MA; Szer, J | 1 |
| Akbilgic, O; Gyamlani, G; Kalantar-Zadeh, K; Kovesdy, CP; Molnar, MZ; Naseer, A; Potukuchi, PK; Soohoo, M; Streja, E; Sumida, K; Thomas, F | 1 |
| Aoki, K; Fujisaki, M; Hamada, M; Ishii, Y; Kajiwara, C; Kato, K; Kimura, S; Murakami, H; Ono, D; Sasaki, M; Sato, A; Sonoda, S; Tateda, K; Tojo, H; Yamaguchi, T | 1 |
| Cheng, A; Chuang, YC | 1 |
| Cuénod, A; Egli, A; Hinic, V; Khanna, N; Kuehl, R; Morgenstern, M; Wüthrich, D | 1 |
| Berenson, CS; Bulman, ZP; Mergenhagen, KA; Sellick, JA; Sumon, ZE; Tsuji, BT | 1 |
| Jamal, M; Nesher, L; Prince, RA; Raad, I; Rice, SA; Rolston, KVI; Rybak, MJ | 1 |
| Gil Romero, Y; Gómez-Garcés, JL | 1 |
| Hamada, M; Ishii, Y; Kato, K; Katoh, R; Nagashima, M; Okazumi, S; Ono, D; Oshiro, T; Sato, A; Sonoda, S; Tateda, K; Yamaguchi, T | 1 |
| Colson, P; Daures, JP; David, H; Eliet, J; Gaudard, P; Morquin, D; Saour, M; Villiet, M | 1 |
| Agnihothram, S; Azevedo, MP; Basco, MDS; Hart, ME; Kothari, A; McKinzie, PB; Revollo, JR; Saccente, M | 1 |
| Galanter, KM; Ho, J | 1 |
| Akizawa, K; Fukumoto, T; Kaku, N; Kimura, H; Konno, S; Morinaga, Y; Nagaoka, K; Suzuki, M; Yamashita, Y; Yanagihara, K | 1 |
| Aktas, G | 1 |
| Abdul-Mutakabbir, JC; Alosaimy, S; Bhatia, S; Davis, SL; Jorgensen, SCJ; Lagnf, AM; Mynatt, RP; Rybak, MJ; Sabagha, N; Trinh, TD; Zasowski, EJ | 1 |
| Ghaemi, EA; Khori, V; Mohammadi-Berenjestanaki, H; Shirzad-Aski, H | 1 |
| Burnham, CD; Lainhart, W; McMullen, AR; Shupe, A; Wallace, MA | 1 |
| Affeld, K; Gabel, G; Gebhardt, M; Goubergrits, L; Kertzscher, U; Kikhney, J; Kursawe, L; Moter, A; Petrich, A; Schmidt, J; Sutrave, S; Wiessner, A | 1 |
| Jin, W; Li, Q; Lin, N; Shi, C; Xie, Y; Xu, S; Zhou, D | 1 |
| Nunez, M; Tuerff, D | 1 |
| Campogiani, L; Eshwara, VK; Rello, J | 1 |
| Balaban, NQ; Bar-Meir, M; Gefen, O; Liu, J; Ronin, I | 1 |
| Cuba, GT; da Costa, TM; Dos Santos, KRN; Kiffer, CRV; Morgado, PGM; Nicolau, DP; Nouér, SA | 1 |
| Baba, T; Enami, J; Hiramatsu, K; Ohsawa, H | 1 |
| Gandhi, TN; Malani, PN | 1 |
| Anagnostou, NA; Andresen, DN; Archuleta, S; Bak, N; Cass, A; Chatfield, MD; Cheng, AC; Davies, J; Davis, JS; Dotel, R; Ferguson, PE; Foo, H; Fowler, VG; Ghosh, N; Gray, TJ; Guy, SD; Holmes, NE; Howden, BP; Johnson, SA; Kalimuddin, S; Lye, DC; McBride, S; McKew, GL; Meagher, N; Nelson, J; O'Sullivan, MVN; Paterson, DL; Paul, M; Price, DJ; Ralph, AP; Roberts, MA; Robinson, JO; Rogers, BA; Runnegar, N; Smith, S; Sud, A; Tong, SYC; Tramontana, AR; van Hal, SJ; Walls, GB; Warner, MS; Yahav, D; Young, BE | 1 |
| Asiimwe, BB; Kateete, DP; Mayanja, R; Najjuka, CF; Rutebemberwa, E | 1 |
| Alvarez, AS; Oyerinde, O; Reinert, JP | 1 |
| Giuliano, C; Jongekrijg, A; Kale-Pradhan, PB; Rybak, MJ | 1 |
| Atalla, E; Mylonakis, E | 1 |
| Pawlak, JM; Saravolatz, LD; Wegner, C | 1 |
| Kılınç, S; Pazarcı, Ö; Sümer, Z; Tunç, T | 1 |
| Kebriaei, R; Nguyen, L; Rice, SA; Rybak, MJ; Sheikh, Z; Singh, NB; Stamper, KC | 1 |
| Butler-Laporte, G; Cheng, MP; De l'Étoile-Morel, S; Lawandi, A; Lee, TC; Paquette, K | 1 |
| Bandari, C; Cichewicz, RH; Gardner, ED; Johnson, BP; Scull, EM; Singh, S; Tonelli, M; You, J | 1 |
| Deng, C; Hu, Y; Liao, L; Liu, L; Wang, C; Wang, Z; Ye, C | 1 |
| Herc, ES; Hutton, MA; Perri, MB; Sundaram, A; Zervos, MJ | 1 |
| Aiba, Y; Azam, AH; Boonsiri, T; Cui, L; Kiga, K; Li, FY; Sasahara, T; Sato'o, Y; Taki, Y; Tan, XE; Thitiananpakorn, K; Watanabe, S; Zhang, Y | 1 |
| Alegria, W; Deresinski, S; Holubar, M; Meng, L | 1 |
| Akalin, H; Ali, R; Bulbul, EN; Kazak, E; Kirkizlar, O; Kirkizlar, TA; Ozakin, C; Ozboz, ES; Ozkalemkas, F; Ozkocaman, V | 1 |
| Algorri, M; Wong-Beringer, A | 1 |
| Günal, İ; Karatosun, V; Muratlı, SK; Uzun, B | 1 |
| Patel, N; Shorman, MA; Smith, ZA; Veve, MP; Wright, LR; Yeager, SD | 1 |
| Forstchen, M; Hansen, E; Kinnear, CL; Morley, VJ; Read, AF; Tracy, KC; Woods, RJ | 1 |
| Alexander, B; Beck, BF; Goto, M; Jones, MP; Livorsi, DJ; Nair, R; Ohl, M; Perencevich, EN; Puig-Asensio, M; Richardson, K; Schweizer, ML; Suh, D; Vaughan Sarrazin, MS | 1 |
| Blanch Sancho, JJ; García Aragonés, L; Martínez Alfaro, E; Mateos Rodriguez, F; Segura Luque, JC; Solís García Del Pozo, J | 1 |
| Assaous, F; Benamrouche, N; Bentchouala, C; Djennane, F; Guettou, B; Henniche, FZ; Laouar, H; Rahal, K; Tali Maamar, H; Tiouit, D; Yamouni, F; Ziane, H | 1 |
| Huang, M; Johnson, TM; Kiser, TH; Miller, MA; Molina, KC; Mueller, SW | 1 |
| Heskamp, B; Körtge, A; Majcher-Peszynska, J; Mitzner, S; Wasserkort, R | 1 |
| Wang, JL; Xu, WH; Yi, YH; Yin, WJ | 1 |
| Dionne, B; Lee, TC | 1 |
| Avedissian, SN; Cortés-Penfield, N; Scheetz, MH | 1 |
| Oliver, JE; Shorman, MA; Veve, MP; Wright, LR; Yeager, SD | 1 |
| Almela, M; Cañas-Pacheco, MA; Castañeda, X; Dahl, A; Falces, C; Fuster, D; García-De-la-Mària, C; García-González, J; Gasch, O; Hernández-Meneses, M; Llopis, J; Marco, F; Miró, JM; Moreno, A; Pericàs, JM; Quintana, E; Soy, D; Tolosana, JM; Vidal, B | 1 |
| Arda, B; Aydemir, S; Demirdal, T; Dizbay, M; Erdem, HA; Kahraman, H; Kurşun, E; Nemli, SA; Öztoprak-Cuvalci, N; Quliyeva, G; Sipahi, H; Sipahi, OR; Suntur, BM; Tasbakan, M; Ulug, M; Ulusoy, S; Uysal, S | 1 |
| Chen, YH; Chen, YS; Cheng, SH; Hsueh, PR; Ko, WC; Lee, CM; Lee, WS; Lee, YL; Liao, CH; Lin, CY; Liu, CP; Liu, PY; Lu, MC; Lu, PL; Shao, PL; Sheng, WH; Shi, ZY; Tsai, HY; Tseng, SH; Wang, FD; Wang, LS; Wu, TS; Yen, MY | 1 |
| Wei, X; Xiao, X; Zhao, M | 1 |
| Bahçecioğlu, ÖF; Durmuş, M; Gök, S | 1 |
| Asempa, TE; Cassino, C; DeRosa, NA; Lehoux, D; Nicolau, DP; Schuch, R | 1 |
| Amara, M; Corvec, S; Grégoire, M; Guinard, J; Huon, JF; Kempf, M; Lavigne-Quilichini, V; Le Breton, E; Le Turnier, P; Leroy, AG; Loufti, B; Neuwirth, C; Pantel, A; Piau, C; Sanchez, R | 1 |
| Aspinall, SL; Buehrle, DJ; Clancy, CJ; Smith, KJ; Vu, M | 1 |
| Russo, A; Venditti, M | 1 |
| Bellés-Medall, MD; Bodega-Azuara, J; Edo-Peñarrocha, J; Ferrando-Piqueres, R; Perez-Alba, A; Reque-Santivañez, J | 1 |
| Falla, E; Mantopoulos, T; Nathwani, D; Vlachaki, I; Zinzi, D | 1 |
| Chang, SC; Chen, YC; Chuang, YC; Huang, SH; Lin, CY; Tseng, TC; Wang, JT | 1 |
| Dewar, S; Kelly, J; Tysall, L | 1 |
| Abate, G; Frisby, J; Wang, G | 1 |
| Barreras Beltran, IA; Polenakovik, H; Salipante, SJ; Waalkes, A; Werth, BJ; Xu, L; Zhang, R | 1 |
| Bae, T; Bhowmick, A; Ghosh, A; Jain, S; Jeong, B | 1 |
| Chang, SC; Chen, YC; Chuang, YC; Sheng, WH; Tsai, CE; Wang, JT; Yang, CJ | 1 |
| Arias, CA; Axell-House, D; Khan, A; Miller, WR; Munita, JM | 1 |
| Carvalhaes, CG; Castanheira, M; DeVries, S; Mendes, RE; Rhomberg, PR; Sader, HS | 1 |
| Ito, Y; Kanda, N; Kano, Y; Kobuchi, S; Okumi, T; Sakaeda, T; Tachi, H | 1 |
| Elmeskov, C; Frees, D; Mollerup, S; Pedersen, MS; Pinholt, M; Sejersen, TS; Westh, H; Worning, P | 1 |
| Araoka, H; Asano-Mori, Y; Ishiwata, K; Kageyama, K; Kaji, D; Makino, S; Mitsuki, T; Nishida, A; Oyama, T; Takagi, S; Taniguchi, S; Taya, Y; Uchida, N; Wake, A; Yamaguchi, K; Yamamoto, G; Yamamoto, H | 1 |
| Bator, C; Cassady, H; Cho, SH; He, Z; Hickner, M; Koshani, R; LeConey, S; Morley, VJ; Muthami, J; Narasimhalu, N; Pitcher, M; Read, AF; Sheikhi, A; Vom Steeg, LG; Woods, RJ; Yeh, SL | 1 |
| Hirano, K; Kasai, M; Kobayashi, A; Koizumi, K; Komatsumoto, S; Murohisa, T; Sakamoto, T; Shimizu, T; Yamakawa, T; Yokoo, T | 1 |
| Chang, SC; Chen, YC; Chuang, YC; Huang, SH; Lin, CY; Lin, HY; Wang, JT; Yang, JL | 1 |
| Del Rosario-García, B; García-Marrero, R; García-Rosado, D; Gómez-Sirvent, JL; González-García, J; López-Lirola, AM; Nazco-Casariego, GJ; Oramas-Rodríguez, JM | 1 |
| Abellà, J; Almirante, B; Colominas, S; Gavaldà, J; Gomis, X; Larrosa, N; Len, O; Lujan, E; Márquez, E; Muñoz, E; Palau, M | 1 |
| Martinez, AI; Santos, CAQ; Trick, WE; Tseng, M; Varughese, CA; Won, SY; Zhang, H | 1 |
| Chang, SC; Chen, YC; Chuang, YC; Huang, SH; Lin, CY; Wang, JT; Yang, JL | 1 |
| Glajzner, P; Lisiecki, P; Szemraj, M; Szewczyk, EM | 1 |
| Pawlak, J; Saravolatz, LD | 1 |
| Aguinaga Pérez, A; Blanco-Di Matteo, A; Carmona-Torre, F; Del Pozo, JL; Garcia-Fernandez, N; Leiva, J; Oteiza, AC | 1 |
| Chatre, C; Dunyach-Remy, C; Lavigne, JP; Pantel, A; Pouget, C; Reynes, J | 1 |
| Chang, SC; Chen, YC; Chuang, YC; Huang, SH; Huang, ST; Lin, CY; Wang, JT; Yang, JL | 1 |
| Ernst, G; Kot, L; Scolari, M; Trovato, D | 1 |
| Biondi, M; Casadidio, C; Censi, R; Cortese, M; De Rosa, G; Di Martino, P; Hennink, WE; Mayol, L; Scuri, S; Vermonden, T | 1 |
| Hasegawa, S; Imai, M; Izumisawa, T; Saito, D; Takahashi, N; Yamasaki, M | 1 |
| Bleick, C; Daffinee, KE; LaPlante, KL; Piehl, EC | 1 |
| Derks, RJE; Frees, D; Giera, M; Guérillot, R; Henriksen, C; Howden, BP; Jacques, N; Jiang, JH; Leeten, K; Mebus, V; Oury, C; Peleg, AY; Petersen, A; Sánchez-López, E; Stinear, TP; Xu, L | 1 |
| El Ghali, A; Holger, D; Kebriaei, R; Kunz Coyne, AJ; Lehman, SM; Rybak, MJ; Shah, RM; Stamper, KC | 1 |
| Baquero-Artigao, F; Calvo, C; Jiménez, C; Méndez-Echevarría, A; Permuy, C; Ruiz-Azcárate, J; Sampedro, M | 1 |
| Cai, Y; Xu, J; Yang, T; Yin, H; Zhang, G; Zhang, N | 1 |
| An, Z; Feng, X; Yang, H; Zhang, Y | 1 |
| Jang, SM; Lewis, SJ; Mueller, BA | 1 |
| Alzahrani, HA | 1 |
66 review(s) available for vancomycin and daptomycin
| Article | Year |
|---|---|
[Recent trend and development of novel antimicrobial agents for MRSA infections].
Topics: Daptomycin; Glycopeptides; Humans; Methicillin Resistance; Peptides; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Virginiamycin | 1992 |
[Bacteremia caused by vancomycin-resistant Enterococcus faecalis. Report of 2 cases].
Topics: Aged; Bacteremia; Cross Infection; Daptomycin; Drug Resistance, Microbial; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Peptides; Pneumonia; Postoperative Complications; Retrospective Studies; Urinary Tract Infections; Vancomycin | 1991 |
Treatment of infection and colonization caused by methicillin-resistant Staphylococcus aureus.
Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Colony Count, Microbial; Daptomycin; Glycopeptides; Humans; Lactams; Methicillin Resistance; Peptides; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 1991 |
Therapeutic update on glycopeptide and lipopeptide antibiotics.
Topics: Bacterial Infections; Daptomycin; Drug Resistance, Microbial; Glycopeptides; Humans; Penicillin Resistance; Peptides; Protein Binding; Staphylococcus; Streptococcus; Teicoplanin; Vancomycin | 1988 |
[New antibacterial agents].
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Oxazolidinones; Protein Synthesis Inhibitors; Vancomycin; Virginiamycin | 1999 |
Antibiotics for gram-positive bacterial infections: vancomycin, quinupristin-dalfopristin, linezolid, and daptomycin.
Topics: Anti-Bacterial Agents; Daptomycin; Gram-Positive Bacterial Infections; Humans; Vancomycin; Virginiamycin | 2004 |
Newer antibiotics for serious gram-positive infections.
Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Middle Aged; Vancomycin; Virginiamycin | 2006 |
Antimicrobial symposium. Part VIII. Glycopeptides, oxazolidinones, and lipopeptides.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Drug Resistance, Microbial; Glycopeptides; Humans; Linezolid; Molecular Structure; Oxazolidinones; Peptides, Cyclic; Vancomycin | 2007 |
[Therapeutic perspectives of linezolid in the management of infections due to multiresistant Gram-positive pathogens].
Topics: Acetamides; Administration, Oral; Anti-Infective Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Practice Guidelines as Topic; Staphylococcus aureus; Streptococcus pneumoniae; Teicoplanin; Tigecycline; Time Factors; Vancomycin; Virginiamycin | 2007 |
Combating the growing problem of methicillin-resistant Staphylococcus aureus: do the newer antibiotics represent a better alternative to vancomycin?
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Linezolid; Methicillin Resistance; Minocycline; Oxazolidinones; Staphylococcus aureus; Tigecycline; Vancomycin; Virginiamycin | 2007 |
Treatment of infections caused by resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin Resistance; Minocycline; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Tigecycline; Vancomycin; Virginiamycin | 2007 |
Optimizing therapy for MRSA pneumonia.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Humans; Linezolid; Methicillin Resistance; Minocycline; Oxazolidinones; Pneumonia, Bacterial; Staphylococcus aureus; Tigecycline; Vancomycin | 2007 |
Optimizing therapy for methicillin-resistant Staphylococcus aureus bacteremia.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Daptomycin; Endocarditis; Equipment Contamination; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Staphylococcus aureus; Vancomycin | 2007 |
[Improvement of bactericide activity in hospital treatment of gram positive infections].
Topics: Anti-Bacterial Agents; Cross Infection; Daptomycin; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Hospitals; Humans; Vancomycin | 2008 |
Antimicrobial agents in treatment of MRSA infections.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Clindamycin; Community-Acquired Infections; Daptomycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluoroquinolones; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tetracyclines; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Vancomycin | 2008 |
Are glycopeptides still appropriate and convenient for empiric use?
Topics: Anti-Bacterial Agents; Daptomycin; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Intensive Care Units; Teicoplanin; United Kingdom; Vancomycin | 2008 |
Review: Daptomycin for the treatment of gram-positive infections in neutropenic cancer patients.
Topics: Anti-Bacterial Agents; Daptomycin; Humans; Leukemia, Myeloid, Acute; Methicillin-Resistant Staphylococcus aureus; Neutropenia; Staphylococcal Infections; Vancomycin | 2008 |
Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions.
Topics: Anti-Bacterial Agents; Daptomycin; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Antibiotics for gram-positive bacterial infections: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, dalbavancin, and telavancin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Peptides, Cyclic; Teicoplanin; Vancomycin; Virginiamycin | 2009 |
[Lipopeptides and oxazolidinones--novel antibiotics in MRSA infection treatment].
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Vancomycin | 2010 |
Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Microbial; Humans; Linezolid; Minocycline; Oxazolidinones; Skin Diseases; Soft Tissue Infections; Tigecycline; Vancomycin | 2010 |
Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naïve patient--a review of the literature.
Topics: Anti-Bacterial Agents; Bacteremia; Cell Wall; Daptomycin; Drug Resistance, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microscopy, Electron, Transmission; Osteomyelitis; Staphylococcal Infections; Vancomycin | 2011 |
Antibiotic dosing during sustained low-efficiency dialysis: special considerations in adult critically ill patients.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Critical Care; Daptomycin; Echinocandins; Fluoroquinolones; Humans; Linezolid; Oxazolidinones; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis; Renal Insufficiency; Vancomycin | 2011 |
Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits?
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Endocarditis, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Pneumonia, Bacterial; Staphylococcal Infections; Teicoplanin; Tigecycline; Treatment Outcome; Vancomycin | 2011 |
[Role of daptomycin in the empirical and directed therapy of infections caused by Gram-positive bacteria in the critically ill patient].
Topics: Anti-Bacterial Agents; Critical Care; Critical Illness; Daptomycin; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Soft Tissue Infections; Vancomycin; Vancomycin Resistance | 2011 |
[Current treatment of Gram-positive infections: from experimental models to clinical experience after approval of new drugs].
Topics: Animals; Anti-Bacterial Agents; Biofilms; Clinical Trials as Topic; Daptomycin; Drug Approval; Drug Evaluation, Preclinical; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Models, Animal; Osteomyelitis; Prosthesis-Related Infections; Rabbits; Rats; Rats, Wistar; Staphylococcal Infections; Vancomycin | 2010 |
[Update of antimicrobial resistance in Gram-positive microorganisms].
Topics: Acetamides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Daptomycin; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Enterococcus; Europe; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; United States; Vancomycin | 2010 |
Clinical activity of anti-Gram-positive agents against methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2011 |
Management of antibiotic-resistant infection in the newborn.
Topics: Acetamides; Anti-Bacterial Agents; Carbapenems; Colistin; Daptomycin; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Linezolid; Oxazolidinones; Vancomycin | 2011 |
[Staphylococcus aureus and antibiotic resistance].
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Protein Synthesis Inhibitors; Staphylococcal Infections; Teicoplanin; Tigecycline; Vancomycin; Vancomycin Resistance; Virginiamycin | 2011 |
[Treatment of resistant Gram-positive bacterial infections].
Topics: Animals; Anti-Bacterial Agents; Catheter-Related Infections; Cloxacillin; Daptomycin; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Kidney Diseases; Methicillin-Resistant Staphylococcus aureus; Rats; Staphylococcal Infections; Vancomycin | 2011 |
[Progress in the study of some important natural bioactive cyclopeptides].
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Cyclosporine; Daptomycin; Depsipeptides; Gramicidin; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Molecular Structure; Neoplasms; Peptides, Cyclic; Quantitative Structure-Activity Relationship; Vancomycin | 2012 |
[The cutting-edge of medicine anti-MRSA agents; how to select and how to use].
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Daptomycin; Dibekacin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Vancomycin | 2012 |
Daptomycin nonsusceptible enterococci in hematologic malignancy and hematopoietic stem cell transplant patients: an emerging threat.
Topics: Anti-Bacterial Agents; Bacteremia; Colitis; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Graft vs Host Disease; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Iowa; Opportunistic Infections; Postoperative Complications; Retrospective Studies; Vancomycin; Vancomycin Resistance | 2013 |
Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cell Wall; Daptomycin; Drug Resistance, Bacterial; Humans; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2013 |
[Guidelines for antimicrobial treatment of the infection by Staphylococcus aureus].
Topics: Acetamides; Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactams; Clindamycin; Daptomycin; Disease Models, Animal; Fluoroquinolones; Fosfomycin; Guidelines as Topic; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2013 |
A current perspective on daptomycin for the clinical microbiologist.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Homeostasis; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcus aureus; United States; United States Food and Drug Administration; Vancomycin | 2013 |
Systematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremia.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Combinations; Enterococcus; Humans; Linezolid; Middle Aged; Oxazolidinones; Retrospective Studies; Survival Analysis; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2014 |
Use of daptomycin to treat infections with methicillin-resistant Staphylococcus aureus isolates having vancomycin minimum inhibitory concentrations of 1.5 to 2 μg/mL.
Topics: Anti-Bacterial Agents; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2013 |
Bioconjugated magnetic nanoparticles for the detection of bacteria.
Topics: Antibodies; Bacteria; Bacteriological Techniques; Biosensing Techniques; Blood-Borne Pathogens; Daptomycin; Humans; Magnetite Nanoparticles; Nanoconjugates; Vancomycin | 2013 |
[Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era].
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Drugs, Investigational; Genes, Bacterial; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Methicillin-Resistant Staphylococcus aureus; Minocycline; Staphylococcal Infections; Tigecycline; Vancomycin | 2014 |
Clinical management of Staphylococcus aureus bacteremia: a review.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Therapy, Combination; Echocardiography, Transesophageal; Endocarditis, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2014 |
Optimizing therapy for vancomycin-resistant enterococcal bacteremia in children.
Topics: Acetamides; Adolescent; Child; Child, Preschool; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Risk Factors; Treatment Outcome; Vancomycin; Vancomycin-Resistant Enterococci; Virginiamycin | 2014 |
Vancomycin-resistant enterococcal bacteremia pharmacotherapy.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Vancomycin; Vancomycin-Resistant Enterococci; Virginiamycin | 2015 |
Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Humans; Linezolid; Oxazolidinones; Retrospective Studies; Treatment Outcome; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2014 |
Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Linezolid; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2015 |
Staphylococcus aureus with reduced susceptibility to vancomycin in healthcare settings.
Topics: Anti-Bacterial Agents; Cross Infection; Daptomycin; Hand Hygiene; Humans; Infection Control; Methicillin-Resistant Staphylococcus aureus; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2014 |
MRSA in Croatia: prevalence and management.
Topics: Animals; Anti-Bacterial Agents; Carrier State; Cattle; Croatia; Daptomycin; Humans; Linezolid; Livestock; Methicillin-Resistant Staphylococcus aureus; Minocycline; Prevalence; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Swine; Teicoplanin; Tigecycline; Vancomycin; Zoonoses | 2016 |
Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Daptomycin; Female; Fluoroquinolones; Glycopeptides; Hospitalization; Humans; Iatrogenic Disease; Internal Medicine; Linezolid; Lipoglycopeptides; Male; Minocycline; Oxazolidinones; Skin Diseases, Infectious; Soft Tissue Infections; Teicoplanin; Tigecycline; Vancomycin | 2016 |
Bacteremia due to Methicillin-Resistant Staphylococcus aureus: New Therapeutic Approaches.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2016 |
Treatment Options for Persistent Coagulase Negative Staphylococcal Bacteremia in Neonates.
Topics: Anti-Infective Agents; Daptomycin; Dose-Response Relationship, Drug; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Linezolid; Retrospective Studies; Rifampin; Sepsis; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2016 |
Methicillin-resistant Staphylococcus aureus infections: A review of the currently available treatment options.
Topics: Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2016 |
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA.
Topics: Anti-Bacterial Agents; Bayes Theorem; Ceftaroline; Cephalosporins; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles; Vancomycin | 2017 |
Future trends in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection: An in-depth review of newer antibiotics active against an enduring pathogen.
Topics: Anti-Bacterial Agents; beta-Lactams; Clinical Trials as Topic; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Multicenter Studies as Topic; Staphylococcal Infections; Vancomycin | 2017 |
Morbidity, mortality, and management of methicillin-resistant S. aureus bacteremia in the USA: update on antibacterial choices and understanding.
Topics: Anti-Bacterial Agents; Bacteremia; Daptomycin; Health Care Costs; Humans; Methicillin-Resistant Staphylococcus aureus; United States; Vancomycin | 2018 |
Current and future treatment options for community-associated MRSA infection.
Topics: Anti-Bacterial Agents; Clindamycin; Community-Acquired Infections; Daptomycin; Doxycycline; Drug Combinations; Humans; Injections, Intravenous; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Sulfadoxine; Trimethoprim; Vancomycin | 2018 |
Can β-Lactam Antibiotics Be Resurrected to Combat MRSA?
Topics: Anti-Bacterial Agents; beta-Lactams; Daptomycin; Drug Synergism; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2019 |
Efficacy and safety of daptomycin versus linezolid treatment in patients with vancomycin-resistant enterococcal bacteraemia: An updated systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Bacteremia; Daptomycin; Humans; Linezolid; Vancomycin | 2020 |
Combination of Vancomycin or Daptomycin and Beta-lactam Antibiotics: A Meta-analysis.
Topics: Anti-Bacterial Agents; beta-Lactams; Daptomycin; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Observational Studies as Topic; Randomized Controlled Trials as Topic; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2020 |
Adjuvant β-Lactam Therapy Combined with Vancomycin or Daptomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia: a Systematic Review and Meta-analysis.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2020 |
Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Clinical Trials as Topic; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2020 |
What do beta-lactams add to vancomycin or daptomycin in the treatment of patients with methicillin-resistant
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cloxacillin; Daptomycin; Floxacillin; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2022 |
Vancomycin or Daptomycin Plus a β-Lactam Versus Vancomycin or Daptomycin Alone for Methicillin-Resistant
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Daptomycin; Drug Therapy, Combination; Humans; Length of Stay; Methicillin-Resistant Staphylococcus aureus; Observational Studies as Topic; Randomized Controlled Trials as Topic; Staphylococcal Infections; Vancomycin | 2021 |
Ceftaroline: Systematic Review of Clinical Uses and Emerging Drug Resistance.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Daptomycin; Drug Resistance; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2022 |
Antimicrobial Susceptibility Testing for Enterococci.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Daptomycin; Enterococcus; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Oxazolidinones; Tetracycline; Vancomycin | 2022 |
Efficacy and safety of vancomycin for the treatment of Staphylococcus aureus bacteraemia: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Bacteremia; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2023 |
24 trial(s) available for vancomycin and daptomycin
| Article | Year |
|---|---|
Pharmacokinetics and bactericidal rates of daptomycin and vancomycin in intravenous drug abusers being treated for gram-positive endocarditis and bacteremia.
Topics: Adult; Bacteremia; Daptomycin; Endocarditis, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Peptides; Substance Abuse, Intravenous; Vancomycin | 1992 |
Ex vivo study of serum bactericidal titers and killing rates of daptomycin (LY146032) combined or not combined with amikacin compared with those of vancomycin.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Corynebacterium; Daptomycin; Drug Therapy, Combination; Enterococcus faecalis; Humans; Microbial Sensitivity Tests; Peptides; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 1989 |
The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Daptomycin; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Penicillins; Skin Diseases, Infectious; Soft Tissue Infections; Treatment Outcome; Vancomycin | 2004 |
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Daptomycin; Endocarditis, Bacterial; Female; Gentamicins; Humans; Male; Methicillin Resistance; Middle Aged; Penicillins; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2006 |
Daptomycin versus vancomycin for complicated skin and skin structure infections: clinical and economic outcomes.
Topics: Abscess; Adult; Aged; Anti-Bacterial Agents; Cellulitis; Cost-Benefit Analysis; Daptomycin; Female; Hospital Costs; Humans; Injections, Intravenous; Male; Middle Aged; Prospective Studies; Skin Diseases, Infectious; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2007 |
Microbiological and genotypic analysis of methicillin-resistant Staphylococcus aureus bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Daptomycin; Endocarditis, Bacterial; Genotype; Hemolysin Proteins; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2008 |
Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Daptomycin; Endocarditis, Bacterial; Female; Gentamicins; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2008 |
Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cohort Studies; Creatinine; Daptomycin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Gentamicins; Humans; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Penicillins; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Young Adult | 2009 |
The efficacy and safety of daptomycin vs. vancomycin for the treatment of cellulitis and erysipelas.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cellulitis; Daptomycin; Erysipelas; Female; Humans; Male; Middle Aged; Prospective Studies; Treatment Outcome; Vancomycin; Young Adult | 2009 |
Clinical characteristics and outcomes of diabetic patients with Staphylococcus aureus bacteremia and endocarditis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Daptomycin; Diabetes Complications; Endocarditis, Bacterial; Female; Gentamicins; Humans; Male; Middle Aged; Penicillins; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Systemic Inflammatory Response Syndrome; Treatment Outcome; Vancomycin | 2009 |
Vascular surgical antibiotic prophylaxis study (VSAPS).
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Chi-Square Distribution; Daptomycin; Drug Administration Schedule; Elective Surgical Procedures; Female; Humans; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Odds Ratio; Prospective Studies; Risk Assessment; Risk Factors; Staphylococcal Infections; Surgical Wound Infection; Treatment Outcome; Vancomycin; Vascular Surgical Procedures; West Virginia | 2010 |
Comparative randomised clinical trial against glycopeptides supports the use of daptomycin as first-line treatment of complicated skin and soft-tissue infections.
Topics: Aged; Anti-Bacterial Agents; Daptomycin; Glycopeptides; Humans; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2012 |
Randomized controlled trial of the safety and efficacy of Daptomycin versus standard-of-care therapy for management of patients with osteomyelitis associated with prosthetic devices undergoing two-stage revision arthroplasty.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biomarkers; Creatine Kinase; Daptomycin; Drug Administration Schedule; Female; Hip Prosthesis; Humans; Knee Prosthesis; Male; Middle Aged; Osteomyelitis; Penicillins; Staphylococcal Infections; Staphylococcus aureus; Synovial Fluid; Treatment Outcome; Vancomycin | 2012 |
Efficacy and safety of intravenous daptomycin in Japanese patients with skin and soft tissue infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Creatinine; Daptomycin; Female; Humans; Kidney Function Tests; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Soft Tissue Infections; Staphylococcal Skin Infections; Vancomycin | 2013 |
Vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations: study protocol for a phase IIB randomized controlled trial.
Topics: Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Administration Schedule; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pilot Projects; Prospective Studies; Research Design; Staphylococcal Infections; Vancomycin; Young Adult | 2014 |
Prospective randomized double-blinded trial comparing 2 anti-MRSA agents with supplemental coverage of cefazolin before lower extremity revascularization.
Topics: Adult; Aged; Antibiotic Prophylaxis; Cefazolin; Chi-Square Distribution; Daptomycin; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lower Extremity; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Patient Safety; Peripheral Vascular Diseases; Preoperative Care; Prospective Studies; Radiography; Risk Assessment; Staphylococcal Infections; Surgical Wound Infection; Treatment Outcome; Vancomycin; Vascular Surgical Procedures | 2015 |
Randomized Controlled Noninferiority Trial Comparing Daptomycin to Vancomycin for the Treatment of Complicated Skin and Skin Structure Infections in an Observation Unit.
Topics: Adult; Anti-Bacterial Agents; Daptomycin; Emergency Service, Hospital; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Prospective Studies; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin | 2015 |
An open-label, pragmatic, randomized controlled clinical trial to evaluate the comparative effectiveness of daptomycin versus vancomycin for the treatment of complicated skin and skin structure infection.
Topics: Adult; Anti-Bacterial Agents; Daptomycin; Drug Costs; Female; Hospital Costs; Humans; Length of Stay; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Skin Diseases, Infectious; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2015 |
CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.
Topics: Anti-Bacterial Agents; Australia; beta-Lactams; Cefazolin; Clinical Protocols; Cloxacillin; Daptomycin; Drug Therapy, Combination; Floxacillin; Humans; Israel; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; New Zealand; Research Design; Singapore; Staphylococcal Infections; Time Factors; Treatment Outcome; Vancomycin | 2016 |
Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cohort Studies; Daptomycin; Humans; Intensive Care Units; Length of Stay; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2016 |
Daptomycin for Complicated Skin Infections: A Randomized Trial.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clindamycin; Creatine Kinase; Daptomycin; Diarrhea; Drug Administration Schedule; Female; Fever; Gram-Positive Bacterial Infections; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Single-Blind Method; Skin Diseases, Bacterial; Vancomycin | 2017 |
A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated study.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Cause of Death; Daptomycin; Drug Resistance, Bacterial; Early Termination of Clinical Trials; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Recurrence; Singapore; Staphylococcal Infections; Time Factors; Treatment Outcome; Vancomycin | 2018 |
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Cloxacillin; Daptomycin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Floxacillin; Follow-Up Studies; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Treatment Failure; Vancomycin | 2020 |
Adjunctive Daptomycin in the Treatment of Methicillin-susceptible Staphylococcus aureus Bacteremia: A Randomized, Controlled Trial.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Canada; Daptomycin; Female; Humans; Male; Methicillin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2021 |
545 other study(ies) available for vancomycin and daptomycin
| Article | Year |
|---|---|
Comparative in-vitro activity of four peptide antibiotics against penicillin-resistant Streptococcus pneumoniae isolated from cerebrospinal fluid (CSF).
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cerebrospinal Fluid; Daptomycin; Erythromycin; Fluoroquinolones; Glycopeptides; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Peptides; Quinolones; Serotyping; Streptococcus pneumoniae; Teicoplanin; Vancomycin | 1992 |
Contribution of animal models in the search for effective therapy for endocarditis due to enterococci with high-level resistance to gentamicin.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Daptomycin; Disease Models, Animal; Drug Resistance, Microbial; Endocarditis, Bacterial; Enterococcus faecalis; Gentamicins; Glycopeptides; Gram-Positive Bacterial Infections; Peptides; Rats; Teicoplanin; Vancomycin | 1992 |
Pharmacodynamic effects of antibiotics. Studies on bacterial morphology, initial killing, postantibiotic effect and effective regrowth time.
Topics: Amdinocillin; Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Cephalosporins; Daptomycin; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Peptides; Piperacillin; Vancomycin | 1992 |
Comparative in vitro activities of teicoplanin, daptomycin, ramoplanin, vancomycin, and PD127,391 against blood isolates of gram-positive cocci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Depsipeptides; Enterococcus faecalis; Fluoroquinolones; Glycopeptides; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Quinolones; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 1992 |
Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Daptomycin; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus; Enterococcus faecalis; Female; Gentamicins; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Penicillin Resistance; Peptides; Rabbits; Vancomycin | 1992 |
In vitro activity of the new glycopeptide decaplanin.
Topics: Anti-Bacterial Agents; Daptomycin; Enterococcus faecalis; Glycopeptides; Gram-Negative Bacteria; Microbial Sensitivity Tests; Peptides; Staphylococcus; Streptococcus; Teicoplanin; Vancomycin | 1992 |
In vitro pharmacodynamic effects of concentration, pH, and growth phase on serum bactericidal activities of daptomycin and vancomycin.
Topics: Blood Bactericidal Activity; Culture Media; Daptomycin; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Peptides; Protein Binding; Serum Bactericidal Test; Staphylococcus aureus; Vancomycin | 1992 |
In-vitro activity of daptomycin against a worldwide collection of methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Daptomycin; Global Health; Methicillin Resistance; Microbial Sensitivity Tests; Peptides; Species Specificity; Staphylococcus aureus; Vancomycin | 1992 |
Activity of mersacidin, a novel peptide, compared with that of vancomycin, teicoplanin, and daptomycin.
Topics: Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Bacteriocins; Daptomycin; Glycopeptides; Macrolides; Microbial Sensitivity Tests; Peptides; Teicoplanin; Vancomycin | 1991 |
Mechanisms and implications of glycopeptide resistance in enterococci.
Topics: Anti-Bacterial Agents; Daptomycin; Depsipeptides; Drug Resistance, Microbial; Enterococcus; Glycopeptides; Peptides; Peptides, Cyclic; Teicoplanin; Vancomycin | 1991 |
Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugs.
Topics: Albumins; Anti-Bacterial Agents; Calcium; Daptomycin; Drug Interactions; Enterococcus faecalis; Microbial Sensitivity Tests; Peptides; Staphylococcus aureus; Vancomycin | 1991 |
Effects of vancomycin, teicoplanin, daptomycin and coumermycin on normal immune capabilities.
Topics: Aminocoumarins; Animals; Anti-Bacterial Agents; Coumarins; Daptomycin; Glycopeptides; Humans; Immunity, Cellular; Leukocytes; Male; Mice; Mice, Inbred BALB C; Organ Size; Peptides; Phagocytosis; Spleen; Teicoplanin; Vancomycin | 1991 |
Bactericidal activity of daptomycin against vancomycin-resistant Enterococcus faecium in an in vitro pharmacokinetic model.
Topics: Albumins; Anti-Bacterial Agents; Daptomycin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Enterococcus faecium; Microbial Sensitivity Tests; Models, Biological; Peptides; Serum Bactericidal Test; Vancomycin | 1991 |
In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and Clostridium difficile.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Daptomycin; Depsipeptides; Drug Resistance, Microbial; Glycopeptides; Gram-Positive Bacteria; Methicillin Resistance; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Rifamycins; Ristocetin; Staphylococcus; Streptococcus; Teicoplanin; Vancomycin | 1990 |
Elution of vancomycin, daptomycin, and amikacin from acrylic bone cement.
Topics: Amikacin; Anti-Bacterial Agents; Atmospheric Pressure; Bacteria; Bone Cements; Daptomycin; Dextrans; Diffusion; Methylmethacrylates; Peptides; Porosity; Vancomycin | 1991 |
Assessment of effects of protein binding on daptomycin and vancomycin killing of Staphylococcus aureus by using an in vitro pharmacodynamic model.
Topics: Daptomycin; Dose-Response Relationship, Drug; Models, Biological; Peptides; Protein Binding; Regression Analysis; Staphylococcus aureus; Vancomycin | 1990 |
Daptomycin versus vancomycin treatment for Staphylococcus aureus bacteremia in a murine model.
Topics: Animals; Daptomycin; Female; Mice; Microbial Sensitivity Tests; Peptides; Sepsis; Staphylococcal Infections; Vancomycin | 1990 |
Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis.
Topics: Animals; Anti-Bacterial Agents; Blood Proteins; Daptomycin; Endocarditis, Bacterial; Glycopeptides; Male; Methicillin Resistance; Microbial Sensitivity Tests; Peptides; Protein Binding; Rabbits; Staphylococcal Infections; Teicoplanin; Vancomycin | 1990 |
Bactericidal activity of vancomycin, daptomycin, ampicillin and aminoglycosides against vancomycin-resistant Enterococcus faecium.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Conjugation, Genetic; Daptomycin; Drug Resistance, Microbial; Drug Synergism; Kinetics; Microbial Sensitivity Tests; Peptides; Streptococcal Infections; Streptococcus; Vancomycin | 1990 |
Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination.
Topics: Animals; Cloxacillin; Daptomycin; Endocarditis, Bacterial; Female; Microbial Sensitivity Tests; Peptides; Rats; Rats, Inbred Strains; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1990 |
Treatment evaluation of experimental staphylococcal infections: comparison of beta-lactam, lipopeptide, and glycopeptide antimicrobial therapy.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefamandole; Cefoperazone; Cephalothin; Daptomycin; Disease Models, Animal; Female; Glycopeptides; Oxacillin; Peptides; Rabbits; Staphylococcal Infections; Sulbactam; Teicoplanin; Vancomycin | 1990 |
Effects of daptomycin and vancomycin on tobramycin nephrotoxicity in rats.
Topics: Animals; Daptomycin; Drug Interactions; Female; Kidney Cortex; Kidney Diseases; Kidney Medulla; Peptides; Rats; Rats, Inbred Strains; Sphingomyelin Phosphodiesterase; Thymidine; Tobramycin; Vancomycin | 1990 |
Staphylococcus aureus ventriculitis treated with single-dose intraventricular vancomycin or daptomycin (LY146032): bacterial and antibiotic kinetics in hydrocephalic rabbits.
Topics: Animals; Bacterial Infections; Cerebral Ventricles; Daptomycin; Encephalitis; Female; Hydrocephalus; Injections, Intraventricular; Male; Peptides; Rabbits; Staphylococcal Infections; Vancomycin | 1990 |
In vitro response to bactericidal activity of cell wall-active antibiotics does not support the general opinion that enterococci are naturally tolerant to these antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; Cell Wall; Daptomycin; Drug Resistance, Microbial; Enterococcus faecalis; Microbial Sensitivity Tests; Penicillins; Peptides; Piperacillin; Vancomycin | 1990 |
Antibiotic resistance of biomaterial-adherent coagulase-negative and coagulase-positive staphylococci.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Biocompatible Materials; Cefazolin; Coagulase; Daptomycin; Drug Resistance, Microbial; Gentamicins; Microbial Sensitivity Tests; Nafcillin; Peptides; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 1990 |
Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Microbial; Evaluation Studies as Topic; Glycopeptides; Microbial Sensitivity Tests; Oxacillin; Peptides; Staphylococcus; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 1989 |
[Bactericidal activity of daptomycin and vancomycin alone or in combination with tobramycin, netilmicin or ampicillin against enterococcus].
Topics: Ampicillin; Anti-Bacterial Agents; Daptomycin; Drug Therapy, Combination; Enterococcus faecalis; Microbial Sensitivity Tests; Netilmicin; Peptides; Streptococcus; Tobramycin; Vancomycin | 1989 |
Comparative evaluation of daptomycin (LY146032) and vancomycin in the treatment of experimental methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits.
Topics: Animals; Anti-Bacterial Agents; Body Weight; Bone and Bones; Daptomycin; Female; Methicillin; Osteomyelitis; Penicillin Resistance; Peptides; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1989 |
In vitro activity of SK&F 104662, a new glycopeptide antibiotic.
Topics: Anti-Bacterial Agents; Clindamycin; Daptomycin; Enterococcus faecalis; Glycopeptides; Gram-Positive Bacteria; Microbial Sensitivity Tests; Peptides; Teicoplanin; Vancomycin | 1989 |
Comparison of in vitro activity of daptomycin, vancomycin and fluoroquinolones in broth and serum against Staphylococcus epidermidis as determined by time-kill kinetics.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Daptomycin; Fluoroquinolones; Kinetics; Microbial Sensitivity Tests; Peptides; Staphylococcus epidermidis; Vancomycin | 1989 |
Treatment of chronic experimental Staphylococcus aureus osteomyelitis with LY146032 and vancomycin.
Topics: Animals; Anti-Bacterial Agents; Chronic Disease; Daptomycin; Male; Osteomyelitis; Peptides; Rats; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1989 |
Comparative in vitro activity of daptomycin (LY146032) and vancomycin against gram-positive cocci determined using a pharmacokinetic model.
Topics: Daptomycin; Enterococcus faecalis; Kinetics; Microbial Sensitivity Tests; Models, Chemical; Peptides; Staphylococcus aureus; Vancomycin | 1989 |
[Bactericidal effect of daptomycin (LY 146032) compared with vancomycine and teicoplanin against gram-positive bacteria].
Topics: Anti-Bacterial Agents; Daptomycin; Glycopeptides; Gram-Positive Bacteria; Microbial Sensitivity Tests; Peptides; Teicoplanin; Vancomycin | 1989 |
In vitro activities of daptomycin and other antimicrobial agents against vancomycin-resistant gram-positive bacteria.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Microbial; Gram-Positive Bacteria; Microbial Sensitivity Tests; Peptides; Vancomycin | 1989 |
In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Microbial; Enterococcus faecalis; Glycopeptides; Microbial Sensitivity Tests; Peptides; Teicoplanin; Time Factors; Vancomycin | 1989 |
Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies.
Topics: Anti-Bacterial Agents; Cefamandole; Cefazolin; Cefuroxime; Ciprofloxacin; Culture Media; Daptomycin; Kinetics; Methicillin; Microbial Sensitivity Tests; Peptides; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 1987 |
Bactericidal activity of deptomycin (LY146032) compared with those of ciprofloxacin, vancomycin, and ampicillin against enterococci as determined by kill-kinetic studies.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Daptomycin; Enterococcus faecalis; Humans; Microbial Sensitivity Tests; Peptides; Vancomycin | 1987 |
Treatment of Clostridium difficile colitis in hamsters with a lipopeptide antibiotic, LY146032.
Topics: Animals; Anti-Bacterial Agents; Clindamycin; Cricetinae; Daptomycin; Disease Models, Animal; Enterocolitis, Pseudomembranous; Male; Mesocricetus; Peptides; Vancomycin | 1987 |
Comparative in-vitro activity of LY146032 a new peptolide, with vancomycin and eight other agents against gram-positive organisms.
Topics: Anti-Bacterial Agents; Daptomycin; Gram-Positive Bacteria; Microbial Sensitivity Tests; Nafcillin; Penicillin Resistance; Peptides; Vancomycin | 1987 |
In-vitro susceptibility of gram-positive cocci to LY146032 teicoplanin, sodium fusidate, vancomycin, and rifampicin.
Topics: Anti-Bacterial Agents; Daptomycin; Fusidic Acid; Glycopeptides; Gram-Positive Bacteria; Microbial Sensitivity Tests; Peptides; Rifampin; Teicoplanin; Vancomycin | 1987 |
In-vitro activity of LY146032 against Staphylococcus aureus and S. epidermidis.
Topics: Anti-Bacterial Agents; Daptomycin; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Peptides; Staphylococcus aureus; Staphylococcus epidermidis; Time Factors; Vancomycin | 1987 |
Comparative activity of LY146032 against anaerobic cocci.
Topics: Anti-Bacterial Agents; Calcium; Culture Media; Daptomycin; Drug Synergism; Glycopeptides; Humans; Penicillin G; Peptides; Peptococcus; Peptostreptococcus; Teicoplanin; Vancomycin | 1987 |
Comparative in vitro activity of the new peptolide antibiotic LY146032 against staphylococci.
Topics: Animals; Anti-Bacterial Agents; Daptomycin; Glycopeptides; Humans; Peptides; Staphylococcus; Staphylococcus aureus; Teicoplanin; Vancomycin | 1987 |
LY146032 treatment of Clostridium difficile colitis in hamsters.
Topics: Animals; Anti-Bacterial Agents; Cricetinae; Daptomycin; Enterocolitis, Pseudomembranous; Male; Mesocricetus; Peptides; Vancomycin | 1987 |
Comparison of cefazolin, cefamandole, vancomycin, and LY146032 for prophylaxis of experimental Staphylococcus epidermidis endocarditis.
Topics: Animals; Anti-Bacterial Agents; Cefamandole; Cefazolin; Cephalosporins; Daptomycin; Drug Resistance, Microbial; Endocarditis, Bacterial; Methicillin; Penicillin Resistance; Peptides; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1988 |
LY146032, alone and in combination with gentamicin, for the treatment of enterococcal pyelonephritis in the rat model.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Enterococcus faecalis; Gentamicins; Male; Microbial Sensitivity Tests; Peptides; Pyelonephritis; Random Allocation; Rats; Rats, Inbred Strains; Streptococcal Infections; Vancomycin | 1988 |
Comparison of the investigational drug, LY146032, with vancomycin in experimental pneumonia due to methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Cricetinae; Daptomycin; Intubation, Intratracheal; Male; Mesocricetus; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Peptides; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin | 1988 |
Early stages of in vitro killing curve of LY146032 and vancomycin for Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Daptomycin; Microbial Sensitivity Tests; Peptides; Staphylococcus aureus; Vancomycin | 1988 |
In vitro activities of daptomycin (LY146032) and paldimycin (U-70,138F) against anaerobic gram-positive bacteria.
Topics: Acetylcysteine; Anti-Bacterial Agents; Bacteria, Anaerobic; Culture Media; Daptomycin; Disaccharides; Glycopeptides; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Penicillin G; Peptides; Vancomycin | 1988 |
[Demonstration of an inoculum effect on the estimation of the minimal inhibitory concentration of LY 146032].
Topics: Anti-Bacterial Agents; Bacteria; Bacteriological Techniques; Daptomycin; Enterococcus faecalis; Microbial Sensitivity Tests; Peptides; Staphylococcus; Staphylococcus aureus; Streptococcus agalactiae; Vancomycin | 1988 |
Antistaphylococcal activity of a cyclic peptide, LY146032, and vancomycin.
Topics: Anti-Bacterial Agents; Daptomycin; Humans; Microbial Sensitivity Tests; Oxacillin; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 1986 |
In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocci.
Topics: Ampicillin; Anti-Bacterial Agents; Daptomycin; Kinetics; Microbial Sensitivity Tests; Oxacillin; Staphylococcus; Streptococcus; Vancomycin | 1987 |
Comparative in vitro activity of LY146032 (daptomycin), a new lipopeptide antimicrobial.
Topics: Ampicillin; Anti-Bacterial Agents; Clostridium; Daptomycin; Glycopeptides; Gram-Positive Bacteria; Humans; Listeria monocytogenes; Microbial Sensitivity Tests; Oxacillin; Peptides; Staphylococcus; Streptococcus; Teicoplanin; Vancomycin | 1987 |
In vitro activity of LY146032 (daptomycin) against selected aerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Corynebacterium; Daptomycin; Listeria monocytogenes; Microbial Sensitivity Tests; Peptides; Staphylococcus; Streptococcus; Vancomycin | 1987 |
Comparative in vitro activity of LY146032 (daptomycin) against gram-positive cocci.
Topics: Aminocoumarins; Anti-Bacterial Agents; Coumarins; Daptomycin; Glycopeptides; Microbial Sensitivity Tests; Peptides; Staphylococcus; Streptococcus; Teicoplanin; Vancomycin | 1987 |
Comparative in vitro activity of the new cyclic lipopeptide LY146032 against Corynebacterium species.
Topics: Aminoglycosides; Anti-Bacterial Agents; Corynebacterium; Daptomycin; Drug Synergism; Microbial Sensitivity Tests; Peptides; Vancomycin | 1987 |
Susceptibility of Clostridium difficile to LY146032.
Topics: Anti-Bacterial Agents; Bacitracin; Clostridium; Daptomycin; Fusidic Acid; Humans; Metronidazole; Microbial Sensitivity Tests; Peptides; Vancomycin | 1987 |
Activity of LY146032 and vancomycin against coagulase-negative staphylococci.
Topics: Anti-Bacterial Agents; Coagulase; Daptomycin; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Staphylococcus; Staphylococcus epidermidis; Vancomycin | 1987 |
Bactericidal activities of peptide antibiotics against multidrug-resistant Enterococcus faecium.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Daptomycin; Depsipeptides; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecalis; Humans; Microbial Sensitivity Tests; Peptides, Cyclic; Vancomycin | 1994 |
Role of tolerance in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis with vancomycin, teicoplanin, and daptomycin.
Topics: Animals; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Microbial; Endocarditis, Bacterial; Female; Microbial Sensitivity Tests; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 1994 |
Activity of daptomycin against enterococci and coagulase-negative staphylococci (CNS): relationship between CNS susceptibility and slime production.
Topics: Anti-Bacterial Agents; Coagulase; Daptomycin; Enterococcus faecalis; Immunocompromised Host; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Peptides; Staphylococcus; Vancomycin | 1993 |
In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Bacteremia; Catheterization, Central Venous; Cefamandole; Cephalosporins; Ciprofloxacin; Clindamycin; Daptomycin; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Neoplasms; Novobiocin; Oxacillin; Penicillins; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Vancomycin; Virginiamycin | 1996 |
In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strains.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple; Enterococcus; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Staphylococcus; Time Factors; Vancomycin; Virginiamycin | 2000 |
In vitro activities of daptomycin, arbekacin, vancomycin, and gentamicin alone and/or in combination against glycopeptide intermediate-resistant Staphylococcus aureus in an infection model.
Topics: Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Dibekacin; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Humans; Microbial Sensitivity Tests; Models, Biological; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2000 |
Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro tests.
Topics: Anti-Bacterial Agents; Calcium; Daptomycin; Enterococcus; Humans; Microbial Sensitivity Tests; Quality Control; Reproducibility of Results; Staphylococcal Infections; Staphylococcus; Teicoplanin; Vancomycin | 2000 |
Comparative In vitro activities of daptomycin and vancomycin against resistant gram-positive pathogens.
Topics: Colony Count, Microbial; Daptomycin; Gram-Positive Bacteria; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Time Factors; Vancomycin | 2000 |
Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus isolates in an in vitro ph
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Microbial; Endocarditis, Bacterial; Enterococcus faecium; Half-Life; Methicillin Resistance; Microbial Sensitivity Tests; Models, Biological; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2001 |
The in vitro activity of daptomycin against 514 Gram-positive aerobic clinical isolates.
Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Daptomycin; Gram-Positive Bacteria; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillins; Vancomycin | 2001 |
In vitro bactericidal activity of daptomycin against staphylococci.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Therapy, Combination; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus; Vancomycin; Virginiamycin | 2002 |
In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates.
Topics: Acetamides; Anti-Bacterial Agents; Corynebacterium; Daptomycin; Gram-Positive Bacteria; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Vancomycin; Virginiamycin | 2003 |
Comparative efficacy of daptomycin and vancomycin in the therapy of experimental foreign body infection due to Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Daptomycin; Diffusion Chambers, Culture; Foreign Bodies; Kinetics; Methicillin Resistance; Microbial Sensitivity Tests; Rats; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2003 |
In vitro bactericidal activities of daptomycin against Staphylococcus aureus and Enterococcus faecalis are not mediated by inhibition of lipoteichoic acid biosynthesis.
Topics: Anti-Bacterial Agents; Daptomycin; Enterococcus; Enterococcus faecalis; Kinetics; Lipopolysaccharides; Microbial Sensitivity Tests; RNA; Staphylococcus aureus; Teichoic Acids; Vancomycin | 2003 |
Daptomycin against multiple drug-resistant staphylococcus and enterococcus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple; Endocarditis, Bacterial; Enterococcus faecium; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Models, Biological; Sensitivity and Specificity; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2003 |
Increased killing of staphylococci and streptococci by daptomycin compared with cefazolin and vancomycin in an in vitro peritoneal dialysate model.
Topics: Anti-Bacterial Agents; Cefazolin; Cephalosporins; Colony Count, Microbial; Daptomycin; Dialysis Solutions; Hydrogen-Ion Concentration; Methicillin Resistance; Peritoneal Dialysis; Peritonitis; Protein Binding; Staphylococcus; Streptococcus; Vancomycin | 2003 |
Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Area Under Curve; Daptomycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Kinetics; Meninges; Meningitis, Pneumococcal; Mutation; Penicillin Resistance; Quinolones; Rabbits; Streptococcus pneumoniae; Vancomycin | 2004 |
Clinical glycopeptide-intermediate staphylococci tested against arbekacin, daptomycin, and tigecycline.
Topics: Aminoglycosides; Analysis of Variance; Anti-Bacterial Agents; Daptomycin; Dibekacin; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Minocycline; Probability; Sampling Studies; Sensitivity and Specificity; Staphylococcus; Tigecycline; Vancomycin | 2004 |
Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model.
Topics: Acetamides; Anti-Bacterial Agents; Area Under Curve; Culture Media; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Half-Life; Kinetics; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Nafcillin; Oxazolidinones; Penicillins; Staphylococcus aureus; Vancomycin | 2004 |
Release of daptomycin from polymethylmethacrylate beads in a continuous flow chamber.
Topics: Anti-Bacterial Agents; Bone Cements; Daptomycin; Diffusion; Drug Carriers; Kinetics; Polymethyl Methacrylate; Vancomycin | 2004 |
Daptomycin for treating infected diabetic foot ulcers: evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infections.
Topics: Adolescent; Adult; Aged; Daptomycin; Diabetic Foot; Female; Humans; Male; Middle Aged; Penicillins; Staphylococcal Skin Infections; Vancomycin | 2005 |
In vitro activity of daptomycin versus linezolid and vancomycin against gram-positive uropathogens and ampicillin against enterococci, causing complicated urinary tract infections.
Topics: Acetamides; Ampicillin; Anti-Bacterial Agents; Cross Infection; Daptomycin; Enterococcus; Genotype; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus; Urinary Tract Infections; Vancomycin | 2005 |
Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations.
Topics: Anti-Bacterial Agents; Culture Media; Daptomycin; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Models, Biological; Staphylococcus aureus; Vancomycin | 2005 |
Effects of daptomycin, linezolid, and vancomycin on establishment of intestinal colonization with vancomycin-resistant enterococci and extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae in mice.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactamases; Daptomycin; Enterococcus; Female; Humans; Intestines; Klebsiella pneumoniae; Linezolid; Mice; Microbial Sensitivity Tests; Oxazolidinones; Vancomycin; Vancomycin Resistance | 2005 |
Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Chronic Disease; Daptomycin; Excipients; Hardness Tests; Male; Methicillin Resistance; Microbial Sensitivity Tests; Osteomyelitis; Polymethyl Methacrylate; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis.
Topics: Animals; Anti-Bacterial Agents; Cerebrospinal Fluid; Daptomycin; Disease Models, Animal; Humans; Meningitis, Bacterial; Methicillin; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2006 |
Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cell Wall; Daptomycin; Linear Models; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2006 |
Using vancomycin concentrations for dosing daptomycin in a morbidly obese patient with renal insufficiency.
Topics: Anti-Bacterial Agents; Area Under Curve; Chromatography, High Pressure Liquid; Daptomycin; Humans; Infusions, Intravenous; Male; Methicillin Resistance; Middle Aged; Obesity, Morbid; Pseudomonas Infections; Renal Insufficiency; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin.
Topics: Anti-Bacterial Agents; Daptomycin; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin | 2006 |
Evaluation of high-dose daptomycin for therapy of experimental Staphylococcus aureus foreign body infection.
Topics: Animals; Anti-Bacterial Agents; Daptomycin; Foreign Bodies; Microbial Sensitivity Tests; Oxacillin; Rats; Staphylococcal Infections; Vancomycin | 2006 |
An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin | 2006 |
Combination therapy with daptomycin, vancomycin, and rifampin for recurrent, severe bone and prosthetic joint infections involving methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Therapy, Combination; Female; Humans; Joint Prosthesis; Male; Methicillin Resistance; Middle Aged; Postoperative Period; Rifampin; Staphylococcal Infections; Vancomycin | 2006 |
Diminished macrophage inflammatory response to Staphylococcus aureus isolates exposed to daptomycin versus vancomycin or oxacillin.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Cells, Cultured; Colony Count, Microbial; Daptomycin; Drug Interactions; Humans; Macrophages; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Nitric Oxide Synthase Type II; Oxacillin; Staphylococcus aureus; Tumor Necrosis Factor-alpha; Vancomycin | 2006 |
Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin.
Topics: Anti-Bacterial Agents; Daptomycin; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2006 |
Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapy.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
In vitro activities of daptomycin, vancomycin, and penicillin against Clostridium difficile, C. perfringens, Finegoldia magna, and Propionibacterium acnes.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium perfringens; Daptomycin; Gram-Positive Bacteria; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillins; Propionibacterium acnes; Time Factors; Vancomycin | 2006 |
The activity of daptomycin against wild-type Staphylococcus aureus and strains with reduced susceptibility to vancomycin.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2006 |
Impact of selective antimicrobial agents on staphylococcal adherence to biomedical devices.
Topics: Acetamides; Anti-Bacterial Agents; Biofilms; Blood Vessel Prosthesis; Ceftriaxone; Daptomycin; Gentamicins; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcus; Vancomycin | 2006 |
Development of daptomycin resistance in a bone marrow transplant patient with vancomycin-resistant Enterococcus durans.
Topics: Bone Marrow Transplantation; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Middle Aged; Vancomycin; Vancomycin Resistance | 2006 |
Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.
Topics: Anti-Bacterial Agents; Colony Count, Microbial; Daptomycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Mutation; Selection, Genetic; Staphylococcus aureus; Time Factors; Vancomycin | 2006 |
Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Blood Proteins; Daptomycin; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Endocarditis, Bacterial; Enterococcus faecalis; Enterococcus faecium; Female; Microbial Sensitivity Tests; Microbial Viability; Protein Binding; Rats; Rats, Wistar; Teicoplanin; Vancomycin | 2006 |
Comparative bactericidal activities of daptomycin and vancomycin against glycopeptide-intermediate Staphylococcus aureus (GISA) and heterogeneous GISA isolates.
Topics: Anti-Bacterial Agents; Daptomycin; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin | 2006 |
Therapy for methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Daptomycin; Humans; Methicillin Resistance; Penicillins; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
Therapy for methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Daptomycin; Endocarditis, Bacterial; Humans; Methicillin Resistance; Penicillins; Research Design; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Teicoplanin; Vancomycin | 2007 |
Concentration-response relationships as a basis for choice of the optimal endpoints of the antimicrobial effect: daptomycin and vancomycin pharmacodynamics with staphylococci in an in vitro dynamic model.
Topics: Anti-Bacterial Agents; Area Under Curve; Daptomycin; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin | 2007 |
Bactericidal activity and resistance development profiling of dalbavancin.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Staphylococcus aureus; Teicoplanin; Vancomycin; Vancomycin Resistance | 2007 |
Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Combinations; Gentamicins; Humans; Microbial Sensitivity Tests; Monocytes; Oxacillin; Rifampin; Staphylococcus aureus; Vancomycin | 2007 |
Daptomycin-reversible rifampicin resistance in vancomycin-resistant Enterococcus faecium.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Daptomycin; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Molecular Sequence Data; Rifampin; Vancomycin; Vancomycin Resistance | 2007 |
In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model.
Topics: Anti-Bacterial Agents; Biofilms; Calcium Carbonate; Catheterization, Central Venous; Daptomycin; Equipment Contamination; Equipment Failure; Reference Values; Staphylococcus aureus; Staphylococcus epidermidis; Sterilization; Time Factors; Vancomycin | 2007 |
Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF.
Topics: Amino Acid Substitution; Aminoacyltransferases; Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; Humans; Microbial Sensitivity Tests; Mutation; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2007 |
In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Colony Count, Microbial; Daptomycin; Drug Resistance, Bacterial; Enterococcus faecium; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Phenotype; Serum; Serum Albumin; Staphylococcus aureus; Streptococcus pneumoniae; Vancomycin; Vancomycin Resistance | 2007 |
Correlation of vancomycin and daptomycin susceptibility in Staphylococcus aureus in reference to accessory gene regulator (agr) polymorphism and function.
Topics: Anti-Bacterial Agents; Area Under Curve; Bacterial Proteins; Culture Media; Daptomycin; Microbial Sensitivity Tests; Polymorphism, Genetic; Staphylococcus aureus; Trans-Activators; Vancomycin; Vancomycin Resistance | 2007 |
Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
Topics: Anti-Bacterial Agents; Asia; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus; Teicoplanin; Vancomycin | 2007 |
Intermediate vancomycin susceptibility in a community-associated MRSA clone.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Daptomycin; Humans; Lumbar Vertebrae; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Osteomyelitis; Staphylococcal Infections; Staphylococcus aureus; Thrombophlebitis; Treatment Outcome; Vancomycin | 2007 |
Daptomycin use after vancomycin-induced neutropenia in a patient with left-sided endocarditis.
Topics: Anti-Bacterial Agents; Daptomycin; Endocarditis; Humans; Male; Methicillin Resistance; Middle Aged; Mitral Valve; Neutropenia; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2007 |
In vitro activity of daptomycin and tigecycline against coagulase-negative staphylococcus blood isolates from bone marrow transplant recipients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bone Marrow Transplantation; Coagulase; Daptomycin; Drug Resistance, Multiple, Bacterial; Female; Fosfomycin; Hematologic Neoplasms; Humans; In Vitro Techniques; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Staphylococcal Infections; Staphylococcus; Staphylococcus epidermidis; Staphylococcus haemolyticus; Tigecycline; Vancomycin | 2007 |
Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells.
Topics: Anti-Bacterial Agents; Cell Division; Ciprofloxacin; Daptomycin; Erythromycin; Gentamicins; Hydrazones; Microbial Sensitivity Tests; Nafcillin; Staphylococcus aureus; Vancomycin | 2007 |
Linezolid- and vancomycin-resistant Enterococcus faecium endocarditis: successful treatment with tigecycline and daptomycin.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Minocycline; Oxazolidinones; Tigecycline; Treatment Outcome; Vancomycin | 2007 |
daptomycin activity against Staphylococcus aureus following vancomycin exposure in an in vitro pharmacodynamic model with simulated endocardial vegetations.
Topics: Anti-Bacterial Agents; Culture Media; Daptomycin; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Models, Biological; Staphylococcus aureus; Vancomycin | 2008 |
Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Clindamycin; Daptomycin; Doxycycline; Folic Acid Antagonists; Global Health; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin; Methicillin Resistance; Minocycline; Oxazolidinones; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Teicoplanin; Tigecycline; Trimethoprim; Vancomycin | 2007 |
Inhibitory activities of 11 antimicrobial agents and bactericidal activities of vancomycin and daptomycin against invasive methicillin-resistant Staphylococcus aureus isolates obtained from 1999 through 2006.
Topics: Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Resistance, Bacterial; Hospitals, University; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Texas; Vancomycin | 2008 |
Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
Topics: Acetamides; Anti-Infective Agents; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Glycopeptides; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcus aureus; Streptococcaceae; Taiwan; Teicoplanin; Tigecycline; Time Factors; Vancomycin | 2008 |
Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Daptomycin; Female; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |
Daptomycin treatment failure for vancomycin-resistant Enterococcus faecium infective endocarditis: impact of protein binding?
Topics: Aged; Daptomycin; Endocarditis, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Male; Protein Binding; Treatment Failure; Vancomycin; Vancomycin Resistance | 2008 |
Mechanisms of resistance to daptomycin in Enterococcus faecium.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Leukocyte-Adhesion Deficiency Syndrome; Microbial Sensitivity Tests; Point Mutation; Polymerase Chain Reaction; Vancomycin | 2008 |
Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Resistance, Bacterial; Endocarditis; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Taiwan; Vancomycin | 2008 |
Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection and in vi
Topics: Acetamides; Animals; Anti-Bacterial Agents; Clindamycin; Colony Count, Microbial; Community-Acquired Infections; Culture Media; Daptomycin; Disease Models, Animal; Doxycycline; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Thigh; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2008 |
Daptomycin is effective in treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Daptomycin; Disease Models, Animal; Endocarditis, Bacterial; Glycopeptides; Heart Valve Diseases; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Models, Biological; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2008 |
Activity of serum concentrations of daptomycin vs. vancomycin against vancomycin-susceptible and resistant Enterococcus faecium in the presence of albumin physiological concentrations: an in vitro pharmacodynamic simulation.
Topics: Daptomycin; Enterococcus faecium; Humans; Microbial Sensitivity Tests; Microbial Viability; Serum Albumin; Vancomycin; Vancomycin Resistance | 2008 |
Activities of ceftobiprole, linezolid, vancomycin, and daptomycin against community-associated and hospital-associated methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Daptomycin; Drug Synergism; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |
Beyond MRSA: the growing menace of hVISA and VISA.
Topics: Anti-Bacterial Agents; Daptomycin; Debridement; Discitis; Drug Resistance, Multiple, Bacterial; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Osteomyelitis; Recurrence; Retreatment; Spinal Diseases; Staphylococcal Infections; Staphylococcus aureus; Thoracic Vertebrae; Vancomycin; Vancomycin Resistance | 2008 |
Fatal bacteremic mycotic aneurysm complicated by acute renal failure caused by daptomycin-nonsusceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus.
Topics: Acute Kidney Injury; Aneurysm, Infected; Daptomycin; Drug Resistance, Multiple, Bacterial; Fatal Outcome; Humans; Male; Methicillin Resistance; Middle Aged; Staphylococcal Infections; Vancomycin | 2008 |
Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with persistent bacteraemia and endocarditis.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Resistance, Bacterial; Endocarditis, Bacterial; Humans; Macrophages; Male; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |
Fatal bacteraemia caused by daptomycin-non-susceptible, vancomycin-intermediate, meticillin-resistant Staphylococcus aureus in a patient with chronic kidney disease.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Chronic Disease; Daptomycin; Drug Resistance, Bacterial; Fatal Outcome; Humans; Kidney Diseases; Male; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2009 |
When less is more: high-dose, short duration regimens and antibiotic resistance.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Microbial; Humans; Infusions, Intravenous; Multicenter Studies as Topic; Penicillins; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Vancomycin | 2008 |
Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; Drug Resistance, Bacterial; Humans; Membrane Fluidity; Membrane Potentials; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Phenotype; Vancomycin | 2008 |
Optimized elution of daptomycin from polymethylmethacrylate beads.
Topics: Bone Cements; Chemistry, Pharmaceutical; Daptomycin; Drug Carriers; Gentamicins; Polymethyl Methacrylate; Vancomycin; Xylitol | 2009 |
Evaluation of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus and heterogeneously vancomycin-intermediate S. aureus in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
Topics: Anti-Bacterial Agents; Colony Count, Microbial; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Viability; Models, Theoretical; Vancomycin; Vancomycin Resistance | 2009 |
[Persistent bacteremia caused by methicillin-resistant Staphylococcus aureus].
Topics: Aged; Bacteremia; Catheterization, Central Venous; Chronic Disease; Daptomycin; Discitis; Humans; Jugular Veins; Male; Methicillin-Resistant Staphylococcus aureus; Pancreatitis; Rifampin; Staphylococcal Infections; Vancomycin; Virginiamycin | 2008 |
Daptomycin resistance and treatment failure following vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE).
Topics: Aged; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Endocarditis, Bacterial; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Mitral Valve; Staphylococcal Infections; Treatment Failure; Vancomycin | 2009 |
[Treatment of mitral MRSA endocarditis using daptomycin].
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Combined Modality Therapy; Daptomycin; Device Removal; Drug Therapy, Combination; Endocarditis, Bacterial; Fatal Outcome; Female; Gentamicins; Hip Prosthesis; Humans; Methicillin-Resistant Staphylococcus aureus; Mitral Valve; Postoperative Complications; Prosthesis-Related Infections; Respiratory Distress Syndrome; Rifampin; Staphylococcal Infections; Thrombocytopenia; Vancomycin | 2008 |
Daptomycin for soft tissue infection and neutropenia in a myelogenous leukemia patient who failed prior vancomycin therapy.
Topics: Anti-Bacterial Agents; Daptomycin; Humans; Leukemia, Myeloid, Acute; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Neutropenia; Soft Tissue Infections; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2008 |
Inhibitory and bactericidal activities of daptomycin, vancomycin, and teicoplanin against methicillin-resistant Staphylococcus aureus isolates collected from 1985 to 2007.
Topics: Abscess; Anti-Bacterial Agents; Blood; Culture Media; Daptomycin; Drug Resistance, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Teicoplanin; Vancomycin | 2009 |
Characterisation of a Staphylococcus aureus strain with progressive loss of susceptibility to vancomycin and daptomycin during therapy.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Resistance, Bacterial; Endocarditis, Bacterial; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Virginiamycin | 2009 |
Successful use of intraperitoneal daptomycin in the treatment of vancomycin-resistant enterococcus peritonitis.
Topics: Adult; Daptomycin; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Injections, Intraperitoneal; Middle Aged; Peritonitis; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2009 |
Impact of sarA on antibiotic susceptibility of Staphylococcus aureus in a catheter-associated in vitro model of biofilm formation.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Catheterization; Daptomycin; Microbial Sensitivity Tests; Mutation; Staphylococcus aureus; Vancomycin | 2009 |
Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Therapy, Combination; Gentamicins; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2009 |
Combination of daptomycin plus ceftriaxone is more active than vancomycin plus ceftriaxone in experimental meningitis after addition of dexamethasone.
Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Chromatography, High Pressure Liquid; Daptomycin; Dexamethasone; Drug Therapy, Combination; Meningitis, Bacterial; Rabbits; Vancomycin | 2009 |
Effects of vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Ceftriaxone; Daptomycin; Dose-Response Relationship, Drug; Fosfomycin; Humans; Minocycline; Skin; Staphylococcus aureus; Tigecycline; Vancomycin | 2009 |
Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Vancomycin | 2009 |
Daptomycin in experimental murine pneumococcal meningitis.
Topics: Animals; Anti-Bacterial Agents; Apoptosis; Brain; Caspase 3; Daptomycin; Dexamethasone; Disease Models, Animal; Imaging, Three-Dimensional; Meningitis, Pneumococcal; Mice; Microbial Sensitivity Tests; Vancomycin | 2009 |
Effects of azithromycin in combination with vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms.
Topics: Anti-Bacterial Agents; Biofilms; Ceftriaxone; Daptomycin; Microbial Sensitivity Tests; Minocycline; Staphylococcus epidermidis; Tigecycline; Vancomycin | 2009 |
Successful salvage therapy with daptomycin after linezolid and vancomycin failure in a liver transplant recipient with methicillin-resistant Staphylococcus aureus endocarditis.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Cross Infection; Daptomycin; Endocarditis, Bacterial; Humans; Linezolid; Liver Transplantation; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Salvage Therapy; Staphylococcal Infections; Treatment Failure; Treatment Outcome; Vancomycin | 2009 |
Regional antibiotic delivery for the treatment of experimental prosthetic graft infections.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Daptomycin; Disease Models, Animal; Drug Delivery Systems; Male; Methicillin-Resistant Staphylococcus aureus; Microspheres; Polymethyl Methacrylate; Prosthesis-Related Infections; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2009 |
Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis.
Topics: Anti-Bacterial Agents; Biofilms; Daptomycin; Endocarditis; Gentamicins; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rifampin; Vancomycin | 2009 |
Vancomycin and daptomycin pharmacodynamics differ against a site-directed Staphylococcus epidermidis mutant displaying the small-colony-variant phenotype.
Topics: Anti-Bacterial Agents; Daptomycin; Models, Theoretical; Mutagenesis, Site-Directed; Mutation; Phenotype; Staphylococcus epidermidis; Vancomycin | 2009 |
Evaluating aztreonam and ceftazidime pharmacodynamics with Escherichia coli in combination with daptomycin, linezolid, or vancomycin in an in vitro pharmacodynamic model.
Topics: Acetamides; Anti-Bacterial Agents; Aztreonam; Ceftazidime; Daptomycin; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Vancomycin | 2009 |
Cost-Effectiveness of daptomycin versus vancomycin and gentamicin for patients with methicillin-resistant Staphylococcus aureus bacteremia and/or endocarditis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cost-Benefit Analysis; Costs and Cost Analysis; Daptomycin; Endocarditis, Bacterial; Female; Gentamicins; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Randomized Controlled Trials as Topic; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult | 2009 |
Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006.
Topics: Anti-Bacterial Agents; Daptomycin; Electrophoresis, Gel, Pulsed-Field; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; United States; Vancomycin | 2009 |
Lack of evidence associating nephrotoxicity with low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis.
Topics: Anti-Bacterial Agents; Bacteremia; Creatinine; Daptomycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Kidney; Sample Size; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2009 |
Community-acquired methicillin-resistant Staphylococcus aureus and Lemierre syndrome.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Community-Acquired Infections; Daptomycin; Female; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Sepsis; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2009 |
Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals.
Topics: Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Tolerance; Hospitals; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Staphylococcal Infections; Teicoplanin; United States; Vancomycin; Vancomycin Resistance | 2009 |
Comparative antibacterial effects of daptomycin, vancomycin and teicoplanin studied in an in vitro pharmacokinetic model of infection.
Topics: Anti-Bacterial Agents; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Models, Theoretical; Staphylococcal Infections; Teicoplanin; Vancomycin; Vancomycin Resistance | 2009 |
Inpatient treatment patterns, outcomes, and costs of skin and skin structure infections because of Staphylococcus aureus.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Daptomycin; Drug Utilization; Drug Utilization Review; Female; Humans; Inpatients; Length of Stay; Linezolid; Male; Middle Aged; Oxazolidinones; Retrospective Studies; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin; Young Adult | 2010 |
Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacteriolysis; Colony Count, Microbial; Daptomycin; Humans; Microbial Sensitivity Tests; Microbial Viability; Octoxynol; Oxacillin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Correlation between vancomycin MIC values and those of other agents against gram-positive bacteria among patients with bloodstream infections caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cohort Studies; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2009 |
Ceftobiprole is superior to vancomycin, daptomycin, and linezolid for treatment of experimental endocarditis in rabbits caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Cephalosporins; Chromatography, High Pressure Liquid; Daptomycin; Disease Models, Animal; Endocarditis, Bacterial; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Rabbits; Random Allocation; Vancomycin | 2010 |
Bactericidal activity of daptomycin versus vancomycin in the presence of human albumin against vancomycin-susceptible but tolerant methicillin-resistant Staphylococcus aureus (MRSA) with daptomycin minimum inhibitory concentrations of 1-2microg/mL.
Topics: Albumins; Anti-Bacterial Agents; Colony Count, Microbial; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Protein Binding; Vancomycin | 2010 |
Variable daptomycin susceptibility in patients receiving intravenous vancomycin for meticillin-resistant Staphylococcus aureus infections.
Topics: Aged; Anti-Bacterial Agents; Daptomycin; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Vancomycin | 2010 |
Vancomycin-resistant Enterococcus spp.: validation of susceptibility testing and in vitro activity of vancomycin, linezolid, tigecycline and daptomycin.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Daptomycin; DNA, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Polymerase Chain Reaction; Reproducibility of Results; Tigecycline; Vancomycin; Vancomycin Resistance | 2010 |
Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Ciprofloxacin; Daptomycin; Enterococcus; Female; Fever; Humans; Incidence; Linezolid; Male; Middle Aged; Neutropenia; Oxazolidinones; Retrospective Studies; Vancomycin; Vancomycin Resistance | 2010 |
Antimicrobial activity of daptomycin tested against Staphylococcus aureus with vancomycin MIC of 2 microg/mL isolated in the United States and European hospitals (2006-2008).
Topics: Anti-Bacterial Agents; Colony Count, Microbial; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Europe; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; United States; Vancomycin | 2010 |
Comparative activities of TR-700 (torezolid) against staphylococcal blood isolates collected in Spain.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; In Vitro Techniques; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Sepsis; Spain; Staphylococcal Infections; Tetrazoles; Vancomycin | 2010 |
Combinations of maggot excretions/secretions and antibiotics are effective against Staphylococcus aureus biofilms and the bacteria derived therefrom.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Biological Products; Clindamycin; Daptomycin; Diptera; Drug Synergism; Humans; Larva; Microbial Viability; Staphylococcus aureus; Vancomycin | 2010 |
Efficacy of vancomycin and daptomycin against Staphylococcus aureus isolates collected over 29 years.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2010 |
In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired meticillin-resistant Staphylococcus aureus (HA-MRSA) isolates.
Topics: Acetamides; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Drug Synergism; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Tobramycin; Vancomycin | 2010 |
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Linezolid; Lipoglycopeptides; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin | 2010 |
In vitro activity of ceftaroline against community-associated methicillin-resistant, vancomycin-intermediate, vancomycin-resistant, and daptomycin-nonsusceptible Staphylococcus aureus isolates.
Topics: Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2010 |
Daptomycin is effective for treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus epidermidis.
Topics: Animals; Daptomycin; Endocarditis; Glycopeptides; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2010 |
Hospital policies and practices on prevention and treatment of infections caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Clinical Protocols; Daptomycin; Formularies, Hospital as Topic; Guidelines as Topic; Health Care Surveys; Hospitals; Humans; Infection Control; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Organizational Policy; Oxazolidinones; Patient Isolation; Pharmacy Service, Hospital; Staphylococcal Infections; Surveys and Questionnaires; Tigecycline; Vancomycin | 2010 |
Antibiotic-loaded chitosan film for infection prevention: A preliminary in vitro characterization.
Topics: Anti-Bacterial Agents; Chitosan; Coated Materials, Biocompatible; Daptomycin; Humans; Materials Testing; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Orthopedic Fixation Devices; Staphylococcal Infections; Tensile Strength; Vancomycin | 2010 |
Intracellular activity of the peptide antibiotic NZ2114: studies with Staphylococcus aureus and human THP-1 monocytes, and comparison with daptomycin and vancomycin.
Topics: Anti-Bacterial Agents; Cell Line; Colony Count, Microbial; Daptomycin; Humans; Microbial Sensitivity Tests; Microbial Viability; Monocytes; Peptides; Staphylococcus aureus; Vancomycin | 2010 |
Outcomes with daptomycin in the treatment of Staphylococcus aureus infections with a range of vancomycin MICs.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Daptomycin; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2010 |
[Comparative study of the susceptibility to daptomycin and other antimicrobials against Staphylococcus spp. resistant to methicillin and Enterococcus spp. using Wider, E-test, and microdilution methods].
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Enterococcus; Humans; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Vancomycin | 2010 |
Catheter-related bacteremia caused by methicillin-resistant coagulase negative staphylococci with elevated minimal inhibitory concentration for vancomycin.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Catheterization, Central Venous; Catheters, Indwelling; Chi-Square Distribution; Child; Coagulase; Daptomycin; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Prospective Studies; Staphylococcus; Vancomycin | 2010 |
In vitro activity of the new multivalent glycopeptide-cephalosporin antibiotic TD-1792 against vancomycin-nonsusceptible Staphylococcus isolates.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Daptomycin; Glycopeptides; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus; Staphylococcus aureus; Vancomycin; Vancomycin Resistance; Virginiamycin | 2010 |
Increased temperature enhances the antimicrobial effects of daptomycin, vancomycin, tigecycline, fosfomycin, and cefamandole on staphylococcal biofilms.
Topics: Anti-Bacterial Agents; Biofilms; Cefamandole; Daptomycin; Fosfomycin; Minocycline; Staphylococcus; Tigecycline; Vancomycin | 2010 |
Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm.
Topics: Anti-Bacterial Agents; Aza Compounds; Biofilms; Clarithromycin; Daptomycin; Fluoroquinolones; Microscopy, Electron, Scanning; Moxifloxacin; Quinolines; Rifampin; Staphylococcus aureus; Vancomycin | 2010 |
Rifampicin enhances activity of daptomycin and vancomycin against both a polysaccharide intercellular adhesin (PIA)-dependent and -independent Staphylococcus epidermidis biofilm.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Daptomycin; Disease Models, Animal; Drug Synergism; Guinea Pigs; Microbial Sensitivity Tests; Polysaccharides, Bacterial; Rifampin; Staphylococcal Skin Infections; Staphylococcus epidermidis; Vancomycin; Virulence Factors | 2010 |
[Vancomycin, what else?].
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Child; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2010 |
An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; Drug Resistance, Multiple, Bacterial; Mutation; Polymorphism, Single Nucleotide; Staphylococcus aureus; Vancomycin | 2010 |
Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Bone and Bones; Bone Marrow; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Female; Joints; Methicillin-Resistant Staphylococcus aureus; Osteomyelitis; Rabbits; Rifampin; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2010 |
Diminished in vitro antibacterial activity of oxacillin against clinical isolates of borderline oxacillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Daptomycin; Drug Resistance, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Oxacillin; Oxazolidinones; Penicillin Resistance; Penicillin-Binding Proteins; Plasmids; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2010 |
A dynamic in vitro model for evaluating antimicrobial activity against bacterial biofilms using a new device and clinical-used catheters.
Topics: Anti-Bacterial Agents; Biofilms; Catheter-Related Infections; Catheterization; Catheters; Daptomycin; Drug Evaluation, Preclinical; Humans; Microbial Sensitivity Tests; Models, Biological; Staphylococcus epidermidis; Vancomycin | 2010 |
Efficacy of usual and high doses of daptomycin in combination with rifampin versus alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Vancomycin | 2010 |
Daptomycin non-susceptible, vancomycin intermediate methicillin-resistant Staphylococcus aureus ST398 from a chronic leg ulcer, Italy.
Topics: Adult; Anti-Bacterial Agents; Chronic Disease; Daptomycin; Female; Humans; Italy; Leg Ulcer; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Skin Infections; Vancomycin | 2010 |
Comparative activity of telavancin and other antimicrobial agents against methicillin-resistant Staphylococcus aureus isolates collected from 1991 to 2006.
Topics: Acetamides; Aminoglycosides; Anti-Infective Agents; Daptomycin; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Tigecycline; Vancomycin | 2010 |
Correlation between vancomycin and daptomycin MIC values for methicillin-susceptible and methicillin-resistant Staphylococcus aureus by 3 testing methodologies.
Topics: Anti-Bacterial Agents; Daptomycin; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2010 |
Flow cytometry as a tool to determine the effects of cell wall-active antibiotics on vancomycin-susceptible and -resistant Enterococcus faecalis strains.
Topics: Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Enterococcus faecalis; Flow Cytometry; Lipoglycopeptides; Microscopy, Confocal; Vancomycin | 2011 |
Regulation of mprF by antisense RNA restores daptomycin susceptibility to daptomycin-resistant isolates of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Blotting, Northern; Daptomycin; Drug Resistance, Bacterial; Gentamicins; Microbial Sensitivity Tests; RNA, Antisense; Staphylococcus aureus; Vancomycin | 2011 |
Presence of adequate intravitreal concentrations of daptomycin after systemic intravenous administration in a patient with endogenous endophthalmitis.
Topics: Anti-Bacterial Agents; Daptomycin; Endophthalmitis; Female; Humans; Injections, Intravenous; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Vancomycin; Vitreous Body | 2010 |
Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: high-dose and combination daptomycin therapy.
Topics: Acetamides; Aged; Daptomycin; Drug Therapy, Combination; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Meningitis, Bacterial; Middle Aged; Oxazolidinones; Vancomycin; Vancomycin Resistance | 2010 |
Investigation of the potential for mutational resistance to XF-73, retapamulin, mupirocin, fusidic acid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus isolates during a 55-passage study.
Topics: Anti-Bacterial Agents; Bridged Bicyclo Compounds, Heterocyclic; Daptomycin; Diterpenes; Fusidic Acid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Mupirocin; Polymerase Chain Reaction; Porphyrins; Sequence Analysis, DNA; Vancomycin | 2011 |
Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Minocycline; Oxazolidinones; Tigecycline; Vancomycin | 2010 |
Ketamine inhibits tumor necrosis factor secretion by RAW264.7 murine macrophages stimulated with antibiotic-exposed strains of community-associated, methicillin-resistant Staphylococcus aureus.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anti-Bacterial Agents; Cell Line; Daptomycin; Dizocilpine Maleate; Drug Synergism; Ketamine; Macrophage Activation; Macrophages; Methicillin-Resistant Staphylococcus aureus; Mice; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate; Time Factors; Tumor Necrosis Factor-alpha; Vancomycin | 2011 |
Susceptibility patterns of coagulase-negative staphylococci to several newer antimicrobial agents in comparison with vancomycin and oxacillin.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; DNA, Ribosomal; Linezolid; Lipoglycopeptides; Microbial Sensitivity Tests; Micrococcal Nuclease; Minocycline; Oxacillin; Oxazolidinones; Penicillin-Binding Proteins; Polymerase Chain Reaction; Staphylococcus; Tigecycline; Vancomycin | 2011 |
Impact of dose de-escalation and escalation on daptomycin's pharmacodynamics against clinical methicillin-resistant Staphylococcus aureus isolates in an in vitro model.
Topics: Daptomycin; Humans; In Vitro Techniques; Methicillin-Resistant Staphylococcus aureus; Vancomycin | 2011 |
Management of gram-positive coccal bacteremia and hemodialysis.
Topics: Anti-Bacterial Agents; Bacteremia; Catheters, Indwelling; Daptomycin; Drug Resistance, Bacterial; Enterococcus; Female; Gentamicins; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Kidney Failure, Chronic; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Renal Dialysis; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2011 |
Case report of a successful treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and MRSA/vancomycin-resistant Enterococcus faecium cholecystitis by daptomycin.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Cholecystitis; Daptomycin; Enterococcus faecium; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Vancomycin | 2011 |
Comparative genome sequencing of an isogenic pair of USA800 clinical methicillin-resistant Staphylococcus aureus isolates obtained before and after daptomycin treatment failure.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Genotype; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microscopy, Electron, Transmission; Middle Aged; Oligonucleotide Array Sequence Analysis; Treatment Failure; Vancomycin | 2011 |
Differences in daptomycin and vancomycin ex vivo behaviour can lead to false interpretation of negative blood cultures.
Topics: Aerobiosis; Anaerobiosis; Anti-Bacterial Agents; Bacteremia; Blood; Cell Culture Techniques; Charcoal; Culture Media; Daptomycin; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Stem Cells; Vancomycin | 2011 |
Activity of simulated serum concentrations of daptomycin versus vancomycin during the first 24h of treatment in the presence of physiological albumin concentrations against vancomycin-susceptible, -tolerant or -intermediate-resistant Staphylococcus aureus
Topics: Anti-Bacterial Agents; Area Under Curve; Daptomycin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Serum Albumin; Staphylococcus aureus; Vancomycin | 2011 |
Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure.
Topics: Anti-Bacterial Agents; Australia; Daptomycin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; New Zealand; Staphylococcal Infections; Staphylococcus aureus; Treatment Failure; Vancomycin | 2011 |
Determination of vancomycin and daptomycin MICs by different testing methods for methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2011 |
In vitro activity and in vivo efficacy of the saponin diosgenyl 2-amino-2-deoxy-β-D-glucopyranoside hydrochloride (HSM1) alone and in combination with daptomycin and vancomycin against Gram-positive cocci.
Topics: Animals; Anti-Bacterial Agents; Daptomycin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Rodent Diseases; Saponins; Surgical Wound Infection; Treatment Outcome; Vancomycin | 2011 |
In vitro activity of linezolid, tigecycline, and daptomycin on methicillin-resistant Staphylococcus aureus blood isolates from adult patients, 2006-2008: stratified analysis by vancomycin MIC.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Bacteremia; Blood; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcal Infections; Taiwan; Tigecycline; Vancomycin | 2011 |
Activity of vancomycin, ciprofloxacin, daptomycin, and linezolid against coagulase-negative staphylococci bacteremia.
Topics: Acetamides; Bacteremia; Catheter-Related Infections; Ciprofloxacin; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Hospital Departments; Hospitals, University; Humans; Length of Stay; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Spain; Staphylococcal Infections; Staphylococcus epidermidis; Staphylococcus haemolyticus; Staphylococcus hominis; Vancomycin | 2011 |
Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Daptomycin; Dose-Response Relationship, Drug; Enterococcus; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Retrospective Studies; Treatment Failure; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2011 |
Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009.
Topics: Acetamides; Bacterial Toxins; Ceftaroline; Cephalosporins; Clindamycin; Daptomycin; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Exotoxins; Leukocidins; Levofloxacin; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Ofloxacin; Oxacillin; Oxazolidinones; Polymerase Chain Reaction; Staphylococcus aureus; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Vancomycin | 2011 |
Daptomycin antibiotic lock therapy in a rat model of staphylococcal central venous catheter biofilm infections.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Catheterization, Central Venous; Daptomycin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rats; Staphylococcal Infections; Vancomycin | 2011 |
In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates.
Topics: alpha-Defensins; Antimicrobial Cationic Peptides; beta-Thromboglobulin; Daptomycin; Genotype; Gentamicins; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Polymyxin B; Vancomycin | 2011 |
Thrombocytopenia, INR prolongation and fall in fibrinogen under daptomycin.
Topics: Anti-Bacterial Agents; Aza Compounds; Daptomycin; Endocarditis, Bacterial; Fibrinogen; Fluoroquinolones; Humans; International Normalized Ratio; Male; Middle Aged; Moxifloxacin; Quinolines; Renal Dialysis; Staphylococcal Infections; Staphylococcus epidermidis; Thrombocytopenia; Vancomycin | 2011 |
Characterizing vancomycin-resistant Enterococcus strains with various mechanisms of daptomycin resistance developed in an in vitro pharmacokinetic/pharmacodynamic model.
Topics: Aminoacyltransferases; Anti-Bacterial Agents; Bacterial Proteins; Cell Membrane; Cell Wall; Daptomycin; Drug Resistance, Bacterial; Enterococcus; Membrane Potentials; Microbial Sensitivity Tests; Phenotype; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2011 |
Antimicrobial activity of daptomycin tested against gram-positive strains collected in European hospitals: results from 7 years of resistance surveillance (2003-2009).
Topics: Anti-Bacterial Agents; Bacteremia; Daptomycin; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests; Soft Tissue Infections; Vancomycin | 2011 |
Gentamicin improves the activities of daptomycin and vancomycin against Enterococcus faecalis in vitro and in an experimental foreign-body infection model.
Topics: Animals; Anti-Bacterial Agents; Daptomycin; Drug Therapy, Combination; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Guinea Pigs; Male; Microbial Sensitivity Tests; Prosthesis-Related Infections; Vancomycin | 2011 |
Adjunctive rifampin is crucial to optimizing daptomycin efficacy against rabbit prosthetic joint infection due to methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Knee Prosthesis; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Prosthesis-Related Infections; Rabbits; Rifampin; Staphylococcal Infections; Vancomycin | 2011 |
Telavancin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Minocycline; Osteomyelitis; Oxazolidinones; Staphylococcal Infections; Tigecycline; Vancomycin | 2011 |
Successful therapy of treatment-emergent, non-clonal daptomycin-non-susceptible Enterococcus faecium infections.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Vancomycin | 2011 |
In vitro activities of daptomycin-, vancomycin-, and teicoplanin-loaded polymethylmethacrylate against methicillin-susceptible, methicillin-resistant, and vancomycin-intermediate strains of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bone Cements; Chromatography, High Pressure Liquid; Daptomycin; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Polymethyl Methacrylate; Staphylococcus aureus; Teicoplanin; Vancomycin; Vancomycin Resistance | 2011 |
[In vitro susceptibility of methicillin-resistant Staphylococcus aureus isolates to vancomycin, teicoplanin, linezolide and daptomycin].
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Female; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Vancomycin | 2011 |
[Pharmacoeconomic assessment of daptomycin as first-line therapy for bacteraemia and complicated skin and skin structure infections caused by gram-positive pathogens in Spain].
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cost-Benefit Analysis; Daptomycin; Data Interpretation, Statistical; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Linezolid; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Oxazolidinones; Salvage Therapy; Skin Diseases, Infectious; Spain; Treatment Failure; Vancomycin; Young Adult | 2011 |
Ubiquitous detection of gram-positive bacteria with bioorthogonal magnetofluorescent nanoparticles.
Topics: Animals; Anti-Bacterial Agents; Cyclooctanes; Daptomycin; Fluorescent Dyes; Gram-Positive Bacteria; Intracellular Space; Magnets; Mice; Nanoparticles; Vancomycin | 2011 |
Retrospective observational study comparing vancomycin versus daptomycin as initial therapy for Staphylococcus aureus infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Daptomycin; Hospital Bed Capacity, 300 to 499; Hospitalization; Hospitals, Private; Humans; Injections, Intravenous; Length of Stay; Medical Records; Middle Aged; Recurrence; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Young Adult | 2011 |
Hepatorenal syndrome precipitated by infective endocarditis.
Topics: Aged; Anti-Bacterial Agents; Contraindications; Daptomycin; Disease Progression; Drug Substitution; Echocardiography, Transesophageal; Endocarditis; Fatal Outcome; Fluid Therapy; Hepatic Encephalopathy; Hepatorenal Syndrome; Humans; Kidney Function Tests; Liver Transplantation; Male; Microbial Sensitivity Tests; Rifampin; Staphylococcal Infections; Staphylococcus lugdunensis; Vancomycin | 2011 |
Comment on: Successful therapy of treatment-emergent, non-clonal daptomycin-non-susceptible Enterococcus faecium infections.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Oxazolidinones; Vancomycin | 2012 |
Vancomycin-resistant Enterococcus bacteremia: an evaluation of treatment with linezolid or daptomycin.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Enterococcus faecalis; Female; Humans; Immunocompromised Host; Linezolid; Male; Middle Aged; Outcome Assessment, Health Care; Oxazolidinones; Retrospective Studies; United States; Vancomycin; Vancomycin Resistance | 2012 |
Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Cell Wall; Daptomycin; Drug Resistance, Multiple, Bacterial; High-Throughput Nucleotide Sequencing; Humans; Microbial Sensitivity Tests; Molecular Typing; Mutation; Polymorphism, Single Nucleotide; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance; Virulence Factors | 2011 |
Daptomycin for methicillin-resistant Staphylococcus aureus bloodstream infection and elevated vancomycin minimum inhibitory concentrations: has the time come?
Topics: Anti-Bacterial Agents; Bacteremia; Daptomycin; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2012 |
Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Daptomycin; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2012 |
Efficacy of daptomycin versus vancomycin in an experimental model of foreign-body and systemic infection caused by biofilm producers and methicillin-resistant Staphylococcus epidermidis.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Catheters, Indwelling; Colony Count, Microbial; Daptomycin; Disease Models, Animal; Female; Humans; Liver; Methicillin Resistance; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Sepsis; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin | 2012 |
Evaluation of telavancin activity versus daptomycin and vancomycin against daptomycin-nonsusceptible Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.
Topics: Aminoglycosides; Anti-Bacterial Agents; Colony Count, Microbial; Daptomycin; Drug Resistance, Bacterial; Endocarditis, Bacterial; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Biological; Staphylococcus aureus; Vancomycin | 2012 |
Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium.
Topics: Ampicillin; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacteremia; beta-Lactams; Daptomycin; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Humans; Microbial Sensitivity Tests; Models, Biological; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2012 |
Is vancomycin MIC "creep" method dependent? Analysis of methicillin-resistant Staphylococcus aureus susceptibility trends in blood isolates from North East Scotland from 2006 to 2010.
Topics: Anti-Bacterial Agents; Bacteremia; Blood; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Prospective Studies; Retrospective Studies; Scotland; Staphylococcal Infections; Time Factors; Vancomycin; Vancomycin Resistance | 2012 |
Contrasting effects of physical wear on elution of two antibiotics from orthopedic cement.
Topics: Acetates; Anti-Bacterial Agents; Arthroplasty; Biomimetics; Bone Cements; Buffers; Crystallization; Daptomycin; Diffusion; Gentamicins; Humans; Kinetics; Microscopy, Electron, Scanning; Vancomycin | 2012 |
A report on the first case of vancomycin-intermediate Staphylococcus aureus (VISA) in Hawai'i.
Topics: Anti-Bacterial Agents; Bacteremia; Daptomycin; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2011 |
Synergistic activity of ceftobiprole and vancomycin in a rat model of infective endocarditis caused by methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Daptomycin; Drug Dosage Calculations; Drug Synergism; Endocarditis, Bacterial; Female; Humans; Injections, Intravenous; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2012 |
Modulating activity of vancomycin and daptomycin on the expression of autolysis cell-wall turnover and membrane charge genes in hVISA and VISA strains.
Topics: Bacterial Proteins; Bacteriolysis; Cell Membrane; Cell Wall; Daptomycin; Gene Expression Regulation, Bacterial; Genes, Bacterial; Hemolysin Proteins; Humans; Mutation; Octoxynol; Phenotype; Quantitative Trait, Heritable; RNA, Messenger; Staphylococcus aureus; Vancomycin; Vancomycin Resistance; Virulence | 2012 |
In vitro activity of TD-1792, a multivalent glycopeptide-cephalosporin antibiotic, against 377 strains of anaerobic bacteria and 34 strains of Corynebacterium species.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Cephalosporins; Colony Count, Microbial; Corynebacterium; Culture Media; Daptomycin; Glycopeptides; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Vancomycin | 2012 |
Pharmacokinetic-pharmacodynamic evaluation of daptomycin, tigecycline, and linezolid versus vancomycin for the treatment of MRSA infections in four western European countries.
Topics: Acetamides; Anti-Bacterial Agents; Belgium; Daptomycin; Ireland; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Spain; Staphylococcal Infections; Tigecycline; United Kingdom; Vancomycin | 2012 |
Daptomycin versus vancomycin in a methicillin-resistant Staphylococcus aureus endophthalmitis rabbit model: bactericidal effect, safety, and ocular pharmacokinetics.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Colony Count, Microbial; Daptomycin; Disease Models, Animal; Drug-Related Side Effects and Adverse Reactions; Endophthalmitis; Eye; Female; Half-Life; Intravitreal Injections; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rabbits; Severity of Illness Index; Staphylococcal Infections; Vancomycin | 2012 |
Daptomycin and tigecycline have broader effective dose ranges than vancomycin as prophylaxis against a Staphylococcus aureus surgical implant infection in mice.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Colony Count, Microbial; Daptomycin; Drug Administration Schedule; Humans; Injections, Intravenous; Knee Prosthesis; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Minocycline; Models, Animal; Molecular Imaging; Prosthesis-Related Infections; Staphylococcal Infections; Tigecycline; Vancomycin | 2012 |
Daptomycin experience in critical care patients: results from a registry.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Critical Care; Daptomycin; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Registries; Retrospective Studies; Sepsis; Treatment Outcome; Vancomycin; Young Adult | 2012 |
Daptomycin or vancomycin for methicillin-resistant Staphylococcus aureus with a vancomycin minimum inhibitory concentration >1 μg/L.
Topics: Anti-Bacterial Agents; Bacteremia; Daptomycin; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2012 |
Genome sequence of Staphylococcus aureus VC40, a vancomycin- and daptomycin-resistant strain, to study the genetics of development of resistance to currently applied last-resort antibiotics.
Topics: Anti-Bacterial Agents; Base Sequence; Daptomycin; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Genome, Bacterial; Molecular Sequence Data; Staphylococcus aureus; Vancomycin | 2012 |
Evaluation of standard- and high-dose daptomycin versus linezolid against vancomycin-resistant Enterococcus isolates in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
Topics: Acetamides; Daptomycin; Endocarditis, Bacterial; Enterococcus; Enterococcus faecalis; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Vancomycin | 2012 |
[Analysis of treatments used in infections caused by gram-positive multiresistant cocci in critically ill patients admitted to the ICU].
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Cohort Studies; Critical Care; Critical Illness; Daptomycin; Drug Prescriptions; Drug Resistance, Multiple, Bacterial; Drug Utilization; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Intensive Care Units; Linezolid; Male; Middle Aged; Oxazolidinones; Retrospective Studies; Teicoplanin; Vancomycin | 2012 |
[Daptomycin therapy in patients with bacteremia].
Topics: Anti-Bacterial Agents; Bacteremia; Daptomycin; Decision Trees; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2012 |
Pharmacodynamic evaluation of the activity of antibiotics against hemin- and menadione-dependent small-colony variants of Staphylococcus aureus in models of extracellular (broth) and intracellular (THP-1 monocytes) infections.
Topics: Anti-Bacterial Agents; Cell Line; Daptomycin; Gentamicins; Glycopeptides; Hemin; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Monocytes; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vitamin K 3 | 2012 |
Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan.
Topics: Acetamides; Aged; Aged, 80 and over; Analysis of Variance; Anti-Bacterial Agents; Bacteremia; Daptomycin; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Incidence; Linezolid; Male; Middle Aged; Oxazolidinones; Proportional Hazards Models; Retrospective Studies; Risk Factors; Taiwan; Vancomycin; Vancomycin Resistance | 2012 |
In vitro activities of LTX-109, a synthetic antimicrobial peptide, against methicillin-resistant, vancomycin-intermediate, vancomycin-resistant, daptomycin-nonsusceptible, and linezolid-nonsusceptible Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oligopeptides; Oxazolidinones; Vancomycin; Vancomycin Resistance | 2012 |
Antimicrobial activity of daptomycin in comparison to glycopeptides and other antimicrobials when tested against numerous species of coagulase-negative Staphylococcus.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Glycopeptides; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus; Teicoplanin; Vancomycin | 2012 |
Correlation between mutations in liaFSR of Enterococcus faecium and MIC of daptomycin: revisiting daptomycin breakpoints.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Cell Wall; Daptomycin; DNA, Bacterial; Drug Resistance, Bacterial; Enterococcus faecium; Microbial Sensitivity Tests; Mutation; Sequence Analysis, DNA; Vancomycin; Vancomycin Resistance | 2012 |
Rates of killing of methicillin-resistant Staphylococcus aureus by ceftaroline, daptomycin, and telavancin compared to that of vancomycin.
Topics: Aminoglycosides; Analysis of Variance; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Colony Count, Microbial; Daptomycin; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2012 |
Vancomycin tolerance in methicillin-resistant Staphylococcus aureus: influence of vancomycin, daptomycin, and telavancin on differential resistance gene expression.
Topics: Aminoacyltransferases; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; DNA-Binding Proteins; Drug Tolerance; Gene Expression Regulation, Bacterial; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance | 2012 |
Daptomycin compared to vancomycin for the treatment of osteomyelitis: a single-center, retrospective cohort study.
Topics: Anti-Bacterial Agents; Cohort Studies; Daptomycin; Follow-Up Studies; Hospitals, Veterans; Humans; Male; Middle Aged; Osteomyelitis; Recurrence; Retrospective Studies; Treatment Outcome; Vancomycin | 2012 |
A mutation in the PP2C phosphatase gene in a Staphylococcus aureus USA300 clinical isolate with reduced susceptibility to vancomycin and daptomycin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; Mutation; Phosphoprotein Phosphatases; Protein Phosphatase 2C; Staphylococcus aureus; Vancomycin | 2012 |
Effects of storage on vancomycin and daptomycin MIC in susceptible blood isolates of methicillin-resistant Staphylococcus aureus.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Blood; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Specimen Handling; Staphylococcal Infections; Time Factors; Vancomycin | 2012 |
Daptomycin-nonsusceptible vancomycin-intermediate staphylococcus aureus vertebral osteomyelitis cases complicated by bacteremia treated with high-dose daptomycin and trimethoprim-sulfamethoxazole.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Osteomyelitis; Spine; Staphylococcal Infections; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2012 |
Genotypic and phenotypic evaluation of the evolution of high-level daptomycin nonsusceptibility in vancomycin-resistant Enterococcus faecium.
Topics: Adaptation, Physiological; Anti-Bacterial Agents; Bacterial Proteins; Cell Membrane; Clone Cells; Daptomycin; Enterococcus faecium; Genotype; Membrane Proteins; Microbial Sensitivity Tests; Open Reading Frames; Phenotype; Phosphotransferases; Polymorphism, Single Nucleotide; Static Electricity; Transferases (Other Substituted Phosphate Groups); Vancomycin; Vancomycin Resistance | 2012 |
[Evaluation of antibiotic susceptibilities and VISA-VRSA rates among MRSA strains isolated from hospitalized patients in intensive care units of hospitals in seven provinces of Turkey].
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Intensive Care Units; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Turkey; Vancomycin; Vancomycin Resistance; Virginiamycin | 2012 |
Genetic features and molecular epidemiology of Enterococcus faecium isolated in two university hospitals in Brazil.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; Bacterial Proteins; Brazil; Carbon-Oxygen Ligases; Daptomycin; DNA Transposable Elements; DNA, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Vancomycin; Vancomycin Resistance; Virulence Factors | 2012 |
Cell envelope stress response in cell wall-deficient L-forms of Bacillus subtilis.
Topics: Anti-Bacterial Agents; Bacillus subtilis; Bacitracin; Bacteriocins; Cell Membrane; Cell Wall; Daptomycin; Drug Resistance, Microbial; Gene Expression Regulation, Bacterial; Genes, Reporter; L Forms; Lac Operon; Membrane Lipids; Peptides; Promoter Regions, Genetic; Signal Transduction; Stress, Physiological; Vancomycin | 2012 |
Transposon library screening for identification of genetic loci participating in intrinsic susceptibility and acquired resistance to antistaphylococcal agents.
Topics: Anti-Bacterial Agents; Daptomycin; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Gene Library; Genetic Loci; Genetic Predisposition to Disease; Mutagenesis, Insertional; Nisin; Pilot Projects; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2013 |
Vancomycin-induced thrombocytopenia without isolation of a drug-dependent antibody.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Daptomycin; Diagnosis, Differential; Doxycycline; Drug Monitoring; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Staphylococcal; Purpura, Thrombocytopenic, Idiopathic; Recurrence; Staphylococcal Infections; Thrombocytopenia; Vancomycin | 2012 |
Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model.
Topics: Aminoacyltransferases; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacterial Proteins; Cathelicidins; Ceftaroline; Cell Membrane; Cell Wall; Cephalosporins; Colony Count, Microbial; Daptomycin; Drug Combinations; Drug Synergism; Fluorescent Dyes; Genome, Bacterial; High-Throughput Nucleotide Sequencing; Methicillin-Resistant Staphylococcus aureus; Microbial Viability; Models, Biological; Mutation; Vancomycin; Vancomycin Resistance | 2013 |
Activity of ethanol and daptomycin lock on biofilm generated by an in vitro dynamic model using real subcutaneous injection ports.
Topics: Biofilms; Colony Count, Microbial; Daptomycin; Disinfectants; Disinfection; Equipment and Supplies; Ethanol; Humans; Injections, Subcutaneous; Microbial Viability; Staphylococcus epidermidis; Vancomycin | 2013 |
Pharmacodynamics of a simulated single 1,200-milligram dose of oritavancin in an in vitro pharmacokinetic/pharmacodynamic model of methicillin-resistant staphylococcus aureus infection.
Topics: Analysis of Variance; Anti-Bacterial Agents; Area Under Curve; Clinical Trials, Phase III as Topic; Colony Count, Microbial; Culture Media; Daptomycin; Drug Dosage Calculations; Glycopeptides; Humans; Infusion Pumps; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Biological; Staphylococcal Infections; Vancomycin | 2013 |
Epidemiology of vancomycin-resistant enterococci with reduced susceptibility to daptomycin.
Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Cephalosporins; Comorbidity; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Immunosuppression Therapy; Male; Metronidazole; Middle Aged; Proportional Hazards Models; Retrospective Studies; Risk Factors; Statistics, Nonparametric; Vancomycin; Vancomycin Resistance | 2012 |
Activity of ceftaroline against extracellular (broth) and intracellular (THP-1 monocytes) forms of methicillin-resistant Staphylococcus aureus: comparison with vancomycin, linezolid and daptomycin.
Topics: Acetamides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Monocytes; Oxazolidinones; Vancomycin | 2013 |
In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice.
Topics: Acetamides; Administration, Oral; Administration, Topical; Animals; Anti-Bacterial Agents; Bacterial Load; Bridged Bicyclo Compounds, Heterocyclic; Clindamycin; Community-Acquired Infections; Daptomycin; Diabetes Mellitus, Type 2; Disease Models, Animal; Diterpenes; Doxycycline; Linezolid; Luminescent Measurements; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Mupirocin; Oxazolidinones; Skin; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Wound Healing | 2013 |
Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
Topics: Acetamides; Adult; Age Factors; Aged; Anti-Bacterial Agents; Cohort Studies; Cost Savings; Daptomycin; Drug Costs; Female; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Oxazolidinones; Retrospective Studies; Severity of Illness Index; Staphylococcal Infections; Time Factors; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2012 |
Fosfomycin synergy in vitro with amoxicillin, daptomycin, and linezolid against vancomycin-resistant Enterococcus faecium from renal transplant patients with infected urinary stents.
Topics: Acetamides; Amoxicillin; Anti-Bacterial Agents; Daptomycin; Drug Synergism; Enterococcus faecium; Fosfomycin; Gram-Positive Bacterial Infections; Humans; Kidney Transplantation; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Stents; Urinary Tract; Urinary Tract Infections; Vancomycin; Vancomycin Resistance | 2013 |
Inoculum effects of ceftobiprole, daptomycin, linezolid, and vancomycin with Staphylococcus aureus and Streptococcus pneumoniae at inocula of 10(5) and 10(7) CFU injected into opposite thighs of neutropenic mice.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Cephalosporins; Colony Count, Microbial; Daptomycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Injections, Subcutaneous; Linezolid; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Oxazolidinones; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Thigh; Vancomycin | 2013 |
[Pharmacoeconomic analysis of the treatment of methicillin-resistant Staphylococcus aureus with daptomycin or vancomycin].
Topics: Adult; Aged; Aged, 80 and over; Bacteremia; Computer Simulation; Cost-Benefit Analysis; Daptomycin; Drug Costs; Drug-Related Side Effects and Adverse Reactions; Economics, Pharmaceutical; Endocarditis, Bacterial; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Models, Economic; Monte Carlo Method; Randomized Controlled Trials as Topic; Retrospective Studies; Spain; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult | 2012 |
Influence of early daptomycin therapy on treatment outcome of meticillin-resistant Staphylococcus aureus bacteraemia with high vancomycin minimum inhibitory concentrations.
Topics: Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2013 |
Daptomycin versus vancomycin in treatment of methicillin-resistant Staphylococcus aureus meningitis in an experimental rabbit model.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Daptomycin; Disease Models, Animal; Meningitis, Bacterial; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Vancomycin | 2013 |
Methicillin-resistant Staphylococcus aureus bacterial nitric-oxide synthase affects antibiotic sensitivity and skin abscess development.
Topics: Abscess; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacterial Proteins; Cathelicidins; Daptomycin; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Mice; Mutation; Nitric Oxide; Nitric Oxide Synthase; Reactive Oxygen Species; Staphylococcal Skin Infections; Vancomycin | 2013 |
Ceftaroline in the treatment of concomitant methicillin-resistant and daptomycin-non-susceptible Staphylococcus aureus infective endocarditis and osteomyelitis: case report.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Debridement; Drug Resistance, Bacterial; Endocarditis, Bacterial; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Osteomyelitis; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2013 |
Update of dalbavancin spectrum and potency in the USA: report from the SENTRY Antimicrobial Surveillance Program (2011).
Topics: Anti-Bacterial Agents; Clindamycin; Daptomycin; Drug Evaluation; Drug Resistance, Bacterial; Enterococcus; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Streptococcus; Teicoplanin; United States; Vancomycin | 2013 |
Comparison of intravitreal vancomycin and daptomycin application in experimental methicillin-resistant Staphylococcus aureus (MRSA) endophthalmitis in rabbits.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Daptomycin; Endophthalmitis; Eye; Intravitreal Injections; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Vancomycin | 2013 |
Early high-dose daptomycin for methicillin-resistant Staphylococcus aureus bloodstream infections with elevated vancomycin minimum inhibitory concentrations: ready for prime time?
Topics: Anti-Bacterial Agents; Bacteremia; Daptomycin; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2013 |
Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Chi-Square Distribution; Cohort Studies; Daptomycin; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2013 |
Early in vitro and in vivo development of high-level daptomycin resistance is common in mitis group Streptococci after exposure to daptomycin.
Topics: Animals; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Microbial Sensitivity Tests; Rabbits; Species Specificity; Streptococcal Infections; Streptococcus anginosus; Streptococcus bovis; Streptococcus mitis; Streptococcus mutans; Vancomycin | 2013 |
Daptomycin non-susceptible Staphylococcus aureus at a US medical centre.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Daptomycin; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Staphylococcus aureus; United States; Vancomycin; Young Adult | 2013 |
Spectrum of gram-positive bacteraemia and in vitro activities of daptomycin, linezolid and vancomycin against organisms isolated from cancer patients.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Daptomycin; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Oxazolidinones; Prevalence; Vancomycin; Young Adult | 2013 |
A liaF codon deletion abolishes daptomycin bactericidal activity against vancomycin-resistant Enterococcus faecalis.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cell Wall; Codon; Daptomycin; Drug Resistance, Bacterial; Enterococcus faecium; Humans; Microbial Sensitivity Tests; Sequence Analysis, DNA; Sequence Deletion; Stem Cells; Vancomycin; Vancomycin Resistance | 2013 |
Pharmacokinetics of daptomycin in a patient with severe renal failure not receiving dialysis.
Topics: Anti-Bacterial Agents; Daptomycin; Female; Gentamicins; Humans; Middle Aged; Renal Dialysis; Renal Insufficiency; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2013 |
Studies on the mechanism of telavancin decreased susceptibility in a laboratory-derived mutant.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Cell Membrane; Cell Wall; Daptomycin; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Lipoglycopeptides; Membrane Fluidity; Microbial Sensitivity Tests; Staphylococcus aureus; Transcriptome; Vancomycin; Vancomycin Resistance | 2013 |
High-dose daptomycin monotherapy cures Staphylococcus epidermidis 'endotipsitis' after failure of conventional therapy.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Catheterization, Central Venous; Catheters; Daptomycin; Drug Resistance, Multiple, Bacterial; Humans; Male; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Failure; Vancomycin | 2013 |
Chitosan sponges for local synergistic infection therapy: a pilot study.
Topics: Amikacin; Anti-Infective Agents; Chitosan; Daptomycin; Drug Delivery Systems; Drug Resistance, Bacterial; Drug Synergism; Microbial Sensitivity Tests; Pilot Projects; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2013 |
In vitro activity of vancomycin and daptomycin against clinical isolates of Staphylococcus aureus and enterococci from India.
Topics: Anti-Bacterial Agents; Daptomycin; Enterococcus; Gram-Positive Bacterial Infections; Humans; India; Microbial Sensitivity Tests; Prospective Studies; Staphylococcus aureus; Vancomycin | 2013 |
Antimicrobial activity of ceftaroline tested against staphylococci with reduced susceptibility to linezolid, daptomycin, or vancomycin from U.S. hospitals, 2008 to 2011.
Topics: Acetamides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Hospitals; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2013 |
Decreased vancomycin susceptibility in Staphylococcus aureus caused by IS256 tempering of WalKR expression.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Daptomycin; DNA Transposable Elements; DNA, Bacterial; Gene Expression Regulation, Bacterial; Genome, Bacterial; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Sequence Data; Mutagenesis, Insertional; Mutagenesis, Site-Directed; Peptidoglycan Glycosyltransferase; Promoter Regions, Genetic; Protein Kinases; Sequence Analysis, DNA; Vancomycin; Vancomycin Resistance | 2013 |
How much is a life worth? Food for thought.
Topics: Anti-Bacterial Agents; Daptomycin; Health Care Costs; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2013 |
Evaluation of vancomycin and daptomycin MIC trends for methicillin-resistant Staphylococcus aureus blood isolates over an 11 year period.
Topics: Anti-Bacterial Agents; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2013 |
History of antibiotics: from fluoroquinolones to daptomycin (Part 2).
Topics: Anti-Bacterial Agents; Carbapenems; Daptomycin; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacterial Infections; History, 20th Century; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Vancomycin | 2013 |
Adaptation of Enterococcus faecalis to daptomycin reveals an ordered progression to resistance.
Topics: Adaptation, Physiological; Alleles; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Epistasis, Genetic; Evolution, Molecular; Gene Expression Regulation, Bacterial; Gene Frequency; Genome, Bacterial; High-Throughput Nucleotide Sequencing; Humans; Mutation; Signal Transduction; Vancomycin; Vancomycin Resistance | 2013 |
Daptomycin use in neutropenic patients with documented gram-positive infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Daptomycin; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Retrospective Studies; Treatment Outcome; Vancomycin | 2014 |
Activity of linezolid and daptomycin against methicillin-resistant coagulase-negative staphylococci with increased MIC for vancomycin isolated from blood cultures in pediatric patients.
Topics: Acetamides; Anti-Bacterial Agents; Child; Coagulase; Daptomycin; Dose-Response Relationship, Drug; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus; Structure-Activity Relationship; Vancomycin | 2014 |
Efficacy of daptomycin on experimental methicillin-resistant Staphylococcus aureus keratitis in rabbits.
Topics: Administration, Ophthalmic; Animals; Anti-Bacterial Agents; Bacterial Load; Colony Count, Microbial; Daptomycin; Disease Models, Animal; Dose-Response Relationship, Drug; Eye Infections, Bacterial; Keratitis; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Ophthalmic Solutions; Rabbits; Staphylococcal Infections; Vancomycin | 2013 |
Activities of fosfomycin and rifampin on planktonic and adherent Enterococcus faecalis strains in an experimental foreign-body infection model.
Topics: Acetamides; Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Calorimetry; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Enterococcus faecalis; Foreign Bodies; Fosfomycin; Gentamicins; Gram-Positive Bacterial Infections; Guinea Pigs; Linezolid; Male; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Vancomycin | 2014 |
Simultaneous quantification of antimicrobial agents for multidrug-resistant bacterial infections in human plasma by ultra-high-pressure liquid chromatography-tandem mass spectrometry.
Topics: Acetonitriles; Anti-Bacterial Agents; Calibration; Chromatography, High Pressure Liquid; Colistin; Daptomycin; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Formates; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Limit of Detection; Protein Denaturation; Reproducibility of Results; Tandem Mass Spectrometry; Teicoplanin; Vancomycin | 2013 |
Daptomycin versus vancomycin for osteoarticular infections due to methicillin-resistant Staphylococcus aureus (MRSA): a nested case-control study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bone Diseases, Infectious; Case-Control Studies; Daptomycin; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2014 |
In vitro pharmacodynamics of human simulated exposures of ceftaroline and daptomycin against MRSA, hVISA, and VISA with and without prior vancomycin exposure.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Colony Count, Microbial; Daptomycin; Drug Combinations; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Statistical; Vancomycin; Vancomycin Resistance | 2014 |
Ineffectiveness of daptomycin in the treatment of septic pulmonary emboli and persistent bacteremia caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Bacteremia; Daptomycin; Fatal Outcome; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pulmonary Embolism; Staphylococcal Infections; Treatment Failure; Vancomycin | 2013 |
Treatment of vertebral osteomyelitis.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Osteomyelitis; Spinal Diseases; Staphylococcal Infections; Vancomycin | 2014 |
Vancomycin and daptomycin minimum inhibitory concentration distribution and occurrence of heteroresistance among methicillin-resistant Staphylococcus aureus blood isolates in Turkey.
Topics: Anti-Bacterial Agents; Area Under Curve; Bacteremia; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Prevalence; Staphylococcal Infections; Turkey; Vancomycin; Vancomycin Resistance | 2013 |
hVISA and MRSA endocarditis: an 8-year experience in a tertiary care centre.
Topics: Aged; Daptomycin; Defibrillators, Implantable; Diagnosis, Differential; Endocarditis, Bacterial; Female; Humans; Israel; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pacemaker, Artificial; Prevalence; Prognosis; Prospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Tertiary Care Centers; Vancomycin; Vancomycin Resistance | 2014 |
Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Computer Simulation; Cross Infection; Daptomycin; Dose-Response Relationship, Drug; Humans; Intensive Care Units; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Minocycline; Models, Biological; Monte Carlo Method; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Vancomycin | 2014 |
Reducing daptomycin expenditures by standardizing doses.
Topics: Anti-Bacterial Agents; Bacterial Infections; Clinical Trials, Phase I as Topic; Daptomycin; Humans; Reference Standards; Vancomycin | 2014 |
Comparison of Sensititre microdilution method to other standard methods for susceptibility testing of coagulase-negative staphylococci from paediatric blood cultures.
Topics: Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clindamycin; Daptomycin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Oxacillin; Staphylococcus epidermidis; Staphylococcus hominis; Tetracycline; Vancomycin | 2014 |
Comparative cost-effectiveness of alternative empiric antimicrobial treatment options for suspected enterococcal bacteremia.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Cost-Benefit Analysis; Daptomycin; Decision Support Techniques; Drug Resistance, Bacterial; Enterococcus; Humans; Linezolid; Models, Economic; Monte Carlo Method; Oxazolidinones; Quality-Adjusted Life Years; Vancomycin | 2014 |
Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments.
Topics: Aminoglycosides; Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Ciprofloxacin; Colistin; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fosfomycin; In Vitro Techniques; Klebsiella pneumoniae; Lipoglycopeptides; Meropenem; Microbial Sensitivity Tests; Minocycline; Rifampin; Thienamycins; Tigecycline; Vancomycin | 2014 |
Adverse events, healthcare interventions and healthcare utilization during home infusion therapy with daptomycin and vancomycin: a propensity score-matched cohort study.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cohort Studies; Daptomycin; Drug-Related Side Effects and Adverse Reactions; Female; Health Facilities; Home Infusion Therapy; Humans; Male; Middle Aged; Propensity Score; Retrospective Studies; Vancomycin | 2014 |
Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Daptomycin; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Vancomycin | 2014 |
Daptomycin is effective as antibiotic-lock therapy in a model of Staphylococcus aureus catheter-related infection.
Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biofilms; Catheter-Related Infections; Daptomycin; Disease Models, Animal; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2014 |
Genotypically different clones of Staphylococcus aureus are diverse in the antimicrobial susceptibility patterns and biofilm formations.
Topics: Acetamides; Anti-Infective Agents; Biofilms; Daptomycin; Genetic Variation; Genotype; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Viability; Minocycline; Oxazolidinones; Staphylococcal Infections; Tigecycline; Vancomycin | 2013 |
Which antibiotic for hospital acquired pneumonia caused by MRSA?
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Pneumonia, Staphylococcal; Tigecycline; Vancomycin; Virginiamycin | 2014 |
Molecular epidemiology of methicillin-resistant S. aureus in the ICU setting.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Genotyping Techniques; Humans; Intensive Care Units; Italy; Linezolid; Methicillin-Resistant Staphylococcus aureus; Molecular Epidemiology; Oxazolidinones; Staphylococcal Infections; Vancomycin | 2014 |
Ceftaroline-heteroresistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2014 |
The efficacy of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bloodstream infection in patients with impaired renal function.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cohort Studies; Daptomycin; Female; Glomerular Filtration Rate; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Renal Insufficiency; Retrospective Studies; Staphylococcal Infections; Tertiary Care Centers; Treatment Outcome; Vancomycin | 2014 |
Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis.
Topics: Adult; Aged; Anti-Bacterial Agents; Cloxacillin; Daptomycin; Endocarditis, Bacterial; Female; Hospital Mortality; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Survival Rate; Vancomycin | 2014 |
Evaluation of ceftaroline, vancomycin, daptomycin, or ceftaroline plus daptomycin against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Colony Count, Microbial; Computer Simulation; Daptomycin; Drug Combinations; Endocarditis, Bacterial; Half-Life; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2014 |
In vitro evaluation of antibiotics for methicillin-resistant Staphylococcus aureus from north India.
Topics: Daptomycin; Humans; India; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2014 |
Comparison of commercial antimicrobial susceptibility test methods for testing of Staphylococcus aureus and Enterococci against vancomycin, daptomycin, and linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Enterococcus; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Vancomycin | 2014 |
[Estimation of MRSA susceptibility to oxacillin, cefoxitine, vancomycin and daptomycin].
Topics: Anti-Bacterial Agents; Cefoxitin; Daptomycin; Dose-Response Relationship, Drug; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Vancomycin | 2013 |
Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Daptomycin; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2014 |
Whole-genome analyses of Enterococcus faecium isolates with diverse daptomycin MICs.
Topics: Amino Acid Substitution; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Boron Compounds; Cell Membrane; Cell Wall; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Fluorescent Dyes; Gene Expression; Genes, Regulator; Genome, Bacterial; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance | 2014 |
In vitro activities of oritavancin and comparators against meticillin-resistant Staphylococcus aureus (MRSA) isolates harbouring the novel mecC gene.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; Gene Expression; Glycopeptides; Linezolid; Lipoglycopeptides; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Oxazolidinones; Vancomycin | 2014 |
Successful treatment of ventriculostomy-associated meningitis caused by multidrug resistant coagulase-negative Staphylococcus epidermidis using low-volume intrathecal daptomycin and loading strategy.
Topics: Adult; Anti-Bacterial Agents; Coagulase; Daptomycin; Drug Resistance, Multiple, Bacterial; Humans; Infusions, Spinal; Male; Meningitis, Bacterial; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin; Ventriculostomy | 2014 |
The effect of inoculum size on selection of in vitro resistance to vancomycin, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Vancomycin | 2014 |
Modeling economic implications of alternative treatment strategies for acute bacterial skin and skin structure infections.
Topics: Acetamides; Acute Disease; Administration, Intravenous; Anti-Bacterial Agents; Daptomycin; Health Expenditures; Humans; Linezolid; Oxazolidinones; Patient Discharge; Skin Diseases, Bacterial; Soft Tissue Infections; United States; Vancomycin | 2014 |
Comparison of the antibiotic activities of Daptomycin, Vancomycin, and the investigational Fluoroquinolone Delafloxacin against biofilms from Staphylococcus aureus clinical isolates.
Topics: Anti-Bacterial Agents; Biofilms; Daptomycin; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Polyamines; Polysaccharides, Bacterial; Spermidine; Spermine; Staphylococcal Infections; Vancomycin | 2014 |
NRPquest: Coupling Mass Spectrometry and Genome Mining for Nonribosomal Peptide Discovery.
Topics: Algorithms; Anti-Bacterial Agents; Bacillus; Biological Products; Daptomycin; Mass Spectrometry; Molecular Structure; Peptide Synthases; Peptides; Proteomics; Streptomyces; Vancomycin | 2014 |
Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteraemia.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2015 |
Precision of vancomycin and daptomycin MICs for methicillin-resistant Staphylococcus aureus and effect of subculture and storage.
Topics: Anti-Bacterial Agents; Bacteremia; Blood; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Preservation, Biological; Prospective Studies; Reproducibility of Results; Specimen Handling; Staphylococcal Infections; Temperature; Vancomycin | 2014 |
Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol.
Topics: Acetamides; Aerosols; Anti-Bacterial Agents; Daptomycin; Equipment Design; Linezolid; Nebulizers and Vaporizers; Oxazolidinones; Particle Size; Vancomycin | 2014 |
First case report of vancomycin-intermediate sequence type 72 Staphylococcus aureus with nonsusceptibility to daptomycin.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Rifampin; Staphylococcal Infections; Vancomycin | 2014 |
Evaluation of the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Daptomycin; Female; Health Care Costs; Hospitalization; Humans; Intensive Care Units; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Retrospective Studies; Staphylococcal Infections; Tennessee; Treatment Outcome; Vancomycin | 2015 |
A correlation between reduced susceptibilities to vancomycin and daptomycin among the MRSA isolates selected in mutant selection window of both vancomycin and daptomycin.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Prevalence; Staphylococcal Infections; Vancomycin | 2014 |
A 5-year survey of antimicrobial susceptibility profiles of methicillin-resistant Staphylococcus aureus (MRSA) isolated from patients with bloodstream infections in Northeast Italy.
Topics: Acetamides; Anti-Bacterial Agents; Blood; Daptomycin; Health Surveys; Humans; Italy; Linezolid; Longitudinal Studies; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Vancomycin | 2015 |
Assessing outcomes of adult oncology patients treated with linezolid versus daptomycin for bacteremia due to vancomycin-resistant Enterococcus.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cohort Studies; Daptomycin; Enterococcus; Female; Humans; Linezolid; Male; Middle Aged; Neoplasms; Retrospective Studies; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2016 |
Daptomycin and methicillin-resistant Staphylococcus aureus isolated from a catheter-related bloodstream infection: a case report.
Topics: Catheter-Related Infections; Daptomycin; Drug Resistance, Multiple, Bacterial; Fatal Outcome; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Vancomycin | 2014 |
Vancomycin-Resistant Staphylococcus hemolyticus Bacteremia Treated Successfully by Intravenous Daptomycin and Catheter Removal in a Hemodialysis Patient.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Daptomycin; Device Removal; Drug Resistance, Bacterial; Female; Humans; Renal Dialysis; Staphylococcal Infections; Staphylococcus haemolyticus; Vancomycin | 2015 |
Telavancin in vitro activity against a collection of methicillin-resistant Staphylococcus aureus isolates, including resistant subsets, from the United States.
Topics: Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; United States; Vancomycin | 2015 |
Daptomycin versus Vancomycin in an Enterococcus faecalis Endophthalmitis Rabbit Model.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Daptomycin; Disease Models, Animal; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Intravitreal Injections; Microbial Sensitivity Tests; Ophthalmic Solutions; Rabbits; Vancomycin | 2016 |
Linezolid, vancomycin and daptomycin modulate cytokine production, Toll-like receptors and phagocytosis in a human in vitro model of sepsis.
Topics: Acetamides; Anti-Bacterial Agents; Cell Line; Cytokines; Daptomycin; Escherichia coli; Gene Expression Profiling; Gram-Positive Bacteria; Humans; Immunologic Factors; Linezolid; Models, Theoretical; Monocytes; Oxazolidinones; Phagocytosis; Sepsis; Toll-Like Receptors; Vancomycin | 2015 |
β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Ceftaroline; Cephalosporins; Daptomycin; Enterococcus faecalis; Enterococcus faecium; Ertapenem; Microbial Sensitivity Tests; Vancomycin; Vancomycin-Resistant Enterococci | 2015 |
Improvement of the antibacterial activity of daptomycin-loaded polymeric microparticles by Eudragit RL 100: an assessment by isothermal microcalorimetry.
Topics: Acrylic Resins; Animals; Anti-Bacterial Agents; Calorimetry; Calorimetry, Differential Scanning; Cell Line; Cell Survival; Chemistry, Pharmaceutical; Daptomycin; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Carriers; Kinetics; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Particle Size; Polymethyl Methacrylate; Solubility; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus; Surface Properties; Technology, Pharmaceutical; Vancomycin | 2015 |
Evolution and single-nucleotide polymorphisms in methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to vancomycin and daptomycin, based on determination of the complete genome.
Topics: Anti-Bacterial Agents; Biological Evolution; Daptomycin; Gene Expression Regulation, Bacterial; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Sequence Data; Polymorphism, Single Nucleotide; Vancomycin | 2015 |
Comparative efficacies of tedizolid phosphate, vancomycin, and daptomycin in a rabbit model of methicillin-resistant Staphylococcus aureus endocarditis.
Topics: Animals; Anti-Bacterial Agents; Daptomycin; Drug Administration Schedule; Endocarditis; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Rabbits; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2015 |
The Prevalence of Vancomycin-Intermediate Staphylococcus aureus and Heterogeneous VISA Among Methicillin-Resistant Strains Isolated from Pediatric Population in a Turkish University Hospital.
Topics: Anti-Bacterial Agents; Area Under Curve; Child; Child, Preschool; Daptomycin; Drug Resistance, Multiple, Bacterial; Female; Hospitals, University; Humans; Male; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Retrospective Studies; Staphylococcal Infections; Turkey; Vancomycin | 2015 |
Clinical Outcomes of Daptomycin for Vancomycin-resistant Enterococcus Bacteremia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Daptomycin; Enterococcus; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retreatment; Retrospective Studies; United States; Vancomycin; Vancomycin Resistance; Young Adult | 2015 |
Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model.
Topics: Anti-Bacterial Agents; Biofilms; Ceftaroline; Cephalosporins; Daptomycin; Drug Therapy, Combination; Half-Life; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rifampin; Vancomycin | 2015 |
RX-P873, a Novel Protein Synthesis Inhibitor, Accumulates in Human THP-1 Monocytes and Is Active against Intracellular Infections by Gram-Positive (Staphylococcus aureus) and Gram-Negative (Pseudomonas aeruginosa) Bacteria.
Topics: Anti-Bacterial Agents; Ceftazidime; Cells, Cultured; Ciprofloxacin; Daptomycin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Guanidines; Humans; Microbial Sensitivity Tests; Monocytes; Moxifloxacin; Protein Synthesis Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Pyrimidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2015 |
TXA709, an FtsZ-Targeting Benzamide Prodrug with Improved Pharmacokinetics and Enhanced In Vivo Efficacy against Methicillin-Resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Benzamides; Cells, Cultured; Cytoskeletal Proteins; Daptomycin; Dogs; Half-Life; Humans; Linezolid; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Prodrugs; Pyridines; Rats; Staphylococcal Infections; Thiazoles; Vancomycin | 2015 |
Antimicrobial susceptibility pattern of vancomycin resistant enterococci to newer antimicrobial agents.
Topics: Anti-Infective Agents; Daptomycin; Humans; Linezolid; Minocycline; Tigecycline; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci; Virginiamycin | 2015 |
Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models.
Topics: Anti-Bacterial Agents; Daptomycin; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin | 2015 |
Duration of prior vancomycin therapy and subsequent daptomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteremia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Daptomycin; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; Staphylococcal Infections; Time Factors; Treatment Outcome; Vancomycin | 2015 |
Activity of daptomycin- and vancomycin-loaded poly-epsilon-caprolactone microparticles against mature staphylococcal biofilms.
Topics: Anti-Bacterial Agents; Biofilms; Caproates; Daptomycin; Lactones; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microspheres; Vancomycin | 2015 |
Modulation of inflammatory mediators during treatment of cellulitis with daptomycin or vancomycin/oxacillin.
Topics: Adolescent; Adult; Aged; Animals; Cellulitis; Cytokines; Daptomycin; Humans; Middle Aged; Oxacillin; Prospective Studies; Time Factors; Treatment Outcome; Vancomycin; Young Adult | 2015 |
Could ceftaroline be an alternative therapy for linezolid resistant Staphylococcus epidermidis infections in Intensive Care Medicine?
Topics: Anti-Bacterial Agents; Bacteremia; Body Fluids; Catheter-Related Infections; Ceftaroline; Cephalosporins; Critical Care; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Exudates and Transudates; Humans; Linezolid; Methicillin; Minocycline; Staphylococcal Infections; Staphylococcus epidermidis; Tigecycline; Vancomycin | 2015 |
Weight-based antibiotic dosing in a real-world European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Body Weight; Daptomycin; Diabetes Complications; Europe; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Peripheral Vascular Diseases; Retrospective Studies; Soft Tissue Infections; Staphylococcal Skin Infections; Teicoplanin; Vancomycin; Young Adult | 2015 |
An investigation of vancomycin minimum inhibitory concentration creep among methicillin-resistant Staphylococcus aureus strains isolated from pediatric patients and healthy children in Northern Taiwan.
Topics: Adolescent; Anti-Bacterial Agents; Carrier State; Child; Child, Preschool; Daptomycin; Electrophoresis, Gel, Pulsed-Field; Female; Genetic Variation; Genotype; Humans; Infant; Infant, Newborn; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Typing; Retrospective Studies; Staphylococcal Infections; Taiwan; Tertiary Care Centers; Vancomycin | 2017 |
Stepwise decrease in daptomycin susceptibility in clinical Staphylococcus aureus isolates associated with an initial mutation in rpoB and a compensatory inactivation of the clpX gene.
Topics: Anti-Bacterial Agents; Daptomycin; Microbial Sensitivity Tests; Mutation; Polymorphism, Single Nucleotide; Rifampin; Staphylococcus aureus; Vancomycin | 2015 |
Activity of vancomycin, linezolid, and daptomycin against staphylococci and enterococci isolated in 5 Greek hospitals during a 5-year period (2008-2012).
Topics: Anti-Bacterial Agents; Daptomycin; Drug Utilization; Enterococcus; Gram-Positive Bacterial Infections; Greece; Hospitals; Humans; Linezolid; Microbial Sensitivity Tests; Staphylococcus; Vancomycin | 2015 |
Observed Antagonistic Effect of Linezolid on Daptomycin or Vancomycin Activity against Biofilm-Forming Methicillin-Resistant Staphylococcus aureus in an In Vitro Pharmacodynamic Model.
Topics: Anti-Bacterial Agents; Biofilms; Colony Count, Microbial; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Protein Synthesis Inhibitors; Staphylococcal Infections; Vancomycin | 2015 |
Impact of Glycopeptide Resistance in Staphylococcus aureus on the Dalbavancin In Vivo Pharmacodynamic Target.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Daptomycin; Drug Resistance, Bacterial; Injections, Intraperitoneal; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2015 |
Increasing Trend of Heterogeneous Vancomycin Intermediate Staphylococcus aureus in a Tertiary Care Center of Northern India.
Topics: Anti-Bacterial Agents; Area Under Curve; Biofilms; Cell Wall; Daptomycin; Humans; India; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Tertiary Care Centers; Vancomycin; Vancomycin Resistance | 2015 |
Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Staphylococcus aureus; Vancomycin | 2016 |
In vitro efficacy of daptomycin and teicoplanin combined with ethanol, clarithromycin or gentamicin as catheter lock solutions.
Topics: Anti-Bacterial Agents; Biofilms; Catheters; Clarithromycin; Daptomycin; Drug Therapy, Combination; Ethanol; Gentamicins; Humans; In Vitro Techniques; Isotonic Solutions; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 2015 |
Tricuspid and mitral endocarditis due to methicillin-resistant Staphylococcus aureus exhibiting vancomycin-creep phenomenon.
Topics: Adult; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Endocarditis, Bacterial; Fatal Outcome; Heart Valve Diseases; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Mitral Valve; Staphylococcal Infections; Tricuspid Valve; Vancomycin | 2015 |
In vitro activity of oritavancin and comparator agents against staphylococci, streptococci and enterococci from clinical infections in Europe and North America, 2011-2014.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus; Europe; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Microbial Sensitivity Tests; North America; Skin Diseases, Bacterial; Staphylococcal Infections; Staphylococcus; Streptococcal Infections; Streptococcus; Vancomycin | 2015 |
Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Bacteremia; Daptomycin; Female; Humans; Intensive Care Units; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Propensity Score; Recurrence; Regression Analysis; Retrospective Studies; Staphylococcal Infections; Treatment Failure; Treatment Outcome; Vancomycin | 2016 |
Antimicrobial susceptibility and molecular characteristics of methicillin-resistant Staphylococcus aureus in a Japanese secondary care facility.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Cross Infection; Daptomycin; Dibekacin; Exotoxins; Humans; Japan; Leukocidins; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Multilocus Sequence Typing; Open Reading Frames; Recombinases; Secondary Care Centers; Skin; Soft Tissue Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Virulence Factors | 2016 |
Susceptibility Profile of Staphylococcus epidermidis and Staphylococcus haemolyticus Isolated from Blood Cultures to Vancomycin and Novel Antimicrobial Drugs over a Period of 12 Years.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Blood Culture; Brazil; Daptomycin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Hospitals, Teaching; Humans; Linezolid; Minocycline; Mutation; Oxacillin; Prevalence; Staphylococcal Infections; Staphylococcus epidermidis; Staphylococcus haemolyticus; Tigecycline; Vancomycin; Virginiamycin | 2016 |
In vitro activity of dalbavancin and five comparator agents against common and uncommon Gram-positive organisms isolated from cancer patients.
Topics: Anti-Bacterial Agents; Daptomycin; Gram-Positive Bacteria; Humans; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Neoplasms; Teicoplanin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2016 |
Sequential Evolution of Vancomycin-Intermediate Resistance Alters Virulence in Staphylococcus aureus: Pharmacokinetic/Pharmacodynamic Targets for Vancomycin Exposure.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Daptomycin; Host-Pathogen Interactions; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moths; RNA, Bacterial; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2015 |
Chlorhexidine Induces VanA-Type Vancomycin Resistance Genes in Enterococci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacillus subtilis; Bacterial Proteins; Carbon-Oxygen Ligases; Cell Wall; Chlorhexidine; Daptomycin; Enterococcus faecium; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Microbial Sensitivity Tests; Transcription Factors; Vancomycin; Vancomycin Resistance | 2016 |
In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Gene Expression Profiling; Hemolysis; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymorphism, Single Nucleotide; Retrospective Studies; Staphylococcal Infections; Teicoplanin; Treatment Outcome; Vancomycin | 2016 |
Methicillin-resistant Staphylococcal periprosthetic joint infections can be effectively controlled by systemic and local daptomycin.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthritis, Infectious; Bone Cements; Daptomycin; Female; Humans; Male; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; Staphylococcal Infections; Staphylococcus; Vancomycin | 2016 |
Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefazolin; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ertapenem; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Staphylococcal Infections; Vancomycin; Vancomycin-Resistant Enterococci | 2016 |
New in vitro and in vivo models to evaluate antibiotic efficacy in Staphylococcus aureus prosthetic vascular graft infection.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Female; Mice; Microbial Sensitivity Tests; Models, Biological; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2016 |
Preventing Implant-Associated Infections by Silver Coating.
Topics: Animals; Anti-Bacterial Agents; Cell Survival; Coated Materials, Biocompatible; Daptomycin; Dental Alloys; Drug Liberation; Female; Kinetics; Leukocytes; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Prostheses and Implants; Silver; Skin; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2016 |
Emergence of a small colony variant of vancomycin-intermediate Staphylococcus aureus in a patient with septic arthritis during long-term treatment with daptomycin.
Topics: Aged; Anti-Bacterial Agents; Arthritis, Infectious; Daptomycin; Drug Resistance, Bacterial; Genotype; Humans; Male; Microbial Sensitivity Tests; Microscopy, Electron; Multilocus Sequence Typing; Phenotype; Staphylococcal Infections; Staphylococcus aureus; Time; Vancomycin; Vancomycin Resistance | 2016 |
Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Daptomycin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Female; Linezolid; Mice; Microbial Sensitivity Tests; Osteomyelitis; Prostheses and Implants; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2016 |
Comparative healthcare-associated costs of methicillin-resistant Staphylococcus aureus bacteraemia-infective endocarditis treated with either daptomycin or vancomycin.
Topics: Anti-Bacterial Agents; Bacteremia; Cost-Benefit Analysis; Daptomycin; Endocarditis; Health Care Costs; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; United Kingdom; Vancomycin | 2016 |
Successful Use of High-dose Daptomycin in a Child With Staphylococcus aureus Endocarditis.
Topics: Anti-Bacterial Agents; Bacteremia; Child, Preschool; Daptomycin; Endocarditis, Bacterial; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Rifampin; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2016 |
High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Comorbidity; Daptomycin; Disease Management; Drug Resistance, Bacterial; Female; Humans; Kaplan-Meier Estimate; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Spain; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2016 |
Effects of vancomycin, daptomycin, and tigecycline on coagulase-negative staphylococcus biofilm and bacterial viability within biofilm: an in vitro biofilm model.
Topics: Anti-Bacterial Agents; Biofilms; Coagulase; Daptomycin; Microbial Viability; Minocycline; Models, Biological; Staphylococcus; Tigecycline; Vancomycin | 2016 |
Comparative efficacy of telavancin and daptomycin in experimental endocarditis due to multi-clonotype MRSA strains.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Daptomycin; Disease Models, Animal; Endocarditis, Bacterial; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Vancomycin | 2016 |
Effect of Linezolid on Hematologic Recovery in Newly Diagnosed Acute Myeloid Leukemia Patients Following Induction Chemotherapy.
Topics: Academic Medical Centers; Adult; Anti-Bacterial Agents; Cohort Studies; Daptomycin; Female; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Linezolid; Male; Middle Aged; Neutropenia; Neutrophils; Retrospective Studies; Time Factors; Vancomycin | 2016 |
In vitro ceftaroline combinations against meticillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Therapy, Combination; Humans; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2016 |
Antibiofilm Activity and Synergistic Inhibition of Staphylococcus aureus Biofilms by Bactericidal Protein P128 in Combination with Antibiotics.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Daptomycin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gentamicins; Linezolid; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Recombinant Fusion Proteins; Staphylococcus aureus; Vancomycin | 2016 |
Comparative Genome Analysis of the Daptomycin-Resistant Streptococcus anginosus Strain J4206 Associated with Breakthrough Bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Base Composition; Cell Wall; Choline; Daptomycin; DNA Transposable Elements; Drug Resistance, Bacterial; Endopeptidases; Genome, Bacterial; Humans; Male; Membrane Proteins; Middle Aged; Streptococcus anginosus; Vancomycin | 2016 |
Treatment of severe MRSA infections: current practice and further development.
Topics: Anti-Bacterial Agents; Critical Illness; Daptomycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2017 |
Vancomycin, teicoplanin, daptomycin, and linezolid MIC creep in methicillin-resistant Staphylococcus aureus is associated with clonality.
Topics: Anti-Bacterial Agents; Daptomycin; Follow-Up Studies; Forecasting; Humans; Incidence; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Taiwan; Teicoplanin; Vancomycin | 2016 |
Vancomycin-resistant Enterococcal Bloodstream Infections in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies: Impact of Daptomycin MICs of 3 to 4 mg/L.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Daptomycin; Enterococcus faecium; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Vancomycin; Vancomycin Resistance | 2016 |
Daptomycin non-susceptible Enterococcus faecium in leukemia patients: Role of prior daptomycin exposure.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cohort Studies; Daptomycin; Drug Resistance, Bacterial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Leukemia; Linezolid; Male; Middle Aged; Retrospective Studies; Risk Factors; ROC Curve; Vancomycin | 2017 |
Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
Topics: Aged; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Endocarditis; Female; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Vancomycin | 2017 |
Daptomycin use: where is the truth?
Topics: Anti-Bacterial Agents; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2017 |
Comparative efficacies of daptomycin, vancomycin, and linezolid in experimental enterococcal peritonitis.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Daptomycin; Disease Models, Animal; Enterococcus; Female; Gram-Positive Bacterial Infections; Linezolid; Mice; Mice, Inbred C57BL; Peritonitis; Vancomycin | 2017 |
Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Female; Hospitalization; Humans; Length of Stay; Male; Methicillin-Resistant Staphylococcus aureus; Michigan; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Salvage Therapy; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2017 |
Synthesis, surfactant properties and antimicrobial activities of methyl glycopyranoside ethers.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple; Enterococcus faecalis; Enterococcus faecium; Glucosides; Gram-Positive Bacterial Infections; Humans; Listeria monocytogenes; Listeriosis; Methicillin; Methyl Ethers; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2017 |
Ceftaroline-Resistant, Daptomycin-Tolerant, and Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Causing Infective Endocarditis.
Topics: Adult; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Gene Expression; Humans; Male; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Staphylococcal Infections; Vancomycin | 2017 |
Development of advanced biantibiotic loaded bone cement spacers for arthroplasty associated infections.
Topics: Anti-Bacterial Agents; Arthroplasty; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bone Cements; Daptomycin; Drug Combinations; Drug Compounding; Humans; Linezolid; Materials Testing; Microbial Sensitivity Tests; Microspheres; Prosthesis-Related Infections; Staphylococcus aureus; Vancomycin | 2017 |
Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Daptomycin; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Retrospective Studies; Treatment Outcome; Vancomycin; Vancomycin-Resistant Enterococci; Veterans | 2017 |
Antimicrobial salvage therapy for native valve MRSA endocarditis.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Daptomycin; Endocarditis, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Vancomycin | 2017 |
Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolates from two Korean hospitals.
Topics: Anti-Bacterial Agents; Asian People; Clostridioides difficile; Clostridium Infections; Cross Infection; Daptomycin; Diarrhea; Electrophoresis, Gel, Pulsed-Field; Feces; Genes, Bacterial; Hospitals; Humans; Metronidazole; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Reproducibility of Results; Republic of Korea; Ribotyping; Vancomycin | 2017 |
Ventilator-associated pneumonia by methicillin-susceptible Staphylococcus aureus: do minimum inhibitory concentrations to vancomycin and daptomycin matter?
Topics: Aged; Aged, 80 and over; Biomarkers; Comorbidity; Daptomycin; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2017 |
Development of High-Grade Daptomycin Resistance in a Patient Being Treated for Corynebacterium striatum Infection.
Topics: Administration, Intravenous; Anti-Bacterial Agents; Corynebacterium; Corynebacterium Infections; Daptomycin; Drug Resistance, Bacterial; Humans; Male; Middle Aged; Vancomycin | 2017 |
Efficient Killing of Planktonic and Biofilm-Embedded Coagulase-Negative Staphylococci by Bactericidal Protein P128.
Topics: Anti-Bacterial Agents; Biofilms; Catheter-Related Infections; Coagulase; Daptomycin; Drug Synergism; Drug Therapy, Combination; Foreign-Body Reaction; Humans; Microbial Sensitivity Tests; Recombinant Fusion Proteins; Staphylococcal Infections; Staphylococcus epidermidis; Staphylococcus haemolyticus; Staphylococcus lugdunensis; Vancomycin | 2017 |
Vascular Graft Impregnation with Antibiotics: The Influence of High Concentrations of Rifampin, Vancomycin, Daptomycin, and Bacteriophage Endolysin HY-133 on Viability of Vascular Cells.
Topics: Anti-Bacterial Agents; Cell Survival; Daptomycin; Endopeptidases; Endothelial Cells; Fibroblasts; Humans; Microbial Sensitivity Tests; Muscle, Smooth, Vascular; Rifampin; Vancomycin; Vascular Grafting | 2017 |
Enterococci in orthopaedic infections: Who is at risk getting infected?
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cohort Studies; Cross Infection; Daptomycin; Enterococcus; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Intraoperative Period; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Orthopedic Procedures; Perioperative Period; Retrospective Studies; Risk Factors; Vancomycin; Young Adult | 2017 |
In vitro stepwise selection of reduced susceptibility to lipoglycopeptides in enterococci.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Teicoplanin; Vancomycin; Vancomycin Resistance | 2017 |
A therapeutic benefit of daptomycin against glycopeptide-resistant gram-positive cocci bloodstream infections under neutropenia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Chemotherapy-Induced Febrile Neutropenia; Daptomycin; Drug Resistance, Bacterial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Leuconostoc; Leukemia, Myeloid, Acute; Microbial Sensitivity Tests; Teicoplanin; Vancomycin | 2017 |
Inhibition of the ATP Synthase Eliminates the Intrinsic Resistance of
Topics: Anti-Bacterial Agents; ATP Synthetase Complexes; Colistin; Daptomycin; Drug Resistance, Bacterial; Gene Library; Microbial Sensitivity Tests; Mutation; Nisin; Polymyxins; Staphylococcus aureus; Vancomycin | 2017 |
[In vitro effect of vancomycin and daptomycin on biofilm formation of coagulase-negative staphylococci strains].
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Biofilms; Catheter-Related Infections; Daptomycin; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Morbidity; Staphylococcal Infections; Staphylococcus; Turkey; Vancomycin | 2017 |
Comparative evaluation of VITEK® 2 and three commercial gradient strip assays for daptomycin susceptibility testing of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Automation, Laboratory; Cross Infection; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Reagent Kits, Diagnostic; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2017 |
High-Dose Daptomycin and Mortality: The Case Is Not Yet Closed.
Topics: Bacteremia; Daptomycin; Humans; Vancomycin; Vancomycin-Resistant Enterococci; Veterans | 2017 |
Evaluation of Oritavancin Dosing Strategies against Vancomycin-Resistant Enterococcus faecium Isolates with or without Reduced Susceptibility to Daptomycin in an
Topics: Anti-Bacterial Agents; Daptomycin; Enterococcus faecium; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2018 |
High-Dose Daptomycin Is Effective as an Antibiotic Lock Therapy in a Rabbit Model of Staphylococcus epidermidis Catheter-Related Infection.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Biofilms; Catheter-Related Infections; Daptomycin; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2018 |
Daptomycin treatment in patients with resistant staphylococcal periprosthetic joint infection.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Prosthesis-Related Infections; Retrospective Studies; Staphylococcal Infections; Treatment Failure; Treatment Outcome; Vancomycin | 2017 |
Comparative analysis of neutropenia in patients receiving prolonged treatment with ceftaroline.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefazolin; Ceftaroline; Cephalosporins; Daptomycin; Female; Humans; Incidence; Leukocyte Count; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Neutropenia; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2018 |
Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Cell Survival; Daptomycin; Drug Resistance, Bacterial; Glycopeptides; HEK293 Cells; Hep G2 Cells; Humans; Male; Membrane Proteins; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Microbial Viability; Staphylococcus aureus; Vancomycin | 2018 |
Genetic Basis of Emerging Vancomycin, Linezolid, and Daptomycin Heteroresistance in a Case of Persistent Enterococcus faecium Bacteremia.
Topics: Aged; Bacteremia; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterococcus faecium; Humans; Linezolid; Male; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance | 2018 |
Cellular Pharmacokinetics and Intracellular Activity of Gepotidacin against Staphylococcus aureus Isolates with Different Resistance Phenotypes in Models of Cultured Phagocytic Cells.
Topics: Acenaphthenes; Anti-Bacterial Agents; Azithromycin; Cell Line; Daptomycin; Heterocyclic Compounds, 3-Ring; Humans; Linezolid; Macrolides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Oxacillin; Phagocytes; Staphylococcus aureus; THP-1 Cells; Vancomycin | 2018 |
Comparison of risk factors and outcomes of daptomycin-susceptible and -nonsusceptible vancomycin-resistant Enterococcus faecium infections in liver transplant recipients.
Topics: Adult; Aged; Anti-Bacterial Agents; Daptomycin; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Liver; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin-Resistant Enterococci | 2018 |
1,2,4-Oxadiazole antimicrobials act synergistically with daptomycin and display rapid kill kinetics against MDR Enterococcus faecium.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Enterococcus faecalis; Enterococcus faecium; Erythrocytes; Gram-Positive Bacterial Infections; Hemolysis; Humans; Kinetics; Microbial Sensitivity Tests; Oxadiazoles; Staphylococcus aureus; Vancomycin; Vancomycin-Resistant Enterococci | 2018 |
Unexpected synergistic and antagonistic antibiotic activity against Staphylococcus biofilms.
Topics: Anti-Bacterial Agents; Biofilms; Daptomycin; Drug Antagonism; Drug Synergism; Gentamicins; Humans; Joint Prosthesis; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcus; Vancomycin | 2018 |
Vancomycin and daptomycin minimum inhibitory concentrations as a predictor of outcome of methicillin-resistant Staphylococcus aureus bacteraemia.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Daptomycin; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Spain; Staphylococcal Infections; Treatment Failure; Treatment Outcome; Vancomycin | 2018 |
ANTI-ADHESIVE AND ANTI-BIOFILM ACTIVITIES IN VITRO OF LINEZOLID, VANCOMYCIN, TIGECYCLINE AND DAPTOMYCIN AGAINST STAPHYLOCOCCUS HAEMOLYTICUS.
Topics: Adhesiveness; Anti-Bacterial Agents; Biofilms; Catheters; Daptomycin; Drug Resistance, Multiple, Bacterial; Linezolid; Microbial Sensitivity Tests; Minocycline; Staphylococcus haemolyticus; Tigecycline; Vancomycin | 2016 |
In vitro activity of tedizolid and comparator agents against clinical Gram-positive isolates recovered from patients with cancer.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Microbial Viability; Oxazolidinones; Tetrazoles; Vancomycin | 2018 |
Daptomycin and vancomycin heteroresistance revealed among CC5-SCCmecII MRSA clone and in vitro evaluation of treatment alternatives.
Topics: Bacterial Proteins; Bacteriolysis; Brazil; Cell Wall; Daptomycin; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Multilocus Sequence Typing; Oxazolidinones; Polymorphism, Single Nucleotide; Staphylococcal Infections; Tetrazoles; Vancomycin | 2018 |
Emergence of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Clinical Isolates Among Daptomycin-Naive Patients in Korea.
Topics: Anti-Bacterial Agents; Cell Wall; Daptomycin; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phenotype; Republic of Korea; Staphylococcal Infections; Vancomycin | 2018 |
A retrospective analysis of adverse events among patients receiving daptomycin versus vancomycin during outpatient parenteral antimicrobial therapy.
Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Communicable Diseases; Daptomycin; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infusions, Parenteral; Logistic Models; Male; Middle Aged; Outpatients; Retrospective Studies; Vancomycin | 2018 |
Activity of dalbavancin and comparator agents against Gram-positive cocci from clinical infections in the USA and Europe 2015-16.
Topics: Anti-Bacterial Agents; Daptomycin; Enterococcus; Enterococcus faecalis; Europe; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Teicoplanin; United States; Vancomycin; Viridans Streptococci | 2018 |
Efficacy of chimeric ectolysin P128 in drug-resistant Staphylococcus aureus bacteraemia in mice.
Topics: Animals; Anti-Infective Agents; Ascitic Fluid; Bacteremia; Bacterial Load; Bacteriolysis; Blood; Daptomycin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Mice; Mice, Inbred BALB C; Recombinant Fusion Proteins; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Treatment Outcome; Vancomycin | 2018 |
What Is the Best Treatment for Vancomycin-Resistant Enterococcal Bloodstream Infections?
Topics: Anti-Bacterial Agents; Bacteremia; Daptomycin; Enterococcus faecium; Humans; Linezolid; Vancomycin | 2018 |
Comparison of risk factors and outcomes of daptomycin-susceptible and -nonsusceptible vancomycin-resistant enterococcus faecium infections in liver transplant recipients; A reply to Lewis et al.
Topics: Daptomycin; Enterococcus faecium; Humans; Liver Transplantation; Risk Factors; Vancomycin | 2018 |
The impact of earlier intervention by an antimicrobial stewardship team for specific antimicrobials in a single weekly intervention.
Topics: Anti-Infective Agents; Antimicrobial Stewardship; Carbapenems; Daptomycin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Retrospective Studies; Teicoplanin; Time Factors; Treatment Outcome; Vancomycin | 2018 |
Case of drug reaction with eosinophilia and systemic symptoms secondary to vancomycin.
Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Daptomycin; Drug Hypersensitivity; Drug Hypersensitivity Syndrome; Eosinophilia; Exanthema; Histamine Antagonists; Humans; Male; Treatment Outcome; Vancomycin | 2018 |
Characterization of compensatory mutations associated with restoration of daptomycin-susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus and the role mprF mutations.
Topics: Amino Acid Substitution; Aminoacyltransferases; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Cell Wall; Daptomycin; Drug Resistance, Multiple, Bacterial; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Sequence Deletion; Staphylococcal Infections; Vancomycin; Whole Genome Sequencing | 2019 |
Daptomycin Resistance and Tolerance Due to Loss of Function in Staphylococcus aureus
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cell Membrane; Daptomycin; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2019 |
Comparison of risk factors and outcomes of daptomycin-susceptible and -nonsusceptible vancomycin-resistant Enterococcus faecium infections in liver transplant recipients: A reply to Jorgenson et al.
Topics: Anti-Bacterial Agents; Daptomycin; Enterococcus faecium; Humans; Liver Transplantation; Risk Factors; Vancomycin | 2019 |
Daptomycin vs. glycopeptides in the treatment of febrile neutropenia: results of the Izmir matched cohort study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Daptomycin; Febrile Neutropenia; Female; Humans; Male; Middle Aged; Non-Randomized Controlled Trials as Topic; Retrospective Studies; Teicoplanin; Treatment Outcome; Turkey; Vancomycin; Young Adult | 2019 |
Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis.
Topics: Adult; Anti-Bacterial Agents; Bacterial Typing Techniques; Daptomycin; Endocarditis; Humans; Lipoglycopeptides; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Pacemaker, Artificial; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Whole Genome Sequencing | 2018 |
Evolution of Daptomycin Resistance in Coagulase-Negative Staphylococci Involves Mutations of the Essential Two-Component Regulator WalKR.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Cross Infection; Daptomycin; Drug Resistance, Bacterial; Histidine Kinase; Humans; Microbial Sensitivity Tests; Polymorphism, Single Nucleotide; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus capitis; Staphylococcus epidermidis; Tertiary Care Centers; Vancomycin | 2019 |
Factors associated with development of nephrotoxicity in patients treated with vancomycin versus daptomycin for severe Gram-positive infections: A practice-based study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Creatinine; Daptomycin; Female; Glomerular Filtration Rate; Gram-Positive Bacterial Infections; Humans; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Retrospective Studies; Risk Factors; Vancomycin | 2019 |
Utilizing genomic analyses to investigate the first outbreak of vanA vancomycin-resistant Enterococcus in Australia with emergence of daptomycin non-susceptibility.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Australia; Bacteremia; Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; Daptomycin; Disease Outbreaks; Enterococcus faecium; Female; Genomics; Genotype; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Oncology Service, Hospital; Treatment Outcome; Vancomycin; Vancomycin-Resistant Enterococci; Whole Genome Sequencing | 2019 |
Vancomycin-Associated Acute Kidney Injury in a Large Veteran Population.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Daptomycin; Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; Risk Factors; Staphylococcal Infections; United States; United States Department of Veterans Affairs; Vancomycin; Veterans | 2019 |
Analysis of synergy between beta-lactams and anti-methicillin-resistant Staphylococcus aureus agents from the standpoint of strain characteristics and binding action.
Topics: Anti-Bacterial Agents; beta-Lactams; Daptomycin; Drug Synergism; Drug Therapy, Combination; Humans; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2019 |
Concerns About the Association Between Poor Clinical Outcomes and the Minimum Inhibitory Concentrations Determined by Etest.
Topics: Bacteremia; Daptomycin; Disk Diffusion Antimicrobial Tests; Humans; Microbial Sensitivity Tests; Vancomycin | 2019 |
Genomic characterization of inpatient evolution of MRSA resistant to daptomycin, vancomycin and ceftaroline.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Evolution, Molecular; Female; Genomics; Humans; Inpatients; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Mutation; Polymorphism, Single Nucleotide; Staphylococcal Infections; Vancomycin | 2019 |
Successful cure of daptomycin-non-susceptible, vancomycin-intermediate Staphylococcus aureus prosthetic aortic valve endocarditis directed by synergistic in vitro time-kill study.
Topics: Aged; Anti-Bacterial Agents; Aortic Valve; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Heart Valve Prosthesis; Humans; Male; Microbial Sensitivity Tests; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2019 |
Bactericidal activity of ceftaroline, vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus isolates from cancer patients.
Topics: Anti-Bacterial Agents; Bacterial Infections; Ceftaroline; Cephalosporins; Daptomycin; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Neoplasms; Staphylococcal Infections; Vancomycin | 2019 |
In vitro activity of ceftaroline in combination with other antimicrobials active against Staphylococcus spp.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Synergism; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcus; Staphylococcus aureus; Vancomycin | 2020 |
Morphological and Biological Characteristics of
Topics: Anti-Bacterial Agents; Biofilms; Culture Media, Serum-Free; Daptomycin; Drug Resistance, Multiple, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rheology; Staphylococcal Infections; Vancomycin | 2019 |
Acute kidney injury during daptomycin versus vancomycin treatment in cardiovascular critically ill patients: a propensity score matched analysis.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Cardiovascular Diseases; Critical Illness; Daptomycin; Endocarditis; Female; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Odds Ratio; Propensity Score; Retrospective Studies; Surgical Wound Infection; Vancomycin | 2019 |
Reduced vancomycin susceptibility and increased macrophage survival in Staphylococcus aureus strains sequentially isolated from a bacteraemic patient during a short course of antibiotic therapy.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Cell Wall; Daptomycin; Humans; Lysostaphin; Macrophages; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mutation; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2019 |
Treatment of tricuspid valve endocarditis with daptomycin and linezolid therapy.
Topics: Adult; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Substitution; Drug Synergism; Endocarditis, Bacterial; Female; Gentamicins; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Treatment Outcome; Tricuspid Valve; Vancomycin | 2019 |
Efficacy of Azithromycin in a Mouse Pneumonia Model against Hospital-Acquired Methicillin-Resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Bacterial Toxins; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Healthcare-Associated Pneumonia; Hemolysin Proteins; Male; Methicillin-Resistant Staphylococcus aureus; Mice, Inbred BALB C; Pneumonia, Staphylococcal; Vancomycin; Virulence Factors | 2019 |
Topics: Anti-Bacterial Agents; Daptomycin; Drug Synergism; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin; Vancomycin-Resistant Enterococci | 2019 |
Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cohort Studies; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2020 |
Topics: Anti-Bacterial Agents; Daptomycin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Imipenem; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillins; Staphylococcal Infections; Vancomycin | 2020 |
Evaluation of telavancin susceptibility in isolates of Staphylococcus aureus with reduced susceptibility to vancomycin.
Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; Drug Tolerance; Female; Humans; Lipoglycopeptides; Male; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Staphylococcus aureus; Tertiary Care Centers; Vancomycin; Young Adult | 2019 |
Effect of daptomycin and vancomycin on Staphylococcus epidermidis biofilms: An in vitro assessment using fluorescence in situ hybridization.
Topics: Anti-Bacterial Agents; Biofilms; Bioreactors; Catheters, Indwelling; Colony Count, Microbial; Daptomycin; Image Processing, Computer-Assisted; In Situ Hybridization, Fluorescence; Staphylococcus epidermidis; Vancomycin | 2019 |
More Frequent Premature Antibiotic Discontinuations and Acute Kidney Injury in the Outpatient Setting With Vancomycin Compared to Daptomycin.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anti-Bacterial Agents; Daptomycin; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Odds Ratio; Retrospective Studies; Risk Factors; Vancomycin; Young Adult | 2020 |
Understanding resistance in enterococcal infections.
Topics: Anti-Bacterial Agents; Bacteremia; Critical Illness; Daptomycin; Drug Resistance, Multiple; Endocarditis; Enterococcus faecium; Humans; Intraabdominal Infections; Linezolid; Microbial Sensitivity Tests; Tigecycline; Vancomycin | 2020 |
Effect of tolerance on the evolution of antibiotic resistance under drug combinations.
Topics: Anti-Bacterial Agents; Daptomycin; DNA-Directed RNA Polymerases; Drug Resistance, Microbial; Drug Therapy, Combination; Evolution, Molecular; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Polymorphism, Single Nucleotide; Rifampin; Staphylococcal Infections; Vancomycin | 2020 |
Pharmacodynamic comparison of different antimicrobial regimens against Staphylococcus aureus bloodstream infections with elevated vancomycin minimum inhibitory concentration.
Topics: Anti-Bacterial Agents; Bacteremia; Brazil; Ceftaroline; Cephalosporins; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Monte Carlo Method; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2020 |
Protective activity of anti-lipoteichoic acid monoclonal antibody in single or combination therapies in methicillin-resistant Staphylococcus aureus-induced murine sepsis models.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Antibodies, Monoclonal; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Humans; Linezolid; Lipopolysaccharides; Methicillin-Resistant Staphylococcus aureus; Mice; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Teichoic Acids; Vancomycin | 2020 |
Combination Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: Not Ready for Prime Time.
Topics: Bacteremia; beta-Lactams; Daptomycin; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Recurrence; Staphylococcal Infections; Treatment Failure; Vancomycin | 2020 |
Species and drug susceptibility profiles of staphylococci isolated from healthy children in Eastern Uganda.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Teicoplanin; Uganda; Vancomycin | 2020 |
Drug-Induced Kidney Disease Associated With Selected Antibiotics.
Topics: Anti-Bacterial Agents; Daptomycin; Humans; Intensive Care Units; Kidney Diseases; Methicillin-Resistant Staphylococcus aureus; Vancomycin | 2020 |
In MRSA bacteremia, adding a β-lactam to usual care did not improve a composite outcome at 90 days.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Recurrence; Staphylococcal Infections; Treatment Failure; Treatment Outcome; Vancomycin | 2020 |
Delafloxacin activity against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid.
Topics: Anti-Bacterial Agents; Daptomycin; Fluoroquinolones; Humans; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2020 |
Research into biocompatibility and cytotoxicity of daptomycin, gentamicin, vancomycin and teicoplanin antibiotics at common doses added to bone cement.
Topics: Animals; Anti-Bacterial Agents; Bone Cements; Cells, Cultured; Cytotoxicity Tests, Immunologic; Daptomycin; Dose-Response Relationship, Drug; Gentamicins; Materials Testing; Mice; Teaching Materials; Teicoplanin; Vancomycin | 2020 |
Combinations of (lipo)glycopeptides with β-lactams against MRSA: susceptibility insights.
Topics: Anti-Bacterial Agents; beta-Lactams; Daptomycin; Glycopeptides; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2020 |
Chemoenzymatic synthesis of daptomycin analogs active against daptomycin-resistant strains.
Topics: Anti-Bacterial Agents; Daptomycin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin | 2020 |
Assessment of invitrosynergy of daptomycin or vancomycin plus ceftaroline for daptomycin non-susceptible Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2020 |
Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Aminoacyltransferases; Anti-Bacterial Agents; Bacterial Proteins; Cell Wall; Daptomycin; Follow-Up Studies; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Genotype; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Phenotype; Staphylococcal Infections; Vancomycin | 2020 |
Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Bacteremia; Cross Infection; Daptomycin; Enterococcus faecium; Febrile Neutropenia; Female; Gram-Positive Bacterial Infections; Hospital Mortality; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Linezolid; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proportional Hazards Models; Retrospective Studies; Risk Factors; Sex Factors; Soft Tissue Infections; Turkey; Urinary Tract Infections; Vancomycin; Vancomycin Resistance | 2020 |
Differential effects of antibiotics on neutrophils exposed to lipoteichoic acid derived from Staphylococcus aureus.
Topics: Anti-Bacterial Agents; CD11b Antigen; Ceftaroline; Cephalosporins; Daptomycin; Humans; L-Selectin; Lipopolysaccharides; Neutrophils; Phagocytosis; Staphylococcal Infections; Staphylococcus aureus; Teichoic Acids; Vancomycin | 2020 |
Biomechanical comparison of tigecycline loaded bone cement with vancomycin and daptomycin loaded bone cements.
Topics: Anti-Bacterial Agents; Bone Cements; Comparative Effectiveness Research; Compressive Strength; Daptomycin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Humans; Outcome Assessment, Health Care; Polymethyl Methacrylate; Prosthesis-Related Infections; Research Design; Tensile Strength; Tigecycline; Vancomycin | 2020 |
Comparison of dalbavancin to standard-of-care for outpatient treatment of invasive Gram-positive infections.
Topics: Adult; Anti-Bacterial Agents; Daptomycin; Endocarditis; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Osteomyelitis; Outpatients; Retrospective Studies; Teicoplanin; Vancomycin | 2020 |
Daptomycin treatment impacts resistance in off-target populations of vancomycin-resistant Enterococcus faecium.
Topics: Adaptation, Physiological; Adult; Anti-Bacterial Agents; Cohort Studies; Daptomycin; Drug Resistance, Bacterial; Enterococcus faecium; Female; Humans; Male; Microbial Sensitivity Tests; Phylogeny; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
Comparative Effectiveness of Switching to Daptomycin Versus Remaining on Vancomycin Among Patients With Methicillin-resistant Staphylococcus aureus (MRSA) Bloodstream Infections.
Topics: Anti-Bacterial Agents; Bacteremia; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2021 |
Vancomycin-resistant Enterococcus faecium in Algeria: phenotypic and genotypic characterization of clinical isolates.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algeria; Anti-Bacterial Agents; Child; Child, Preschool; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Female; Genotype; Gram-Positive Bacterial Infections; Hospitals; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Teicoplanin; Tigecycline; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci; Virulence Factors; Young Adult | 2021 |
Combination ceftaroline and daptomycin salvage therapy for complicated methicillin-resistant Staphylococcus aureus bacteraemia compared with standard of care.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Drug Synergism; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Rifampin; Salvage Therapy; Standard of Care; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2021 |
Antibiotics Removal by Continuous Venovenous Hemofiltration with a Novel Asymmetric Triacetate Membrane Hemofilter: An in vitro Study.
Topics: Acetates; Anti-Bacterial Agents; Continuous Renal Replacement Therapy; Daptomycin; Filtration; Hemofiltration; Humans; Membranes, Artificial; Meropenem; Vancomycin | 2021 |
Probable Immortal Time Bias in Comparison of Daptomycin and Vancomycin for Methicillin-resistant Staphylococcus Aureus Bloodstream Infections.
Topics: Bacteremia; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2021 |
Early Switch From Vancomycin to Daptomycin in Methicillin-Resistant Staphylococcus aureus Bacteremia: Still More Questions Than Answers.
Topics: Bacteremia; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2021 |
Comparison of linezolid step-down therapy to standard parenteral therapy in methicillin-resistant Staphylococcus aureus bloodstream infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Daptomycin; Drug Administration Routes; Female; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; Sepsis; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2021 |
Effectiveness of vancomycin plus cloxacillin compared with vancomycin, cloxacillin and daptomycin single therapies in the treatment of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in a rabbit model of experimental endocarditis.
Topics: Animals; Anti-Bacterial Agents; Cloxacillin; Daptomycin; Endocarditis; Endocarditis, Bacterial; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rabbits; Staphylococcus aureus; Vancomycin | 2021 |
Daptomycin versus teicoplanin in the treatment of osteomyelitis: Results of the Göztepe retrospective cohort study.
Topics: Adult; Aged; Anti-Bacterial Agents; Cohort Studies; Daptomycin; Drug Resistance, Multiple, Bacterial; Female; Glycopeptides; Humans; Male; Middle Aged; Osteomyelitis; Retrospective Studies; Teicoplanin; Treatment Outcome; Turkey; Vancomycin | 2021 |
Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: Results from the 2019-2020 Nationwide Surveillance of Multicenter Antimicrobial Resist
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Resistance, Bacterial; Enterococcus faecium; Epidemiological Monitoring; Gram-Positive Bacterial Infections; Humans; Linezolid; Lipoglycopeptides; Microbial Sensitivity Tests; Oxazolidinones; Taiwan; Tetracyclines; Tetrazoles; Tigecycline; Vancomycin; Vancomycin-Resistant Enterococci; Virginiamycin | 2021 |
Optimization of dosing regimens of vancomycin, teicoplanin, linezolid and daptomycin against methicillin-resistant
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Body Weight; Chemotherapy-Induced Febrile Neutropenia; Creatinine; Daptomycin; Dose-Response Relationship, Drug; Female; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Staphylococcal Infections; Teicoplanin; Vancomycin | 2021 |
Daptomycin in combination with rosuvastatin induced blood creatine phosphokinase elevation.
Topics: Aged; Anti-Bacterial Agents; Creatine Kinase; Daptomycin; Humans; Male; Rosuvastatin Calcium; Vancomycin | 2021 |
Efficacy assessment of lysin CF-296 in addition to daptomycin or vancomycin against Staphylococcus aureus in the murine thigh infection model.
Topics: Animals; Anti-Bacterial Agents; Daptomycin; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Thigh; Vancomycin | 2021 |
Accuracy of gradient diffusion method for susceptibility testing of dalbavancin and comparators.
Topics: Anti-Bacterial Agents; Daptomycin; Humans; Microbial Sensitivity Tests; Retrospective Studies; Teicoplanin; Vancomycin | 2022 |
Exploratory Cost-Effectiveness Analysis for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: Is Linezolid or Daptomycin Favored Over Vancomycin?
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Sepsis; Staphylococcal Infections; Vancomycin | 2021 |
Vertebral osteomyelitis caused by vancomycin-resistant Enterococcus spp.: a case series.
Topics: Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Daptomycin; Discitis; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Female; Gentamicins; Humans; Italy; Linezolid; Male; Middle Aged; Osteomyelitis; Retrospective Studies; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci; Young Adult | 2021 |
Vancomycin and daptomycin stability in heparin or sodium citrate lock solutions.
Topics: Anti-Bacterial Agents; Citrates; Daptomycin; Heparin; Humans; Sodium Citrate; Vancomycin | 2023 |
Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective.
Topics: Anti-Bacterial Agents; Daptomycin; Floxacillin; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Quality of Life; State Medicine; Teicoplanin; Vancomycin | 2022 |
Influence of daptomycin dose and fosfomycin susceptibility on outcome of vancomycin-resistant Enterococcus faecium bloodstream infections treated with daptomycin and fosfomycin combination.
Topics: Anti-Bacterial Agents; Bacteremia; Daptomycin; Enterococcus faecium; Fosfomycin; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Monobactams; Prospective Studies; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Daptomycin susceptibility testing and therapeutic use in enterococcal bloodstream infection (EBSI) in a setting with high rates of vancomycin-resistant Enterococcus faecium (VREfm).
Topics: Anti-Bacterial Agents; Daptomycin; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Sepsis; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Emergence of Dalbavancin, Vancomycin, and Daptomycin Nonsusceptible Staphylococcus aureus in a Patient Treated With Dalbavancin: Case Report and Isolate Characterization.
Topics: Anti-Bacterial Agents; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2022 |
Unravelling the physiological roles of mazEF toxin-antitoxin system on clinical MRSA strain by CRISPR RNA-guided cytidine deaminase.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Cytidine Deaminase; Daptomycin; Methicillin-Resistant Staphylococcus aureus; Mice; Oxacillin; RNA; Toxin-Antitoxin Systems; Vancomycin | 2022 |
Evaluation of the synergistic effect of ceftaroline against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2022 |
Activity of Tedizolid and Comparator Agents Against Gram-positive Isolates Causing Skin and Skin Structure Infections in Pediatric Patients in United States Hospitals (2015-2019).
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Daptomycin; Hospitals; Humans; Infant; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Tetrazoles; United States; Vancomycin | 2022 |
Comparing the pharmacokinetics and organ/tissue distribution of anti-methicillin-resistant
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Rats; Sepsis; Tissue Distribution; Vancomycin | 2022 |
Rapid in vivo development of resistance to daptomycin in vancomycin-resistant Enterococcus faecium due to genomic alterations.
Topics: Anti-Bacterial Agents; Cross Infection; Daptomycin; Enterococcus faecium; Genomics; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Clinical and microbiological characteristics of bacterial meningitis in umbilical cord blood transplantation recipients.
Topics: Anti-Bacterial Agents; Cord Blood Stem Cell Transplantation; Daptomycin; Gram-Positive Bacterial Infections; Humans; Meningitis, Bacterial; Microbial Sensitivity Tests; Vancomycin | 2022 |
Ion Exchange Biomaterials to Capture Daptomycin and Prevent Resistance Evolution in Off-Target Bacterial Populations.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Biocompatible Materials; Cholestyramine Resin; Daptomycin; Drug Resistance, Bacterial; Electrolytes; Ion Exchange; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Vancomycin | 2022 |
The systemic immune response due to cholesterol crystal embolization syndrome: a case report.
Topics: Aged; Cholesterol; Daptomycin; Embolism, Cholesterol; Humans; Immunity; Male; Methicillin-Resistant Staphylococcus aureus; Nephritis, Interstitial; Vancomycin | 2022 |
Daptomycin area under the curve to minimum inhibitory concentration ratio by broth microdilution for predicting the outcome of vancomycin-resistant Enterococcus bloodstream infection.
Topics: Anti-Bacterial Agents; Bacteremia; Daptomycin; Enterococcus; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Retrospective Studies; Vancomycin | 2022 |
Vancomycin versus daptomycin for the treatment of confirmed gram-positive catheter-related bloodstream infections in oncology patients.
Topics: Anti-Bacterial Agents; Bacteremia; Catheters; Daptomycin; Humans; Medical Oncology; Neoplasms; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2022 |
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Catheter-Related Infections; Daptomycin; Hypochlorous Acid; Microbial Sensitivity Tests; Rabbits; Saccharomyces cerevisiae; Saline Solution; Staphylococcus epidermidis; Vancomycin | 2022 |
Computing antimicrobial use/antimicrobial resistance ratios: A novel way to assess inpatient antimicrobial utilization using current National Healthcare Safety Network metrics.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Benchmarking; Carbapenems; COVID-19 Drug Treatment; Daptomycin; Delivery of Health Care; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Inpatients; Linezolid; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Retrospective Studies; Vancomycin | 2022 |
The combination of daptomycin with β-lactam antibiotics is more effective than daptomycin alone for vancomycin-resistant Enterococcus faecium bloodstream infection.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Daptomycin; Enterococcus faecium; Humans; Microbial Sensitivity Tests; Monobactams; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Vancomycin heteroresistance among methicillin-resistant clinical isolates S. haemolyticus, S. hominis, S. simulans, and S. warneri.
Topics: Anti-Bacterial Agents; Coagulase; Daptomycin; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus; Teicoplanin; Vancomycin | 2023 |
In vitro activity of fosfomycin alone and in combination against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid.
Topics: Anti-Bacterial Agents; Cefazolin; Ceftaroline; Daptomycin; Fosfomycin; Humans; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2022 |
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Catheter-Related Infections; Central Venous Catheters; Coagulase; Daptomycin; Humans; Staphylococcus; Teicoplanin; Vancomycin | 2023 |
Effect of Antibiotic Exposure on
Topics: Anti-Bacterial Agents; Bacteremia; Biofilms; Catheters; Daptomycin; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2023 |
Risk factors for mortality after linezolid treatment of vancomycin-resistant Enterococcus bloodstream infection.
Topics: Anti-Bacterial Agents; Bacteremia; Daptomycin; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Risk Factors; Vancomycin; Vancomycin-Resistant Enterococci | 2023 |
[Adverse drug reactions to multiple antibiotics].
Topics: Anti-Bacterial Agents; Daptomycin; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2023 |
Anionic polysaccharides for stabilization and sustained release of antimicrobial peptides.
Topics: Antimicrobial Peptides; Daptomycin; Delayed-Action Preparations; Hydrogels; Polysaccharides; Vancomycin | 2023 |
Effects of Antibacterial Agents on Cancerous Cell Proliferation.
Topics: Anti-Bacterial Agents; Cell Proliferation; Daptomycin; Humans; Linezolid; Male; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Vancomycin | 2023 |
Eradication of Staphylococcus epidermidis within Biofilms: Comparison of Systemic versus Supratherapeutic Concentrations of Antibiotics.
Topics: Anti-Bacterial Agents; Biofilms; Daptomycin; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Rifampin; Staphylococcus epidermidis; Vancomycin | 2023 |
A Clinically Selected Staphylococcus aureus
Topics: Anti-Bacterial Agents; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2023 |
Optimization of Phage-Antibiotic Combinations against Staphylococcus aureus Biofilms.
Topics: Anti-Bacterial Agents; Bacteriophages; Biofilms; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2023 |
Usefulness of daptomycin lock therapy in children with catheter-related bacteremia after failed vancomycin lock therapy.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Catheters; Daptomycin; Vancomycin | 2023 |
Bleeding Complications in Vancomycin-Induced Thrombocytopenia: A Real-world Postmarketing Pharmacovigilance Analysis.
Topics: Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Pharmacovigilance; Teicoplanin; Thrombocytopenia; Tigecycline; Vancomycin | 2023 |
Vancomycin and daptomycin dosing recommendations in patients receiving home hemodialysis using Monte Carlo simulation.
Topics: Anti-Bacterial Agents; Daptomycin; Dialysis Solutions; Hemodialysis, Home; Humans; Monte Carlo Method; Vancomycin | 2023 |
Quinoline-2-one derivatives as promising antibacterial agents against multidrug-resistant Gram-positive bacterial strains.
Topics: Anti-Bacterial Agents; Daptomycin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Quinolines; Vancomycin | 2023 |